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Chapter 1 
Recent advances in the catalytic 
asymmetric synthesis of -amino acids 
 
This chapter describes the progress in catalytic asymmetric synthesis of -amino acids 
covering the literature since 2002. The chapter is structured into three parts: 1) 
transition metal catalysis, 2) organocatalysis and 3) biocatalysis. The respective 
paragraphs are subdivided into the most important synthetic methods, such as 




















-Amino acids are key structural elements of peptides, peptidomimetics and other 
natural products.1 In addition, they are essential chiral building blocks for the synthesis 
of pharmaceuticals.1 Furthermore, -amino acids are presursors for -lactams which are 
potentially biologically active and of interest as antibiotics.2 Some -amino acids show 
interesting pharmacological properties by themselves, but most are valuable 
intermediates in routes to novel molecules with biological and pharmacological activity. 
-Peptides have secondary structures comparable to their -amino acid analogues.3 -
Amino acids are subdivided into 2-, 3- and 2,3-amino acids depending on the position 
of the side chain at the 3-aminocarboxylic acid core (figure 1.1).4 Additionally, cyclic 
amino acids have the amino and ester moiety as substituents or the amino group is 















Figure 1.1. General structure of -amino acids. 
Until recently, methods for the synthesis of -amino acids relied predominantly on 
classical resolution, stoichiometric use of chiral auxiliaries or homologation of -amino 
acids. Much of the work related to asymmetric synthesis of -amino acids before 2002 
has been reviewed by Sibi,6 and summarized in the book Enantioselective synthesis of -
amino acids edited by Juaristi and Soloshonok in 20057,8. Seebach and coworkers 
described recently the preparation of 2-amino acids for -peptide synthesis.9 Therefore, 
this chapter is focussed on catalytic asymmetric synthesis using transition metals, 
organocatalyst and biocatalysts covering the literature since 2002. Methods using chiral 
auxiliaries and kinetic resolution (biocatalysis) are not discussed herein. 
1.2 Transition metal catalysis 
Various transition metals and chiral ligands have been used for the synthesis of -amino 
acids. The most frequently employed methods are catalytic asymmetric hydrogenation, 
conjugate addition of carbon- and nitrogen nucleophiles to ,-unsaturated systems and 
the Mannich reaction.  
1.2.1 Hydrogenation 
The enantioselective hydrogenation of -substituted--(amino)acrylates has been 
extensively discussed (scheme 1.01).10 Therefore, this part concerning catalytic 
asymmetric hydrogenation is kept relatively brief, focussing on key contributions since 
2002. The geometrical isomers of the -(amino)-acrylates show different reactivity and 
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selectivity in metal-catalyzed hydrogenations: (E)-isomers generally lead to higher 
enantioselectivities, and (Z)-isomers frequently react faster, although the 














Scheme 1.01. Rhodium catalyzed hydrogenation of (E)-and (Z)--dehydroamino acid derivatives. 
The first example of an asymmetric hydrogenation of N-acyl--(amino)acrylates was 
published in 1991 by Noyori and coworkers using Ru(O2CCH3)2 and (R)-Binap, 
providing >90% ee.11 Their advances in Ru- and Rh-catalyzed homogeneous 
hydrogenations have since then become a standard procedure for the synthesis of -
amino acids, using a variety of chiral bidentate and monodentate phosphorous ligands.10-
12 An important breakthrough by Hsiao and coworkers was the use of chiral 
ferrocenylphosphine ligand 1.003 in the hydrogenation of (Z)-enamine esters with an 
unprotected amine group in trifluoroethanol (TFE) as solvent to yield the corresponding 
amino esters with excellent ee (up to 97%) (scheme 1.02).13 This represents the first 
example of a high yielding enantioselective hydrogenation of unprotected -enamine 


















82-97% ee  
Scheme 1.02. Rhodium-ferrocenylphosphine catalyzed hydrogenation of unprotected enamines. 
TangPhos 1.006 was employed in the synthesis of N-aryl--amino acids by Zhang and 
coworkers.14 Starting from (Z)-enamines, the products were obtained with up to 96% ee 





















Scheme 1.03. Rhodium-Tangphos catalyzed hydrogenation of (Z)-enamines. 
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The Rh-catalyzed enantioselective hydrogenation of (E)- and (Z)--acylamino acrylates 
using BDPMI 1.009 gave under mild conditions ee’s of 97% and 92%, respectively 




















Scheme 1.04. Rhodium-BDPMI catalyzed hydrogenation of (Z)-enamines. 
Börner and coworkers used 1,3-diphenyl-1,3-bis(diphenylphosphino)propane 1.010 in 
the hydrogenation of (E)-enamines to give 3-amino esters with up to 97% ee (scheme 
1.05).16,17 (Z)-Enamines as substrates lead to significantly lower enantioselectivities (ee 


















Scheme 1.05. Rhodium-diphenylphosphino-propane catalyzed hydrogenation of (E)-enamines. 
MalPhos 1.014 catalyzed the hydrogenation of (E)-enamines with 99% ee and of the 
corresponding (Z)-enamines with up to 90% ee (scheme 1.06).18 Me-DuPhos 1.015 gave 
also high ee with these (E)-enamines, but the ee in the hydrogenation of (Z)-enamines 











1.014 or 1.015 (1.0 mol%)
THF or MeOH, 
1 atm H21.011
1.012    (E)-   79-99% ee                          
             (Z)-   57-90 % ee                         
1.013    (E)-   92-99% ee








Scheme 1.06. Rhodium catalyzed hydrogenation of (E)- and (Z)-enamines with MalPhos and Me-DuPhos. 
Zhang and coworkers synthesized bisphosphepine ligand 1.018, that catalyzes the 
hydrogenation of (Z)-enamines with very high enantioselectivity (ee >99%) (scheme 
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1.07).19 On the contrary, (E)-enamines give only low enantioselectivity (ee 32%) using 




















Scheme 1.07. Rhodium-bisphosphepine catalyzed hydrogenation of (Z)-enamines using bisphosphepine lignds. 
Using (S)-C3-TunaPhos 1.021 as ligand in a ruthenium catalyzed reaction, Zhang and 
coworkers synthesized cispentacin with excellent ee (up to 99%) (scheme 1.08).20 In the 
same reaction, TangPhos 1.006 and Me-DuPhos 1.015 gave cispentacin derivative 1.020 








1.021  8 examples
             44-99% ee
1.006  1 example
             57% ee









Scheme 1.08. Ru-catalyzed hydrogenation towards cyclic -amino acids. 
Monodentate ligands such as phosphites and other phosphorous ligands can also result in 
high enantioselectivities in Rh-catalyzed hydrogenations.21 Phosphite-based ligands with 
a carbohydrate moiety have been applied in the Rh-catalyzed homogeneous 
hydrogenation. 2-Amino acid derivatives are formed with up to 99% ee when 
phthalimide protected acrylates are hydrogenated using carbohydrate-phosphite 1.024 






























Scheme 1.09. Rh-catalyzed hydrogenation of phthalimide protected acrylates. 
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Several phosphite ligands were screened for the hydrogenation of 1.028 identifying 
1.030 as optimal ligand (scheme 1.10). Hydrogenation of (E)-enamines with ligand 
1.030 gave the products 1.029 with up to 93% ee, but the corresponding (Z)-enamines 







10-30 atm H21.028 1.029
(E)-    4 examples
          65-92% conversion
          93-98% ee
(Z)-    8 example
          6-96% conversion












Scheme 1.10. Rh-phosphite catalyzed hydrogenation of acrylates. 
The use of monodentate phosphoramidite ligands in the rhodium-catalyzed 
hydrogenation of (E)/(Z)--dehydroamino acids has been described by Feringa, 
Minnaard, de Vries and coworkers (scheme 1.11).10,24 Ligand 1.031 leads to -amino 
acid precursors with excellent enantioselectivities for (E)-substrates, while a slight 
modification in the amine backbone of the ligand leads to very good enantioselectivities 






1.031 or 1.032 (2.0 mol%)
CH2Cl2 or i-PrOH,
1-25 bar H21.028 1.029
1.031   (E)-    4 examples 
                        100% conversion
                        98-99% ee  
1.032   (Z)-    6 examples
                        100% conversion













Scheme 1.11. Rh-phosphoramidite catalyzed hydrogenation of (E)- and (Z)-enamines. 
The mixed ligand approach has been employed in the hydrogenation catalyzed by 
rhodium-phosphoramidite complexes in order to further enhance the enantioselectivity 
(scheme 1.12).10,24,25 Hereby, three different catalysts are in equilibrium with one 
another, namely the two homo-complexes Rh-LALA and Rh-LBLB and the hetero 
combination LALB. Enhanced enantioselectivities are observed when Rh-LALB is more 
active and more selective than each of the hetero combinations.26 Chiral 
phosphoramidite 1.035 in combination with achiral tris-o-tolyl-phosphine was used for 
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Scheme 1.12. Mixed ligand approach towards -amino acids. 
Furthermore, the combination of Ir(I) and phosphoramidite ligand 1.036 has been used 
by Beller and coworkers in the hydrogenation of (E)- and (Z)-N-(acylamino)acrylates, 
















(E)-    10 examples
          49-99% conversion
          6-94% ee 
(Z)-    11 examples
          10-99% conversion





Scheme 1.13. Ir-phosphoramidite catalyzed asymmetric hydrogenation. 
As demonstrated previously10 and discussed in the preceeding paragraphs, the 
hydrogenation of -dehydroamino acids represents an important tool for the synthesis of 
-amino acids. High enantioselectivities have been achieved starting from both (E)- or 
(Z)-enamines.  
1.2.2 Mannich reaction 
The Mannich reaction is an important C-C-bond forming reaction involving the addition 
of metal enolates of carbonyl compounds to imines.28,29 The versatility and potential of 
the Mannich reaction to form -amino carbonyl compounds has made it an important 
method to synthesize -amino acids. Recently, several successful examples of catalytic 
asymmetric Mannich reactions have been developed.28 Earlier work relied on the 
stoichiometric use of chiral auxiliaries.  
Sodeoka and coworkes published in 2005 the addition of -ketoesters to various imines 
catalyzed by a chiral cationic palladium complex (scheme 1.14).30 The catalysts derived 
from SegPhos 1.040 and Binap 1.041 were investigated. Two stereogenic centers are 
created in this reaction; high diastereomeric ratios (up to 95:5) are obtained, along with 
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excellent ee’s (up to 99%). Next to the p-methoxyphenyl (PMP) protecting group, Boc 
and tosyl protecting groups for the imine could be employed. Moreover, the three 
component coupling, using p-anisidine, -aldehyde esters and cyclic -keto esters, gave 









































Scheme 1.14. Pd-catalyzed addition of -ketoesters to -imino esters. 
Diethylzinc and bridged-Binol 1.046 form in situ the active catalyst that has been used 
by Shibasaki and coworkers in the anti-selective Mannich reaction of hydroxyketone 
1.043 with N-Dpp imines 1.042 (scheme 1.15).31 The anti-Mannich products 1.044 are 
obtained with high diastereomeric ratio and high enantiomeric excess from imines with 
aromatic, heteroaromatic and cyclopropyl-groups. The -amino ketone was transformed 
into the corresponding -amino ester by Baeyer-Villiger oxidation.  
 







































R = 4-MeC6H4 74%
H
 
Scheme 1.15. Zn-catalyzed addition of hydroxyketones to imines. 
Shibasaki and coworkers also used the bridged-binol complex 1.046 with In(III) that 
catalyzes the addition of N-(2-hydroxyacetyl)pyrrole 1.048 to various imines 1.047 
(scheme 1.16).32 The diastereomeric ratio depends on the imine used. In general, the syn-
adducts were obtained with good dr and high ee with alkenyl and phenyl substituted 
imines and the anti-adducts with a moderate diastereomeric ratio and high enantiomeric 
excess using o-aryl-substituted imines. The N-acyl-pyrrole group was transformed under 





















(syn/anti) 59:41 - 91:9 dr
6 examples, 70-87%















Scheme 1.16. In-catalyzed addition of N-(2-hydroxyacetyl)pyrrole to imines. 
Moreover, La(III)-iPr-pybox 1.055 was studied by Shibasaki and coworkers in the direct 
asymmetric Mannich reaction of trichloromethyl ketones 1.052 and pyridyl- or 
thienylsulfonyl-protected imines 1.051 (scheme 1.17).33 The syn-isomers were 
preferentially formed with high ee (>99%) using the thienylsulfonyl protecting group. 
Aliphatic, aromatic and heteroaromatic imines were employed as substrates. The product 
1.053 was transformed into the N-Boc-protected 2-amino ester 1.054 using 














































Scheme 1.17. La-catalyzed addition of trichloromethyl ketones to imines. 
The same group investigated the homonuclear Ni2-Schiff base complex 1.060 for the 
synthesis of tetrasubstituted anti-,-diamino acids (scheme 1.18).34 Boc-protected 
aromatic and aliphatic imines 1.056 gave with nitro-acetate 1.057 the corresponding 
adducts 1.058 with high dr’s (up to 97:3) and high ee’s (up to 99%). Using 
NaBH4/NiCl2, the nitro group was reduced to give the ,-diamino ester 1.059. 





































R = Ph 94%
H
 
Scheme 1.18. Ni-catalyzed addition of nitroacetate to imines. 
The Jørgensen group developed Cu-phosphino-oxazoline complex 1.064 that catalyzes 
the asymmetric Mannich reaction of glycine derivatives 1.061 and imines 1.062 (scheme 
1.19).35 Preferentially, syn-adducts were formed with high diastereomeric- and 
enantiomeric excess using aromatic and aliphatic imines as substrates. The highest 
selectivities in the synthesis of the ,-diamino ester derivatives 1.063 were obtained 






























Scheme 1.19. Cu-catalyzed addition of glycine derivatives to imines. 
Furthermore, the group of Kobayashi investigated copper salts in the direct three-
component Mannich reaction producing protected ,-diamino esters using Me-Duphos 
1.015 as ligand (scheme 1.20).36 Simple aromatic and enolizable aliphatic aldehydes 
1.065, secondary amines 1.066 and glycine derivatives 1.061 are used as starting 
materials in this reaction. (R,R)-Me-Duphos leads to a 1:1 mixture of syn/anti 




























Scheme 1.20. Cu-catalyzed three-component Mannich reaction of a glycine derivative, aldehyde and amine. 
In the asymmetric Mannich type reaction of N-acylimino esters 1.068 and silyl enol 
ethers 1.069, Kobayashi and coworkers have studied copper-diamine complexes 1.071 as 
catalysts (scheme 1.21).37 The Mannich adducts were obtained in high yields with high 
ee’s. In the reactions of -substituted silyl enol ethers (X = -methyl or benzyloxy), the 
desired syn-adducts were obtained again with high enantio- and diastereomeric excess. 
When CuClO4-(S)-xylyl-Binap was used as a catalyst system in the addition of tert-
butylthio-trimethylsiloxy-propene and N-benzoylimino esters, the syn-adduct was 
obtained with high diastereo- and enantioselectivity starting from (Z)-enolates, and the 





























Scheme 1.21. Cu-catalyzed addition of silylenol ethers to N-acylimino esters. 
The same group studied also the iron(II)-complex of 3,3’-I2Binol complex 1.075 in the 
asymmetric Mannich-reaction (scheme 1.22).38 The reaction of -dimethyl silyl 
enolethers 1.073 with protected aromatic imines 1.072 provided the adducts 1.074 with 
good ee’s (up to 84%).  




























Scheme 1.22. Fe-catalyzed addition of silylenol ethers to aromatic imines. 
Kobayashi and coworkers also used chiral catalysts based on Binol and Zr(IV) in the 
Mannich reaction.39 In the synthesis of -methyl--amino acid derivatives by 
condensation of (E)-silyl ketene acetals 1.078 with aldimines, the chiral zirconium 
catalyst 1.079 prepared from Zr(OtBu)4, 6,6’-dipentafluoroethyl-1,1’-bi-2-naphthol and 
N-methylimidazole (NMI) was used (scheme 1.23a).39a,40 Aromatic and aliphatic imines 
were employed as substrates, giving the anti-adducts in good yields with high diastereo- 
and enantiomeric excess. The products were transformed into -methyl--amino esters 
by transesterification of the Mannich adduct followed by deprotection of the amino 
group via a sequence involving methylation of the phenolic OH-group and deprotection 
using AgNO3 in the presence of excess (NH4)2S2O8. This chiral air-stable zirconium 
catalyst as a mixture with powdered moleculars sieves (ZrMS-1.079) could be stored for 
53 d under air without loss of activity, and be recycled for a second catalytic cycle.39b 
The enantioselectivity was enhanced in the presence of molecular sieves; from the (E)-
silyl enolether 1.078 the syn-adduct is formed, while from the (Z)-silyl enolether the 




































































Scheme 1.23. Zr-catalyzed addition of silylenol ethers to imines. 
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Further optimization studies identified bridged-bis-Binol 1.080 and ligand 1.081 as the 
best ligands, but the enantioselectivity could not be further increased (scheme 1.23b).39c 
When they were applied in the Zr-catalyzed reactions, the Mannich adducts 1.076 of 
various aromatic imines were provided in high yield with up to 94% ee.  
In conclusion, chiral Lewis acids are useful catalysts for the asymmetric Mannich 
reaction to produce -amino acid derivatives. Many combinations of metals, such as 
Cu(I), Cu(II), Fe(II), In(III), La(III), Ni(II), Zr(IV), and various ligands as source of the 
chiral information have been developed. The Mannich reactions discussed here (see also 
paragraph 1.3.1 for organocatalysts) represent highly stereoselective and frequently 
atom-economic methods for the synthesis of chiral 2- and 2,3-amino acid derivatives 
and diamino acids. 
1.2.3 Conjugate addition 
The catalytic asymmetric conjugate addition when applied in the synthesis of -amino 
acids can be achieved in two ways: 1) addition of carbon nucleophiles, such as 
organometallic reagents, cyanide or Michael donors, and 2) nitrogen nucleophiles, such 
as aromatic amines, hydroxylamines, and carbamates.41  
1.2.3.1 Carbon nucleophiles 
The conjugate addition of carbon nucleophiles to ,-unsaturated compounds is an 
important C-C-bond formation reaction.42 This transformation shows a broad scope due 
to the large variety of acceptors (,-unsaturated aldehydes, esters, ketones, 
phosphonates, sulfones, thioesters and nitroalkenes) and nucleophiles (organometallic 
reagents, Michael donors, other carbanions).43 In particular, nitro-olefins are versatile 
acceptors for the synthesis of -amino acids. 
Organozinc species have been successfully applied in copper-catalyzed 1,4-additions to 
form chiral -substituted esters and enones. The use of phosphoramidite ligands derived 
from 2,2’-binaphthol resulted in a breakthrough providing catalysts thats show high 
activity and excellent chemo- and regio-selectivity. The groups of Sewald44, Wendisch45 
and Feringa46 have successfully used 3-nitropropenoates or acetal substituted 
nitropropenoates as acceptors and bisalkyl zinc reagents as nucleophiles to synthesize -
amino acid precursors.47 In 2002, Sewald and coworkers reported the addition of diethyl 
zinc to methyl-3-nitropropenoate 1.082 catalyzed by a Cu-phosphoramidite 1.085 
complex (scheme 1.24a).44 Adduct 1.083 was obtained with 92% ee, and the nitro group 
could easily be reduced by catalytic transfer hydrogenation using ammonium formate. 
The amino group was N-Boc protected and subsequent ester hydrolysis gave N-Boc-2-
amino acid 1.084. 
 





















































Scheme 1.24. Cu-catalyzed addition of diethyl zinc to a nitro-olefin. 
Around the same time, Wendisch and coworkers reported the addition of bisalkyl zinc 
reagents to nitropropenoate 1.082 using phosphoramidite 1.087 as chiral ligand (scheme 
1.24b).45 In MeOtBu as solvent, the adduct was obtained in high yield with up to 85% ee 
using diethyl zinc as nucleophile. Furthermore, phosphoramidite 1.087 was employed in 
the Michael addition of trimethyl aluminium to nitroolefin 1.082 (scheme 1.25).48 At low 














74-92% ee  
Scheme 1.25. Cu-catalyzed addition of trimethyl aluminium to a nitro-olefin. 
Excellent enantioselectivities (up to 98%) were obtained by Feringa and coworkers in 
the addition of dialkyl zinc reagents to acetal-substituted nitropropenoates (scheme 
1.26).46 The adducts of Et2Zn, Me2Zn and Bu2Zn were obtained with high yields and 
high ee’s. The corresponding N-Boc protected 2-amino acids were formed via Raney-
Nickel reduction of the nitroalkane, followed by Boc-protection of the amine group and 
































Scheme 1.26. Cu-catalyzed addition of dialkyl zinc reagents to acetal-substituted nitropropenoates. 
Recently, carboxylic acid derivatives that have all carbon quaternary stereocenters have 
been synthesized through copper catalyzed asymmetric conjugate addition of dialkyl 
zinc reagents to 2-aryl acrylates 1.092 (scheme 1.27).49 Fillion and coworkers tested 
phosphoramidite ligand 1.087 to obtain the adducts in high yields with up to 94% ee. -
Amino acid derivative 1.094 was synthesized through deprotection of adduct 1.093, 






























Ar=Ph, R=Et, X=Me 62%
 
Scheme 1.27. Cu-catalyzed addition of dialkyl zinc reagents to 2-aryl-acrylates to form quaternary 
stereocenters. 
Trost and coworkers reported a heterodinuclear asymmetric chiral catalyst 1.099 
comprising Mg and Zn and a chiral proline-derived ligand for the addition of -
hydroxyketones to -substituted nitroalkenes 1.096 (scheme 1.28).50 As substrates 
aromatic, aliphatic and alkynyl--substituted nitroalkenes and phenyl- and furyl-
hydroxyketones were employed leading to up to 92% ee and good diastereoselectivities 
in favor of the anti-products. Reduction of the nitro group and of the ketone to the 
corresponding amino-diol, followed by Boc-protection and oxidative cleavage of the diol 
gave the corresponding 2-amino acid 1.098. 
 











































Scheme 1.28. Heterodinuclear catalyst for the addition of -hydroxyketones to nitroalkenes. 
An enantioselective rhodium catalyzed enolate protonation method for the synthesis of 
2-amino acids was reported by Sibi and coworkers (scheme 1.29).51 A complex 
prepared from Rh(acac)(ethylene)2 and difluoroPhos 1.102 catalyzed the conjugate 
addition of aryl boronic acids to -acrylates 1.100. Enantioselective protonation of the 
oxa--allyl-rhodium intermediate resulted in good yields with high enantioselectivitites 




























Scheme 1.29. Enantioselective rhodium catalyzed conjugate addition and protonation. 
Jacobsen and coworkers reported the enantioselective conjugate addition of cyanide to 
,-unsaturated imides using aluminium salen catalyst 1.106 (scheme 1.30).52 The 
adducts were obtained with up to 98% ee in high yields and were transformed into -
amino acids by basic hydrolysis of the imide to the corresponding carboxylic acid, 
followed by Curtius rearrangement with diphenylphosphoryl azide (dppa) and hydrolysis 











































Scheme 1.30. Al-Salen catalyzed addition of cyanide to ,-unsaturated imides. 
The addition of dialkyl zinc and aluminium reagents as well as -ketoesters to ,-
unsaturated nitro alkenes represent valuable methods to synthesize 2-amino acid 
precursors with high enantioselectivities. Some methods can also be applied in the 
construction of all carbon quaternary stereocenters. Moreover, cyanide could be used in 
the addition to ,-unsaturated imides to yield 2-amino acids after three subsequent 
transformations. Furthermore, a rhodium-catalyzed addition of aryl boronic acids 
followed by enantioselective protonation gave optically active 2-amino acid derivatives. 
1.2.3.2 Nitrogen nucleophiles 
Conjugate addition of amine nucleophiles to ,-unsaturated carboxylic acid derivatives 
is one of the most attractive and atom-economic methods for the synthesis of -amino 
acids. In the past, mostly chiral Michael acceptors or chiral amines have been used for 
diastereoselective conjugate additions.41 Recently, several groups have reported 
significant progress towards catalytic asymmetric versions of conjugate additions of 
amines.41,53  
For the enantioselective addition of primary aromatic amines to ,-unsaturated 
oxazolidinones 1.107, Hii and coworkers investigated cationic palladium-Binap complex 
1.109 (scheme 1.31a).54 Using aniline and crotonyl-oxazolidinone, the adducts were 
obtained in good yield with ee’s up to 93%. However, when the substrate incorporated 
longer aliphatic chains than methyl, i.e. ethyl and propyl, a significantly lower ee was 
observed.  
 




























































Scheme 1.31. Pd-catalyzed addition of aromatic amines to ,-unsaturated imides. 
A similar cationic palladium complex 1.112 was tested in the addition of aromatic 
amines to N-alkenoylcarbamates (scheme 1.31b).55 High enantioselectivities and high 
yields were achieved using various aliphatic substrates (R = Me, Et, Pr). The products 
were converted to N-aryl-3-amino acids by hydrolysis of the imide under basic 
conditions. Moreover, the authors compared isolated and in situ formed complexes, and 
the obtained results being comparable.56 
Also, Sodeoka and coworkers employed a cationic catalyst derived from Binap, which 
was used in its dimeric form 1.114 (scheme 1.32).57 Aromatic amines substituted with 
electron donating or withdrawing groups gave the adducts in high yield with high ee’s 







































The Jørgensen group investigated Ni(II)-bisoxazoline catalyst 1.116 in the addition of 
secondary aromatic amines to oxazolidinones 1.107 (scheme 1.33).58 Various -
substituted aliphatic ,-unsaturated oxazolidinones were used resulting in the amine 


























. 6H2O (5 mol%),
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Scheme 1.33. Ni-catalyzed addition of aromatic amines to ,-unsaturated imides.  
Iodo(binaphtholate)samarium complex 1.117 has been used in the addition of aromatic 
amines to N-alkenoyloxazolidinones (scheme 1.34).59 Substrates with aromatic 
substituents and p-anisidine as nucleophile resulted in the adducts 1.113 with ee’s (up 





















Scheme 1.34. Sm-catalyzed addition of aromatic amines to oxazolidinones.  
Besides aromatic amines, hydroxylamines have been widely used in catalytic 
enantioselective conjugate additions. Sibi and coworkers used Mg-bisoxazoline complex 
1.120 in the addition of O-benzylhydroxyl amine to oxazolidinones 1.118 (scheme 
1.35a).60 However, only moderate enantioselectivities (up to 81%) were observed with 
high catalyst loadings of 30 mol%. The sterechemical outcome of this transformation 
depends on the temperature, i.e. at 0°C or room temperature the configuration reversed 
compared to the reaction at 60°C, and the ee was in general lower. 3-Amino esters 
were synthesized upon hydrolysis of the imide to the corresponding methyl ester.  























































Scheme 1.35. Mg-catalyzed addition of hydroxylamines to ,-unsaturated imides.  
The addition of N-benzylhydroxyl amines to ,-disubstituted imide 1.121 catalyzed by 
bisoxazoline ligand 1.120 and Mg(NTf2)2 lead to the formation of isoxazolidinones 
1.122 (scheme 1.35b).61 The anti-adducts were obtained in high yields with high 
diastereo- and enantiomeric excess. Upon hydrogenolysis, the 2,3-amino esters 1.123 
were obtained in high yield. 
Shibasaki and coworkers studied heterobimetallic catalysts 1.127 and 1.128 in the 
enantioselective aza-Michael addition of methoxylamine (scheme 1.36).62 
Heterobimetallic catalysts are often combinations of rare earth metals and alkali metals. 
For instance, they show a cooperative effect of the two mutual centers, i.e. a Lewis acid 
to activate the electrophiles and a Brønsted base to deprotonate the nucleophiles to form 
activated metal nucleophiles.63 Herein, Lewis acid-Lewis acid cooperative catalysis is 
employed using Li as alkali metal and Y or Dy as rare earth metal. Both Li and the rare 
earth metal are activating the ,-unsaturated compound and control the orientation of 
the amine. Drierite (CaSO4) was added as dessicant because traces of water decreased 
the rate of the reaction. Molecular sieves could not be used due to the absorption of 
methoxylamine. Mechanistic studies revealed that the ionic radius of the rare earth 
metals plays a major role. The enantiomeric excess of the adducts reaches up to 96%. 
The N-acylpyrrole group of 1.125 was easily transformed into the corresponding methyl 























RE (rare earth metal) = Y, M=Li 1.127




















Scheme 1.36. Heterobimetallic catalysts for the aza-Michael addition of hydroxylamines.  
Sc(OTf)3/i-Pr-pybox complex 1.131 has been used for the enantioselective addition of 
O-benzylhydroxylamine to ,-unsaturated 3-acyloxazolidinones (scheme 1.37).64 The 
adduct 1.129 was obtained in good yield with high ee’s (up to 91%); using 
crotonoyloxazolidinone as substrate, N-benzyloxyamide 1.130 was also formed in 23% 

































Scheme 1.37. Sc-catalyzed addition of benzylhydroxylamine to oxazolidinones.  
Palomo and coworkers investigated Cu(II)-bisoxazoline 1.135 for the addition of 
carbamates to -hydroxy-enones (scheme 1.38).65 Benzyl-, tbutyl, methyl and ethyl 
carbamate were successfully added to aliphatic and aromatic -hydroxy-enones 1.132 
providing the adducts in high yield with high ee. The -hydroxy ketone was oxidatively 
cleaved using NaIO4 to yield the corresponding 3-amino acid 1.134.  
 


































Scheme 1.38. Cu-catalyzed addition of carbamates to -hydroxy enones.  
Aromatic amines, hydroxylamines and carbamates were successfully added to ,-
unsaturated carbonyl compounds using Lewis acids as catalyst. However, all methods 
described here and in the older literature41 use activated carbonyl compounds as 
acceptors. Simple carboxylic esters were not yet successfully employed to give -amino 
esters via highly enantioselective conjugate additions. 
1.2.4 Miscellaneous 
Several reactions to form -amino acids in an enantioselective manner which do not fit 
in the above described categories are discussed herein.  
In 2007, an asymmetric Friedel-Crafts alkylation of 2-methoxyfuran with nitroalkenes 
was described (scheme 1.39).66 A diphenylamine-tethered bisoxazoline 1.140-Zn(II) 
complex was used to add methoxyfuran 1.136 to aromatic nitroolefins 1.137 with ee’s up 
to 96%. The furan-ring was subsequently oxidatively cleaved and the intermediate 
treated with diazomethane to form the -nitro ester 1.138 which could be further 
































Scheme 1.39. Zn-catalyzed Friedel-Crafts reaction of 2-methoxyfuran with nitroalkenes.  
Sodeoka and coworkers have tested chiral cationic dimeric palladium catalysts for the -
fluorination of -ketoesters with N-fluorobenzenesulfonamide (NFSI) (scheme 1.40).67 
Catalyst 1.144 derived from DTBM-SegPhos gave excellent enantioselectivities up to 
94%. The products were converted to -amino esters using a sequence involving 
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Ph3SiH/TFA for the diastereoselective (dr >95:5) reduction of the ketone to the 
corresponding anti-fluoro-alcohol or Ph3SiH/TBAF for the reduction to the syn-fluoro-
alcohol. Both diastereomers were subsequently transformed into the respective azides 
using the Mitsunobu reaction, followed by reduction and in situ Boc-protection to give 






























































R1=Ph, R2=R3=Me 31% R1=Ph, R2=R3=Me 52%
 
Scheme 1.40. Pd-catalyzed enantioselective fluorination of -ketoesters.  
2-Amino acids were also synthesized by rhodium-catalyzed C-H insertion of aromatic 
diazoacetates 1.146 into N-Boc-N-benzyl-N-methylamine (scheme 1.41).68 Benzylamine 
1.145 is the optimal substrate for the insertion of various aromatic, heteroaromatic and 



























Scheme 1.41. Rh-catalyzed C-H-activation for the synthesis of 2-amino acids.  
Walsh and coworkers have developed a multi-step procedure for the synthesis of -
unsaturated 2-amino acid derivatives with high ee (scheme 1.42).69 First, an 
enantioselective vinylzinc addition to aldehydes yields allylic alcohol 1.150, followed by  
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Overman’s [3,3]-sigmatropic imidate rearrangement to yield 1.151 by a one-pot 
deprotection-oxidation sequence. The vinylzinc reagents were generated in situ via 
hydroboration of  terminal alkyne 1.149 with dicyclohexylborane and transmetalation of 
the vinylborane with diethylzinc. Ligand 1.153 catalyzes the addition of the vinylzinc 
reagent to aromatic and aliphatic aldehydes in high yield with excellent ee’s (up to 99%). 
Then, the trichloroacetimidate was synthesized using trichloracetonitrile in DBU and 
heated to reflux yielding the rearranged product 1.151. One-pot deprotection of the trityl 
alcohol and oxidation of the free hydroxy-group using chromium trioxide in sulfuric acid 




































Scheme 1.42. Enantioselective addition of vinylzinc reagents to aldehydes as a key step for the synthesis of 2-
amino acids.  
Ru-salen catalyst 1.157 was tested in an enantioselective cyclopropanation in order to 
prepare 2-cyclopropane amino acids (scheme 1.43).70 The cyclopropanation of styrene 
with ethyl diazoacetate 1.154 proceeded with good diastereo- and enantioselectivity. For 
the synthesis of trans-cyclopropyl -amino acid derivatives, the phenyl ring was 
oxidatively cleaved giving the free carboxylic acid which was used in a subsequent 
Curtius rearrangement. The resulting isocyanate was converted into N-Boc-protected 































Scheme 1.43. Enantioselective Ru-catalyzed cyclopropanation as a key step in the synthesis of 2-
cyclopropane-amino acids.  
Johnson and coworkers developed an asymmetric cyanation/1,2-Brook-
rearrangement/C-acylation reaction sequence for the synthesis of -amino--hydroxy--
phenyl amino acid derivatives (scheme 1.44).71 Using cyanoformate 1.159, acylsilane 
1.158 and 15 mol% of salen-aluminium complex 1.162, high enantioselectivities in the 
formation of 1.160 were achieved. First, enantioselective cyanation of the acylsilane 
occurs, leading to a chiral metaloxide that undergoes a 1,2-Brook-rearrangement to give 
the product 1.160 upon reaction with a second molecule of the cyanoformate. The nitrile 
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Scheme 1.44. Enantioselective cyanation/1,2-Brook-rearrangement/C-acylation for the synthesis of -amino 
acids. 
Feringa and coworkers developed the catalytic asymmetric allylic substitution of 
Grignard reagents using Taniaphos 1.166 as a chiral ligand and used this transformation 
as a key step in a new route to 2-amino acids (scheme 1.45).72 Allylic amine 1.163 was 
treated with methylmagnesium bromide in the presence of the chiral copper catalyst to 
give 1.164 in high yield with an 95% ee. The olefin was oxidatively cleaved with RuCl3-
NaIO4, and the N-Boc-N-tosyl protected -amino acid 1.165 was obtained in 79% yield.  
 



























Scheme 1.45. Cu-catalyzed asymmetric allylic substitution using Grignard reagents. 
Moreover, the catalytic asymmetric allylic amination of allylic carbonates catalyzed by 
Ir-phosphoramidite 1.170 was used for the preparation of 3-amino acid derivatives 
(scheme 1.46).73 N-Boc-N-acetylamine was employed as nucleophile giving the 
branched products with high regioselectivity (>99:1) and excellent ee (up to 99%). The 
product was in situ deacylated under basic conditions to give N-Boc-protected aliphatic 
and aromatic allylic amines. Hydroboration-oxidation and subsequent oxidation of the 































Scheme 1.46. Ir-catalyzed asymmetric allylic amination. 
Jørgensen and coworkers employed the asymmetric Henry reaction to synthesize -
hydroxy-2-amino acid esters (scheme 1.47).74 Copper-bisoxazoline 1.174 complex was 
used to add nitromethane to aliphatic and aromatic -ketoesters to give the adducts in 
good yield with high ee’s (up to 94%). Upon reduction of the nitro group, the 




























Scheme 1.47. Cu-catalyzed asymmetric Henry reaction. 
Enantioselective [3+2]-cycloadditions of nitrones and ,-unsaturated 2-acyl imidazole 
1.176 were used to synthesize 2,3-hydroxy-amino acid derivatives (scheme 1.48).75 
Evans and coworkers employed Ce(IV)-bisoxazoline catalyst 1.179 to achieve the 
addition of aliphatic and aromatic nitrones 1.175 to 2-acyl imidazoles 1.176 in high yield 
with up to 99% ee with an endo:exo ratio >99:1. The isoxazolidines 1.177 were 











































endo:exo 75:5 - 99:1
80-99% ee
 
Scheme 1.48. Catalytic asymmetric [3+2]-cycloaddition. 
Chiral nucleophilic quinuclidine alkaloid derived catalyst 1.184 in combination with 
Ti(OiPr)4 as Lewis acid  has been employed in the asymmetric aza-Baylis-Hillman 
reaction (scheme 1.49).76 Starting from aromatic aldehydes, tosylamide and methyl 
acrylate, Adolfsson and coworkers studied catalyst 1.184 to obtain the Baylis-Hillman 























Scheme 1.49. Catalytic asymmetric Baylis-Hillman reaction. 
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Using bifunctional asymmetric catalyst 1.188, Lectka and coworkers synthesized -
lactams from acyl chlorides 1.185 and imine 1.186 (scheme 1.50).77 A combination of 
In(OTf)3 and quinidine derivative 1.188 gave the syn--lactam 1.187 with high dr (up to 

























Scheme 1.50. In-quinidine catalyzed asymmetric formation of -lactams. 
The catalytic asymmetric Sharpless aminohydroxylation and dihydroxylation of ,-
unsaturated carboxylic acid derivatives are important methods for the synthesis of -
hydroxy--amino acids which are key building blocks for the synthesis of Taxol 
analogues. -Trifluoromethylisoserine 1.192 was synthesized by dihydroxylation from 
2-(trifluoromethyl) acrylic ester 1.189, followed by treatment with Burgess reagent to 
give sulfamidate 1.191 which was hydrolyzed in acidic medium to give the -amino acid 
with 90% ee (scheme 1.51a).78 The aminohydroxylation was used in the synthesis of 
polyhydroxylated -amino acid constituents of microsclerodermic cyclic peptides 
(scheme 1.51b).79 -Alkoxy-(E)-alkene 1.193 was transformed into syn--amino--
hydroxy ester 1.194 with 97% ee using (DHQD)2PHAL as catalyst and tert-













































97% ee  
Scheme 1.51. Aminohydroxylation and dihydroxylation for the synthesis of -amino acid derivatives. 
There are many versatile catalytic enantioselective methods to synthesize 2- or 3-
amino acids. Among the most frequently employed are those based on cycloadditions 
and Sharpless amino- and dihydroxylation. However, these methods are most often used 
for the synthesis of specific amino acids, for example as key step in natural product 
synthesis.  
1.3 Organocatalysis 
Asymmetric transformations promoted by small chiral organic molecules have become 
very useful among the recently developed methods for the synthesis of -amino acids.80 
Important catalysts used for this purpose are proline, proline-derived amines, chiral 
Brønsted acids, (thio)ureas, and cinchona alkaloids.81 In this paragraph Mannich 
reactions, conjugate additions and miscellaneous organocatalytic synthesis of -amino 
acids are presented, covering the recent literature since 2002. 
1.3.1 Mannich reaction 
Organocatalytic Mannich reactions represent a direct entry into -amino carbonyl 
compounds.82 Low-molecular weight synthetic molecules that have hydrogen-bond 
donor abilities and a secondary interaction side, such as aromatic, and acidic or basic 
functionalities, can catalyze a variety of C-C and C-heteroatom bond forming reactions 
with high enantioselectivity.83 Chiral Brønsted acids are an important class of 
organocatalysts. Hydrogen bonds are formed between the catalyst and the electrophile to 
activate it and to organize the transitionstate.84 Chiral Brønsted acids are classified into 
two categories: 1) neutral Brønsted acids, such as thiourea and Taddol derivatives which 
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are called hydrogen-bonding catalysts, and 2) stronger Brønsted acids, such as Binol 
derivatives and phosphoric acids.  
Chiral phosphoric acid 1.197 derived from Binol gave high stereoinduction in the 
reaction of aromatic aldimines with silylenol ethers (scheme 1.52).85 High 
































Scheme 1.52. Mannich reaction catalyzed by a chiral Binol-derived phosphoric acid. 
Yamamoto and coworkers studied chiral Brønsted acid 1.201 which was proposed to 
activate imine 1.199 through hydrogen bonding (scheme 1.53a).86 An achiral Brønsted 
acid (R3OH) protonates the amine moiety of the intermediate to give the adducts 1.198 
with good ee (up to 78%).  
Taddol-derived phosphoric acid 1.202 was also used to catalyze the addition of silylenol 














































Scheme 1.53. Brønsted acid catalyzed Mannich reactions for the synthesis of 2,2,3-amino acids. 
The reaction of aromatic N-Boc-protected aldimines with nitroacetate 1.204 using amine 
catalyst 1.206 gave the products in good yield and high ee (up to 98%) (scheme 1.54).88 
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Using tributyl tinhydride and AIBN, the nitro group was removed to provide the 

























Scheme 1.54. Mannich reaction catalyzed by a chiral amine. 
Phase transfer catalyst 1.209, developed by Shibasaki and coworkers, is effective in the 
addition of glycine-Schiff-base 1.207 to aromatic imines (scheme 1.55).89 The glycine-
Schiff-base is deprotonated by Cs2CO3, presumably at the interface between liquid and 
solid phase, where upon counterion exchange with 1.209 takes place, followed by the 
asymmetric C-C-bond formation. The Mannich adducts 1.208 were obtained with good 





































Scheme 1.55. Mannich reaction catalyzed by a chiral phase transfer catalyst. 
Jacobsen and coworkers studied thiourea 1.212 as catalyst in the Mannich reaction of 
silylenol ethers 1.210 with N-Boc-aldimines 1.203 (scheme 1.56).90 Aromatic 3-amino 
acid derivatives were obtained in high yields with up to 98% ee. Variation in the amine 
part of the catalyst, i.e. thiourea 1.213, gave comparable enantioselectivities for the 
Mannich reaction.91 
 




































1.212  14 examples
             84-99%
             86-98% ee 
1.213  Ar=Ph 100% conversion





Scheme 1.56. Thiourea catalyzed asymmetric Mannich reaction. 
Deng and coworkers tested catalyst 1.223 with a thiourea and a quinine alkaloid moiety 
(scheme 1.57a).92 The thiourea-group is proposed to activate and direct the electrophilic 
imine, and the tertiary nitrogen of the quinine moiety activates the nucleophile. The 
products 1.215 resulting from the addition of malonates to N-Boc-protected aromatic 
aldimines were obtained in high yield with high ee (up to 99%). Upon hydrogenation, 
the benzyl ester was deprotected and subsequent decarboxylation provided the N-
protected 3-amino acid 1.216 in high yield. The same group also tested catalyst 1.223 
for the Mannich reaction with in situ generated carbamate-protected imines 1.218 
(scheme 1.57b).93 The Mannich adducts were obtained in high yield with up to 96% ee 
starting from -amino sulfone 1.218, dibenzyl malonate 1.219, and catalyst 1.223. 
Dixon and coworkers used a similar thiourea-cinchonine alkaloid catalyst 1.224 for the 
addition of malonates to N-Boc- and N-Cbz protected aldimines 1.221 (scheme 1.57c).94 
The Mannich adducts of dimethyl malonate 1.220 and the protected aromatic aldimines 


















































































Scheme 1.57. Thiourea-quinine and cinchonine derived catalysst for the asymmetric Mannich reaction. 
The asymmetric Mannich reaction of -keto esters with imines catalyzed by cinchonine 
alkaloid 1.229 was reported by Schaus and coworkers (scheme 1.58a).95 Cinchonine 
1.299 catalyzed the formation of the Mannich adducts with high diastereoselectivity (dr 
up to 20:1) and high enantioselectivity (ee up to 96%). Upon reduction with Zn(BH4)2 
the syn-amino alcohol derivative 1.228 was obtained. The same catalyst was also tested 
in the addition to cyclic -keto esters, providing high yield and high diastereo- and 
enantioselectivities (scheme 1.58b).96 
 





























































Scheme 1.58. Cinchonine catalyzed asymmetric Mannich reaction of cyclic and acyclic -ketoesters. 
Jørgensen and coworkers investigated quinidine alkaloid derivative 1.235 in the reaction 
of -cyanoacetates 1.232 with -imido carboxylates 1.233 (scheme 1.59).97 Aromatic -
cyanoacetates 1.232 gave the corresponding Mannich adducts 1.234 in high yield in a 
highly diastereo- and enantioselective transformation; the highest ee and dr were 































Scheme 1.59. Quinidine alkaloid catalyzed asymmetric Mannich reaction of -imido carboxylates and -
cyanoacetates. 
Barbas III and coworkers studied the Mannich reaction of thioesters with in situ 
generated N-Boc imines catalyzed by cinchona alkaloid 1.239 (scheme 1.60).98 






























Scheme 1.60. Cinchonina alkaloid catalyzed asymmetric Mannich reaction. 
Proline and proline derivatives are important catalysts for organocatalytic 
transformations.99 Proline acts hereby as a multifunctional catalyst.83 The amine group of 
proline condensates with the carbonyl group of the substrate to generate an enamine, the 
carboxylic acid functionality activates the electrophile via hydrogen-bonding in a higly 
ordered transition state.81 The H-donor functionality was found to be important to 
arrange the electrophile relative to the pyrrolidine ring and thus lowering the activation 
barrier for the C-C-bond formation by stabilizing charge build up in the transition state.  
Barbas III and coworkers have used proline 1.244 as catalyst in the addition of aliphatic 
aldehydes to PMP-protected -imido ethylesters 1.241 (scheme 1.61).100 The syn-
products 1.242 were obtained with high dr’s and ee’s, and subsequently oxidized and 
cyclized to obtain -lactam 1.243. When an aqueous medium, such as THF/H2O (9:1), 
was used in this Mannich reaction, the syn-adduct was obtained with high diastereo- 







































Scheme 1.61. Proline catalyzed asymmetric Mannich reaction of aldehydes and -imido carboxylates to form 
-lactams. 
Quaternary all carbon stereocenters were synthesized via a Mannich reaction using 
proline catalysis and -branched aldehydes (scheme 1.62).102 ,-Disubstituted 
aldehydes 1.245 were used as donor reagents in the addition to -imido ethylester 1.241 
to provide quaternary -formyl substituted -amino acid derivatives in high yield with 
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excellent dr’s (up to 96:4 syn:anti) and high ee’s (up to 99%, syn). The products were 
further converted to form spiro-lactams 1.247. However, high catalyst loadings (30 




































Scheme 1.62. Proline catalyzed asymmetric Mannich reaction to form quaternary all carbon stereocenters. 
An extension of the scope of the direct asymmetric Mannich reaction of unmodified 
aldehyde donors was reported in 2003 by Barbas III (scheme 1.63).103 Several 
substituted proline derivatives were investigated in the addition of aldehydes to -imino 
ethyl glyoxylate, revealing that proline gives the best diastereoselectivities for the 
formation of the syn-adduct with high enantioselectivity. However, (S)-2-
methoxymethylpyrrolidine shows reversed diastereoselectivity, i.e. that the anti-adduct 
is formed preferentially but with only moderate enantioselectivity. The effect of water on 
the Mannich reaction with preformed aromatic aldimines was also studied: the reaction 
tolerates a significant amount of water (up to 10%) without affecting the 
enantioselectivity. For substituted aromatic amines (with electron withdrawing 
functional groups) a diastereomeric ratio (up to 91:9) for the syn-adduct is obtained. 
Furthermore, the authors describe the one-pot-three-component reaction of aliphatic 
aldehydes, p-anisidine and substituted aromatic aldehydes to give adducts with high 
diastereomeric ratio (up to 95:5) and high ee (up to 99%) (scheme 1.63). Hayashi and 
coworkers also reported the three component Mannich reaction of aromatic and 
heteroaromatic aldehydes, p-anisidine and aliphatic aldehydes to give the syn-adducts 
with high diastereomeric ratio (up to 95:5) and high ee (scheme 1.63).104 The same three-
component Mannich reaction has been described by Córdova and coworkers for the 
synthesis of -amino alcohols.105 Córdova investigated a broader aldehyde scope such as 
heteroaromatic, aliphatic aldehydes and ethyl glyoxylate which gave the corresponding 




























Scheme 1.63. Proline-catalyzed asymmetric one-pot-three component Mannich reaction. 
Using glycol aldehydes as substrates, Córdova and coworkers describe an entry into the 
synthesis of protected amino-tetroses 1.253 (scheme 1.64a) and syn--hydroxy--amino 
acids 1.256 (scheme 1.64b).107 However, high catalyst loadings of proline are necessary 
to achieve excellent enantioselectivities (ee up to 99%) and good diastereoselectivity. 
The diastereomeric ratio is in some cases up to 91:9 but for most substrates it does not 
exceed 80:20 (syn/anti). In 2008, the synthesis of -hydroxy--amino acid derivatives 
was improved using higher catalyst loadings and preformed imines to yield higher 
enantioselectivities (ee up to 99%) (X=TBS and PG=Boc) and diastereoselectivities (dr 
up to 95:5) for the syn-adducts (scheme 1.64b).108 The products were converted by 






















































Scheme 1.64. Proline-catalyzed asymmetric synthesis of -hydroxy--amino aldehydes. 
List and coworkers reported excellent diastereoselectivities (dr up to 99:1) and 
enantioselectivities (ee up to 99%) towards the syn-adduct for the proline catalyzed 
addition of aldehydes to aromatic N-Boc-protected imines 1.254 (scheme 1.65a).109 A 
scope of aliphatic, heteroaromatic and aromatic imines is described. Employing slightly 
different reaction conditions, Córdova and coworkers also reported this transformation 
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(scheme 1.65b).110 For a variety of aliphatic and allylic aldehydes the syn-products 1.257 

































93-99% ee  
Scheme 1.65. a) Proline catalyzed asymmetric Mannich reaction of N-Boc-imines by List and b) by Córdova. 
In 2008, the List group reported the proline catalyzed reaction of N-Boc-imines with 
acetaldehyde (scheme 1.66).111 The -amino aldehydes are obtained with excellent ee 
(up to 99%), however, the yields are low (23-58%), and a high catalyst loading of 





















Scheme 1.66. Proline-catalyzed Mannich reaction of acetaldehyde. 
Hayashi and coworkers conducted experimental studies towards the mechanism and 
compared the reactivity of aldimines to aldehydes employing NMR-spectroscopy and 
theoretical calculations using density functional theory (B3LYP/6-31G*).112 In the 
Mannich reaction of p-anisidine and two equivalents of benzaldehyde, the formed imine 
reacts seven times faster with the second equivalent of aldehyde than the aldehyde enol 
would react with itself (aldol reaction). The authors attribute their findings to the fact 
that a protonation of the basic nitrogen atom of the aldimine by the carboxylic acid 
group of proline is more favourable than protonation of the aldehyde. 
Several alternative organocatalysts based on proline have been designed in recent years. 
Jørgensen and coworkers used TMS-protected catalyst 1.261 in the Mannich reaction of 
PMP-protected -imino ethylglyoxylate 1.038 and aliphatic aldehydes 1.240 (scheme 
1.67a).113 This catalyst gives the anti-adducts with high dr’s and high ee’s. Direct 
asymmetric Mannich reactions of aliphatic aldehydes with -imino ethylglyoxylate were 
also described by Córdova and coworkers using related catalyst 1.262 giving the anti-
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Scheme 1.67. a) Mannich reaction of aldehydes catalyzed by proline derivatives by Jørgensen and b) by 
Córdova. 
Hayashi and coworkers performed calculations using density functional theory (B3LYP) 
and experiments on the Mannich reaction with catalyst 1.261 and 1.262. The addition of 
acetaldehyde to N-Bz-, N-Boc- and N-Ts-protected aromatic imines revealed that in the 
presence of p-NO2PhCO2H as additive better yields and excellent enantioselectivities 
were obtained.115 Experimentally, N-Boc- and N-Bz protected imines were investigated; 
all reactions gave the anti-adducts in good yield with high enantioselectivity (up to 
98%).  
Moreover, pipecolic acid 1.264, the 6-ring analogue of proline, was used by Barbas III 
and coworkers in the addition of aliphatic aldehydes to -imino ethylglyoxylate (scheme 
1.68).116 The ee’s are high for both diastereomers (ee >99%), but the selectivity towards 


























Scheme 1.68. Mannich reaction catalyzed by pipecolic acid. 
The enantioselective aminomethylation of aldehydes was investigated by Gellman and 
coworkers for the synthesis of 2-amino acid building blocks for peptide synthesis 
(scheme 1.69a).117 An iminium species was in situ generated by elimination of MeOH 
from aminal 1.268. Proline derivative 1.262 catalyzed the addition of aliphatic aldehydes 
to give the adducts in good yields with high ee’s (up to 92%). The -amino aldehydes 
were in situ reduced to the corresponding alcohols. For the synthesis of 2-amino acids, 
the amino alcohol was recrystallized as hydrochloride salt to increase the ee, the 
protecting groups removed by hydrogenation followed by Boc-protection, and the 
alcohol oxidized to the corresponding carboxylic acid 1.268. Córdova and coworkers 
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screened further additives and found that LiBr increases the enantioselectivity (ee up to 
98%) (scheme 1.69b).118 The corresponding 2-amino acid 1.268 was synthesized by 
deprotection of the benzyl-protecting group and reprotection using Boc2O, followed by 
oxidation of the alcohol to the carboxylic acid providing N-Boc--amino acid 1.268 with 
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Scheme 1.69. a) Organocatalytic aminomethylation for the synthesis of 2-amino acids by Gellman and b) by 
Córdova. 
In recent years, the organocatalyzed Mannich reaction has found widespread application 
in the synthesis of -amino acids. Both, 2- and 3-amino acids are accessible with high 
diastereoselectivities towards syn- or anti-Mannich products depending on catalyst 
source and substrate. However, when proline or its derivatives are used as catalysts, in 
most cases high catalyst loadings of 20-30% are still needed to achieve a highly 
stereoselective transformation. 
1.3.2 Conjugate addition 
The addition of carbon and nitrogen nucleophiles to ,-unsaturated compounds is an 
important organic transformation for the synthesis of pharmaceuticals and natural 
products. Organocatalytic C-N bond formations are especially important for the 
synthesis of -amino acids via conjugate addition.  
MacMillan and coworkers designed nitrogen nucleophile 1.270 that readily undergoes a 
conjugate addition to ,-unsaturated aldehydes (scheme 1.70).119 In the presence of an 
imidazolidinone organocatalyst 1.273 (as TFA-adduct), benzyl tert-
butyldimethylsiloxycarbamate 1.270 was added to aliphatic and benzyloxy-substituted 
,-unsaturated aldehydes 1.269. The nucleophile was designed to enhance the 
nucleophilicity through the N-O functionality via the -effect while the carbamate 
moiety renders the amino aldehyde product effectively nonbasic (pKa ~ 9). The products 
2.171 are obtained in high yield with up to 97% ee, and were subsequently oxidized to 











































Scheme 1.70. Organocatalytic aza-Michael addition. 
Following a similar approach, Córdova and coworkers reported that proline-derived 
chiral amine 1.262 catalyzes the conjugate addition of N-Cbz-methoxylamine 1.274 to 
,-unsaturated aldehydes (scheme 1.71a).120 The -amino aldehydes were obtained in 
high yield with high enantiomeric excess (up to 99%). A subsequent oxidation of the 
aldehyde 1.274 to the corresponding carboxylic acid and deprotection of the amine 
provided 3-amino acids 1.276. When carbamate-protected hydroxylamines 1.277 were 
used as nucleophile, the cyclic 5-hydroxy-isooxazolidinones 1.278 were obtained with 
high ee up to 98% (scheme 1.71b).121 They were subsequently cleaved by 

























































Scheme 1.71. Organocatalytic aza-Michael addition. 
Proline derivative 1.261 has also been used for intramolecular aza-Michael addition 
(scheme 1.72).122 Piperidines and pyrrolidines were synthesized with up to 95% ee. The 
aldehydes were oxidized to the corresponding carboxylic acids, such as homopipecolic 
acid derivative 1.281. 
 







































Scheme 1.72. Intramolecular organocatalytic aza-Michael addition. 
Sibi and coworkers used thiourea catalyst 1.284 for the conjugate addition of O-
substituted hydroxylamines to pyrazole crotonates 1.282 (scheme 1.73).123 Aliphatic ,-
unsaturated compounds gave high enantioselectivities but phenyl-substituted substrates 




























Scheme 1.73. Thiourea catalyzed aza-Michael addition of hydroxylamines. 
Moreover, carbon-nucleophiles have been added to ,-unsaturated substrates using 
organocatalysts. An illustrative example leading to -amino acids pertains to the addition 
of malonates to ,-unsaturated nitroalkenes catalyzed by thiourea 1.291 (scheme 
1.74).124 The products 1.287 were obtained with high enantioselectivity. Subsequent 
Baeyer-Villiger oxidation gave the corresponding ester 1.288, and a subsequent 
reduction with DIBAL-H provided the diol 1.289, which was oxidatively cleaved. 














































Scheme 1.74. Thiourea-catalyzed aza-Michael addition of malonates to nitroalkenes. 
The organocatalytic addition of amine nucleophiles to ,-unsaturated carbonyl 
compounds proceeds generally with very high enantioselectivities. However, relatively 
high catalyst loadings of 20-30% are employed. A major challenge is to further optimize 
the organocatalyzed conjugate addition of nitrogen nucleophiles to ,-unsaturated 
carbonyl compounds with regard to catalyst loading and substrate scope. This reaction 
represents a fast atom-economic entry towards the synthesis of -amino acids; many 
synthetically useful Michael adducts might be made readily in enantiomerically pure 
form via conjugate additions. 
1.3.3 Miscellaneous 
Several other reaction types were used for the synthesis of -amino acids using 
organocatalysts such as substituted proline derivatives, cinchona alkaloids, thioureas and 
N-heterocyclic carbenes. 
For instance, Lewis base 1.294 catalyzes the hydrosilylation of -enamino esters 
(scheme 1.75).125 The aromatic, aliphatic or cyclic (Z)-enamino esters 1.292 were 
hydrosilylated using trichlorosilane to give the corresponding 3-amino esters 1.293 in 























Scheme 1.75. Organocatalytic hydrosilylation of enamino esters. 
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List and coworkers studied the transfer hydrogenation of -nitroalkenes catalyzed by 
thiourea 1.297 (scheme 1.76).126 The Hantztsch ester was used as hydrogen source, 
leading to -amino acid precursors 1.296 with high enantiomeric excess when (E)-















       91-97%
       94-95% ee
(Z)- 11 example
       61-92% 














Scheme 1.76. Thourea catalyzed conjugate reduction of nitroalkenes. 
An alternative approach to -amino acids based on a dynamic kinetic resolution was 
applied in the reduction of enamines with trichlorosilane (scheme 1.77).127 -Amino acid 
derived amide 1.301 was used in the reduction with trichlorosilane of imines 1.299 
which are in equilibrium with the corresponding enamines 1.298. The syn-2,3-amino 

































Scheme 1.77. Dynamic kinetic resolution of enamines towards -amino acid derivatives. 
Thiourea catalyst 1.305 was studied by Berkessel and coworkers for the kinetic 
resolution of racemic oxazinones 1.302 (scheme 1.78).128 With up to 57% conversion, 
the chiral remaining oxazinones 1.302 were isolated with >99% ee and the ring-opened 
3-amino ester 1.303 with 84% ee. When the reaction was driven to 25% conversion, the 
ring-opened product had 96% ee. Using hydrolytic workup, the N-benzoyl--amino acid 
















































Scheme 1.78. Organocatalytic kinetic resolution of oxazinones. 
Córdova and coworkers reported that proline derivative 1.262 catalyzes the aziridination 
of ,-unsaturated aldehydes (scheme 1.79).129 The ,-aziridine aldehydes 1.307 were 
obtained in a highly enantioselective transformation (up to 99%), and were converted in 
one step into the corresponding Cbz-protected amino esters 1.308 in the presence of an 
































Scheme 1.79. Organocatalytic aziridination of ,-unsaturated aldehydes. 
A multistage, one-pot procedure was used for the synthesis of ,-amino diesters 
(scheme 1.80a).130 A proposed mechanism involves dehalogenation of 1.310 catalyzed 
by benzoylquinine (BQ) 1.314 and stoichiometric amounts of proton sponge (PS) 1.315, 
resulting in the formation of imine 1.318 (scheme 1.80b). This reacts subsequently with 
enolate 1.317 derived from carboxylic acid chloride 1.310 via ketene 1.316. The 
obtained -lactam 1.312 undergoes ring opening upon treatment with methanol to yield 
aspartic acid derivative 1.313. Moreover, in one step, -lactams were synthesized from 
preformed imines 1.319 and acylchloride catalyzed by benzoylquinine 1.320 in the 
presence of stoichiometric amounts of base and 15-crown-5 (scheme 1.80c).131 
 




















































































Scheme 1.80. Multistage one-pot procedure for the synthesis of -lactams catalyzed by benzoylquinine. 
Jørgensen and coworkers used the [1,3]-sigmatropic rearrangement of O-allylic 
trichloroacetimidates 1.321 to synthesize N-protected -amino esters 1.322 catalyzed by 
dihydroquinidine (DHQD)2PHAL (scheme 1.81).132 The products of the rearrangement 
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Scheme 1.81. [1,3]-Sigmatropic rearrangement for the synthesis of -amino esters. 
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Chiral nucleophilic quinidine catalyst 1.314 has been employed in the asymmetric aza-
Baylis-Hillman reaction (scheme 1.82).133 Aromatic imine 1.323 and activated alkene 
1.324, 1,1,1,3,3,3-hexafluoroisopropyl acrylate, were reacted to give the Baylis-Hillman 
adducts 1.325 in moderate yield with moderate enantiomeric excess (up to 73%). 








































Scheme 1.82. Aza-Baylis-Hillman reaction for the synthesis of -lactams. 
N-Heterocyclic carbene 1.330 was shown to catalyze the addition of nitrosobenzene to 
,-unsaturated aldehydes via a reaction involving umpolung of 1.306. This 
transformation gives isooxazolidinone intermediates which were hydrolyzed under 






















Scheme 1.83. Addition of ,-unsaturated aldehydes to nitrosobenzene catalyzed by N-heterocyclic carbenes. 
In this section routes to 2- and 3-amino acids and -lactames based on a variety of 
methods including (transfer)hydrogenation, aziridination, (dynamic) kinetic resolution, 
one-pot reactions of imines with enolates, 1,3-sigmatropic rearragement, aza-Baylis-
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Hillman reaction and umpolung of ,-unsaturated aldehydes were discussed. In most 
cases, this reactions have limited scope so far to prepare specific -amino acid presursors 
or -lactams. 
1.4 Biocatalytic routes 
There are only few recent biocatalytic methods reported for the synthesis of -amino 
acid apart from kinetic resolutions.135  The biocatalytic preparation of enantiopure -
amino acids has been reviewed in 2006,135 therefore, this part will focus on non-kinetic 
resolutions since 2006. 
A -transaminase from Mesorhizobium sp. LUK was cloned and characterized as new 
biocatalyst for the synthesis of -amino acids (scheme 1.84).136 However, only phenyl 
substituted -ketoester 1.331 was screened as presursor in combination with a lipase 
from Candida rugosa which catalyzes the hydrolysis of 1.331 to -keto acid 1.332 being 
the substrate for the transamination. Racemic -alanine was used as nitrogen source and 























>99% ee  
Scheme 1.84. Transaminase catalyzed synthesis of -phenylalanine. 
Saccharomyces carlsbergensis old yellow enzyme was studied in the asymmetric 
bioreduction of -nitroacrylates (scheme 1.85).137 NADPH was supplied by a cofactor 
regeneration system (glucose-6-phosphate/bakers yeast glucose-6-phosphate 
dehydrogenase). (Z)-Alkenes substituted in -position to the carboxylate with ethyl-, 
propyl or iso-propyl groups were reduced with high conversion and high ee (up to 96%). 
Subsequent hydrogenation and acidic hydrolysis gave the corresponding 2-amino acids 







a) [S. carlbergensis old yellow enzyme]











Scheme 1.85. Synthesis of 2-amino acids via bioreduction. 
-Styryl- and -aryl--alanine derivatives have been synthesized using phenylalanine 
amino mutase (PAM) (scheme 1.86).138 Aromatic and heteroaromatic -amino acids 
were employed to synthesize the corresponding -amino acids with high 
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Scheme 1.86. PAM catalyzed synthesis of -amino acids from -amino acids. 
Janssen, Feringa and coworkers reported the use of PAM to catalyze the amination of 
cinnamic acid derivatives in a synthetic procedure for -amino acids (scheme 1.87).140 A 
mixture of - and -amino acids is obtained which were not separated from each other or 
isolated. With electron donating substituents in para-position of the aromatic ring, 














R=Me        96 (99% ee)                    4 (99% ee)    
R=OMe     86 (99% ee)                  14 (99% ee)    
R=H          49 (99% ee)                   51(99% ee)    
R=NO2       2                                   98 (99% ee)  
Scheme 1.87. PAM catalyzed synthesis of -amino acids form cinnamic acid derivatives. 
Biocatalytic processes are a valuable addition to the organocatalytic and transition metal 
catalyzed methods for the synthesis of -amino acids. Enantioselectivities are in general 
very high (>99%), but most enzymes have a small substrate scope so far. Additionally, 
in the reports discussed here, frequently the -amino acids were not isolated, but only 
conversion was measured, and substantial work is required to make these methods 
applicable to synthetic organic chemistry. 
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1.5 Conclusion and outlook 
The synthesis of -amino acids remains a challenging target for organic chemists due to 
the importance of these building blocks as pharmaceuticals intermediates and 
peptidomimetics. In the past 15 years, tremendous progress has been made as shown in 
this review and preceeding overviews.6-8 Using many different methodologies, 2- and 
3-amino acids with various substitution patterns are now available. Organocatalysis has 
played an important role in recent years in the field of catalytic asymmetric synthesis and 
quickly provided a useful method to prepare -amino acids, especially transformations 
based on the Mannich reaction. However, in many cases high catalyst loadings have to 
be used, and reaction times are in some cases rather long. On the other hand, one of the 
more promising catalysts, (S)-proline, is a naturally occuring amino acid, and therefore 
very cheap. Homogeneous catalysis using transition metals provided the most important 
methods in recent years to synthesize -amino acids. Among them, the hydrogenation of 
enamines has been applied in industrial synthesis of -amino acids because high 
turnover, high enantioselectivity and low catalyst loadings can be used. However, some 
transition metals are highly toxic and harmful for the environment. Therefore, 
biocatalysis would provide an important alternative, but up to now no enzymes are 
known that have a broad substrate scope in combinations with high turnover numbers. 
Most enzymatic methods rely on kinetic resolutions, which means that only 50% of the 
starting materials can be converted, unless a dynamic kinetic resolution protocol is used. 
Therefore, the catalytic asymmetric synthesis of -amino acids starting from simple and 
cheap starting materials and using recycable sustainable catalysts remains an important 
challenge for synthetic organic chemists. 
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Chapter 2 
Biocatalytic synthesis of non-natural 
amino acids with aspartate ammonia 
lyases 
 
The goal of this project was to use aspartate ammonia lyases to synthesize non-natural 
amino acids. The enzymatic studies were focused on aspartate ammonia lyase from 
Bacillus sp. YM55-1 (AspB). Using this enzyme in the reverse reaction, a set of four N-
substituted aspartic acids was prepared via the Michael addition of hydroxylamine, 
hydrazine, methoxylamine and methylamine to fumarate. Both hydroxylamine and 
hydrazine are excellent substrates for AspB. The products of the enzyme-catalyzed 
addition of hydrazine, methoxylamine and methylamine to fumarate were isolated and 
characterized by NMR spectroscopy and HPLC analysis, revealing that AspB catalyzes 
all additions with excellent enantioselectivity (>97% ee). The broad nucleophile 
specificity and high catalytic activity make AspB an attractive enzyme for the 
enantioselective synthesis of N-substituted aspartic acids, which are interesting building 














Part of this chapter has been published: Weiner, B.; Poelarends, G. J.; Janssen, D. B.; Feringa, B. 
L. “Biocatalytic enantioselective synthesis of N-substituted aspartic acids by aspartate ammonia 




Aspartate ammonia lyases (also referred to as aspartases; EC 4.3.1.1) are microbial 
enzymes that play a key role in nitrogen metabolism by catalyzing the reversible 
elimination of ammonia from L-aspartate 2.02 to yield fumarate 2.01 (scheme 2.01). 
Several related aspartases have been purified and characterized from gram-positive and 
gram-negative bacteria, including E. coli,1 Hafnia alvei,2 Pseudomonas fluorescens,3 












Scheme 2.01. General reaction of aspartase. 
The aspartase from E. coli (AspA) has been studied most extensively, and its crystal 
structure has been elucidated.6 AspA functions as a homotetramer, of which each 
monomer consists of 478 amino acid residues, and the enzyme is allosterically activated 
by its substrate (L-aspartate) and Mg2+ ions, which are required for activity at alkaline 
pH. Stereochemical data, kinetic isotope labelling, and pH-rate profiles indicate that 
AspA carries out an anti elimination reaction where an active site base with a pKa of 
~6.5 abstracts a proton from C-3 of L-aspartate to form the enzyme-stabilized enolate 
intermediate 2.04 (scheme 2.02).7,8,9 This forms upon elimination of ammonia the 
product, fumarate. The rate-determining step is the cleavage of the carbon-nitrogen 
bond, which may be facilitated by a general acid that protonates the leaving ammonia 
group. Although several active site residues have been investigated by site-directed 
mutagenesis, kinetic analysis, and chemical modification, the essential catalytic base and 
presumed catalytic acid have not yet been identified. The crystal structure and site 
directed mutagenesis experiments indicate that two positively charged residues (Arg-29 




















Scheme 2.02. Mechanism of deamination of L-aspartate catalyzed by AspA. 
AspA is one of the most specific enzymes known.11 Extensive studies over the last 80 
years have shown that no other substrates can replace L-aspartic acid in the deamination 
reaction.8 Only the suicide substrate L-aspartate--semialdehyde is deaminated by AspA, 
but the enzyme is at the same time irreversibly inactivated.12 In contrast, many 
competitive inhibitors were reported and these all require a carboxylic acid or similarly 
charged functional groups at each end of the carbon chain such as phosphate-, 
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phosphono- or nitro-groups.7 Interestingly, Emery reported in 1963 that hydroxylamine 
is an alternative nucleophile for aspartase but the produced N-hydroxyaspartic acid was 
too unstable for isolation.13 The high selectivity of AspA for its natural substrates limits 
the practical application of this enzyme. The reverse reaction catalyzed by AspA, i.e., the 
amination of fumarate, is used commercially in the industrial production of the artificial 
sweetener aspartame (N-L--aspartyl-L-phenylalanine-1-methyl ester).14,15 An excess of 
ammonia is used in this process to drive the equilibrium from fumarate towards L-
aspartic acid. The yields are usually quantitative, and L-aspartic acid is obtained with an 












Figure 2.1. a) Monomeric structure of AspB. b) Homotetramer of AspB.16 
In our studies we focus on aspartase (AspB) from the thermophilic bacterium Bacillus 
sp. YM55-1.5 This aspartase is an interesting enzyme for industrial application because 
of its high activity, relative thermostability, and lack of allosteric regulation by substrate 
or metal ions. The crystal structure of AspB has been elucidated in 2003 by Fujii et al. 
(figure 2.1).16 The overall topology and active site structure of AspB are similar to that 
observed in AspA and fumarase C (FumC) from E. coli, confirming its membership in 
the aspartase/fumarase superfamily of enzymes. Like AspA, AspB functions as a 
homotetramer (figure 2.1b), in which each subunit (figure 2.1a) is composed of 468 
amino acid residues. The tetramer contains four active sites. Up to date, there is no 
crystal structure of AspB (or any other aspartase) complexed with substrate or product 
available, and details of the catalytic mechanism are not yet elucidated.  
A structural model of AspB with aspartate in the active site was recently suggested.16,17 
Hydrogen bonding of amino acid residues Asn-326, Lys-324 and Thr-187 with the -
carboxylate and of Thr-141 and Ser-140 with the -carboxylate of the substrate (figure 
2.2a), and a model of the active side residues were proposed (figure 2.2b). The amino 
group undergoes likely hydrogen bonding-interactions with Thr-101, Asn-142 and His-
188. Based on this model, the mechanism of the enzyme and modifications in the active 





















            
Figure 2.2. (a) Residues involved in binding of aspartate in the active site of AspB. b) Putative active site 
residues of AspB.18 
In this chapter, cloning and overexpression of the aspB gene in E. coli, and the efficient 
one-step affinity purification of the recombinant His6-tagged enzyme are reported. By 
using 1H-NMR spectroscopy, the purified enzyme was extensively screened for its 
ability to process alternative substrates. Four amines were identified that can replace 
ammonia as substrate in the AspB-catalyzed Michael addition to fumarate. The resulting 
N-substituted aspartic acids are interesting building blocks for peptide synthesis and 
peptidomimetics. Attempts to convert the enzymatically-synthesized N-substituted 
aspartic acids to functionalized and stable -amino acid derivatives are reported, along 
with their chemical synthesis. 
2.2 Expression, purification and characterization of AspB 
The aspB gene was amplified from plasmid pUCBA and cloned in frame with both the 
initiation ATG start codon and the sequences that code for the myc epitope and 
polyhistidine region of the expression vector pBAD/Myc-His A (figure 2.3), resulting in 
the construct pBAD(AspB-His) (figure 2.4). Sequencing of the cloned gene verified that 
no mutations had been introduced during the amplification and cloning procedures. The 
aspB gene in pBAD(AspB-His) is under transcriptional control of the araBAD promoter 
and the recombinant aspartase containing the C-terminal fusion peptide was produced 
upon induction with arabinose in soluble and active form in E. coli TOP10.  



























Figure 2.4. pBAD(AspB-His) fusion expression plasmid. 
Expression of the aspB gene was most efficient when cells were cultivated at 37°C and 
when 0.04% (w/v) arabinose was used. The recombinant enzyme was purified by a one-
step protocol (the C-terminal His6-tag forms a metal binding site for affinity purification 
on metal-chelating resin Ni-NTA), which typically provided 20-30 mg of homogeneous 
enzyme per liter of culture. The SDS-page gel of the purification process shows that 
AspB is obtained in good purity (figure 2.5). The His6-tagged AspB was found to 
migrate during non-denaturing polyacrylamide gel electrophoresis with similar mobility 
as native AspB carrying no fusion tag, which suggests that gross conformational changes 
are not present and that the homotetrameric quaternary structure of native AspB is 

















































































Figure 2.5. SDS-Page gel of AspB after purification with affinity chromatography: from left to right the cell 
free extract (CFE), the flow through of the Ni-NTA column, two times washing of the Ni-NTA column with 
buffer, and the eluted samples of protein in three different concentrations.  
A mixture containing His6-tagged AspB and L-aspartic acid was monitored by 1H NMR 
spectroscopy to verify that the product of the reaction is fumarate, as previously reported 
for the aspartase from E. coli. The enzymatic conversion of L-aspartic acid yields 
fumarate, as indicated by a singlet at =6.39 ppm. This spectrum is identical to that of a 
reference sample,19 confirming that fumarate is the product of the AspB-catalyzed 
conversion of L-aspartic acid. The rate of deamination of L-aspartate by His6-tagged 
AspB was monitored spectrophotometrically by following the formation of fumarate at 
240 nm in 50 mM NaH2PO4 buffer (pH 8.5) at 25°C. A kcat of 40 s-1 and a Km of 15 mM 
were found, which results in a kcat/Km of ~2.7 x 103 M-1s-1 (table 2.1, entry 1). Similar 
kinetic parameters were previously found for purified AspB in its native form (table 2.1, 
entry 2).5 
Table 2.1. Kinetic parameters for the deamination of AspB. (240 nm, 50 mM NaH2PO4 buffer (pH 8.5) at  
25°C ).  
entry Km [mM] kcat [s1] kcat/Km [l mol1 s1] 
1 15 ± 2 40 ± 7 2.7 x 103 
2 28a -b - 
a See ref.5 b The authors give only a value for the specific activity Vmax = 700 U mg1.  
Since the C-terminal fusion peptide does not interfere with the structural and enzymatic 
properties of AspB, and because purification of His6-tagged AspB is very efficient, this 
AspB variant was used for all experiments described below. 
Chapter 2: Biocalatytic synthesis of non-natural amino acids with aspartate ammonia lyase 
 63
2.3 Screening for alternative substrates 
2.3.1 Amino acids and fumarate analogues 
Several amino acids were tested as potential substrates of AspB. The deamination 
reactions were monitored using a colorimetric assay that follows ammonia production 
upon incubation with 25 mM substrate in 100 mM Na2HPO4 buffer (pH 9.0) at 37°C. The 
compounds D-aspartic acid 2.06, L-cysteine 2.07, L-histidine 2.08, L-phenylalanine 2.09, 
L-glutamine 2.10 L-tyrosine 2.11, L-serine 2.12, L-alanine 2.13, L-valine 2.14, L-leucine 
2.15, L-threonine 2.16, L-lysine 2.17, -methyl-DL-aspartic acid 2.18, -methyl-DL-
aspartic acid 2.19, L-glutamate 2.20, -alanine 2.21, -DL-aminobutyric acid 2.22, -
asparagine 2.23, -phenylalanine 2.24, and -leucine 2.25 were not processed by AspB 
(figure 2.6). This screening thus failed to identify any alternative amino acid substrate 
that can replace L-aspartic acid. The specificity for L-aspartic acid has also been clearly 





























































Figure 2.6. Screening of amino acids. 
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Some fumarate analogues were also tested as potential substrates in the reverse ammonia 
addition monitored by 1H NMR spectroscopy (figure 2.7). Mixtures (pH 7.0) containing 
trans-cinnamic acid 2.26, trans-methyl crotonate 2.27, acrylic acid 2.28 and methyl 
acrylate 2.29 did not show formation of their products. Mono-methyl fumarate 2.30 and 




CO2H CO2Me CO2H CO2Me







Figure 2.7. Screening of fumarate analogues. 
2.3.2 Nucleophiles 
It has previously been determined that E. coli aspartase can catalyze the reverse reaction, 
the trans-addition of ammonia to fumarate, with high stereoselectivity, exclusively 
yielding L-aspartic acid.7 With this observation in hand it was examined if AspB 
catalyzes the stereoselective amination of fumarate and if different nucleophiles can be 
used in this enzyme-catalyzed Michael addition. The addition reactions were monitored 
by 1H NMR spectroscopy under a variety of conditions, including different enzyme 
concentrations, and different pH values (7.0, 8.0, and 9.5). Representative conversions 
for each reaction are summarized in table 2.2. Interestingly, a robust activity of AspB 
with hydroxylamine and hydrazine, and a small but significant activity with 
methoxylamine and methylamine is observed. In the absence of AspB, these amines do 
not react with fumarate. 
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Table 2.2. Addition of various nucleophiles (250 mol) to fumarate (25.0 mol) catalyzed by AspB in 









entry nucleophile pH time conversion [%] 
1 H2NOHa 7.0 20 min 100 
2 MeONH2b 7.0 12 d 100 
3 MeONH2b 8.0 6 d 100 
4 H2NNH2b 7.0 1 d 100 
5 MeNH2c 8.0 7 d 100 
6 EtNH2c 8.0 14 d - 
7 EtNH2c 9.5 14 d - 
8 EtNH2d 8.0 14 d - 
9 ethanolaminec 8.0 14 d - 
10 allylaminec  8.0 14 d - 
11 NaN3b 7.0 14 d - 
12 NaCNb 7.0 14 d  - 
13 NaCNb 8.0 14 d - 
14 NaOCNb 7.0 14 d - 
15 NaOCNb 8.0 14 d - 
16 Glyc 8.0 14 d - 
17 Glyc 9.5 14 d - 
18 Glyd 8.0 14 d - 
19 Gly-methylesterc 8.0 14 d - 
20 formamidec 8.0 14 d - 
21 formamidec 9.5 14 d - 
22 formamided 8.0 14 d - 
a AspB 1.12 mol, 200 mol nucleophile, 20.0 mol fumarate; b 9.34 mol 
AspB; c 8.95 mol AspB; d 17.9 mol AspB. 
Hydroxylamine appears to be the best alternative substrate for AspB (entry 1, table 2.2). 
The 1H NMR spectrum recorded 20 min after the addition of the enzyme shows complete 
disappearence of the signals corresponding to fumarate (=6.41 ppm), and the formation 
of new signals corresponding to the expected N-hydroxyaspartic acid (=3.65 (dd, 1H), 
2.50 (dd, 1H), 2.29 (dd, 1H) ppm; see 2.8). The NMR spectra taken at  a later stage are 
rather complex which we assume results from chemical decomposition of the N-
hydroxyaspartic acid. The instability of this class of compounds was previously reported 
by Emery[12] and Ottenheijm and Herscheid.[17] Methoxylamine is a poor substrate for 
AspB. The spectrum recorded one day after the addition of enzyme shows hardly any 
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conversion of the starting material, but after 2 weeks of incubation at pH 7.0, the 
spectrum shows complete loss of the signals corresponding to fumarate (entry 2, table 
2.2) and formation of new signals corresponding to the expected N-methoxyaspartic acid 
(=2.39 (dd, 1H), 2.58 (d, 1H), 3.59 (s, 3H), 3.85 (dd, 1H) ppm; see 2.8). The screening 
was repeated at pH 8.0, and it was established that after one week the reaction was 
complete (entry 3, table 2.2). When hydrazine was used as the nucleophile, complete 
disappearance of the starting material and the formation of the expected 2-
hydrazinosuccinic acid (=2.31 (dd, 1H), 2.49 (dd, 1H), 3.49 (dd, 1H) ppm; see 2.8) was 
observed after incubation for one day (entry 4, table 2.2). Using methylamine as the 
nucleophile, the reaction was complete after one week of incubation at pH 8.0 and the 
expected N-methylaspartic acid (=2.62 (s, 3H), 2.88 (d, 2H), 3.75 (dd, 1H) ppm; see 
2.8) was formed (entry 5, table 2.2). 
The data clearly show that AspB efficiently processes small substituted amines such as 
hydroxylamine and hydrazine (-nucleophiles), but displays very low (methoxylamine 
and methylamine) or no (ethylamine, ethanolamine, allylamine, glycine, glycine 
methylester, and formamide) activity with larger amine nucleophiles or amides. Small 
charged nucleophiles (azide, cyanide, and cyanate) are also not processed. Taken 
together, these observations suggest that the nucleophile binding pocket of AspB is 
designed to bind small amine compounds and excludes any charged or large 
nucleophiles. 
2.4 Kinetic parameters 
The rate of amination of fumarate catalyzed by AspB was measured by following the 
decrease in absorbance at 270 nm in phosphate buffer (pH 8.0) at 22 °C. Both 
hydroxylamine and hydrazine are good substrates for the enzyme, and the kinetic 
parameters are summarized in tables 2.3 and 2.4. The data clearly show that AspB 
processes both amines with similar catalytic efficiency (figure 2.8).20 While the kcat 
values are comparable to those observed for the AspB-catalyzed addition of ammonia to 
fumarate, the Km values are slightly higher (1.8-fold for hydroxylamine and 3.6-fold for 
hydrazine) (table 2.3). As a result, the kcat/Km values are 1.6- and 3.4-fold lower for 
hydroxylamine and hydrazine, respectively. 
Table 2.3. Kinetic parameters for the AspB-catalyzed addition of different amine nucleophiles to fumarate 
(using a fixed concentration of 20 mM fumarate). 
entry nucleophile Km [mM] kcat [s1] kcat/Km [l mol1 s1] 
1 NH3a 85 ± 40 89 ± 12 1040 
2 H2NOHa 151 ± 22 99 ± 5.5 654.3 
3 H2NNH2b 308 ± 49 94 ± 7.6 304.1 
Steady state kinetic parameters were measured in 50 mM phosphate buffer (pH 8.0) at 
22°C. Errors are standard deviations. a [AspB] =  0.041 M, b [AspB] = 0.082 M. 


















Figure 2.8. Lineweaver Burk plot for the addition of different concentration of amine nucleophiles to fumarate; 
kcat and Km were calculated from fitting to the Michaelis Menten equation.  
The kinetic measurements also show that similar Km values for fumarate are found for 
the three AspB-catalyzed amination reactions (table 2.4 and figure 2.9). The kcat values 
obtained with a fixed concentration of amine nucleophile (table 2.4) are slightly lower 
compared to those obtained with a fixed and saturating concentration of fumarate (table 
2.3).21 Nevertheless, these observations suggest that the three different amine 
nucleophiles are optimally positioned in the active site of AspB to carry out an amination 
reaction, and that the binding and positioning of fumarate is not significantly affected by 
the binding of the different amine nucleophiles. 
Table 2.4. Kinetic parameters for the AspB-catalyzed amination of fumarate using different nucleophiles at a 
fixed concentration (c (NH3) = 200 mM, c (H2NOH) = 400 mM, c (H2NNH2) = 750 mM, pH 8.0).Kinetic 
parameters for the AspB-catalyzed addition of different amine nucleophiles to fumarate (using a fixed 
concentration of 20 mM fumarate). 
entry nucleophile Km [mM] kcat [s1] kcat/Km [l mol1 s1] 
1 NH3a 1.61 ± 0.76 59 ± 17 36414 
2 H2NOHa 2.78 ± 0.56 92 ± 11 33166 
3 H2NNH2b 1.54 ± 0.24 31 ± 6.8 20193 
Steady state kinetic parameters were measured in 50 mM phosphate buffer (pH 8.0) at 


















Figure 2.9. Lineweaver Burk plot for the amination of fumarate(with different concentrations of fumarate); kcat 
and Km were calculated from fitting to the Michaelis Menten equation. 
Under the conditions used, the observed initial rates for the AspB-catalyzed addition of 
methoxylamine or methylamine to fumarate were too low to measure accurate kinetic 
parameters. Although a structural basis for this observation is not yet known, the lower 
rates observed with methoxylamine and methylamine suggest that these slightly larger 
amines are not optimally bound in the active site of AspB to undergo an addition 
reaction. 
2.5 Isolation and characterization of N-substituted aspartic 
acids 
The AspB-catalyzed amine additions to fumarate were performed routinely in 5 mM 
phosphate buffer at pH 8.0 and 37°C. The enzyme concentration was varied depending 
on the rate of the reaction. In order to isolate and characterize N-hydroxyaspartic acid, 
the addition of hydroxylamine to fumarate was scaled up to 1.0 mmol of substrate. Using 
9.34 μmol (0.9 mol%) of enzyme the reaction was complete within 15 min, as assessed 
both by UV-analysis and 1H-NMR spectroscopy. Several attempts to purify the 
enzymatically-formed N-hydroxyaspartic acid by ion exchange column chromatography 
on cationic Dowex 50 resin, SPE-SCX cation exchange, and basic Amberlite IRA 140 
all failed. Identification of N-hydroxyaspartic acid as the product of the AspB-catalyzed 
addition of hydroxylamine to fumarate was established by 1H NMR spectroscopy by 
comparison with chemically synthesized N-hydroxyaspartic acid (see 2.5.1). Both 
enzymatically and chemically synthesized N-hydroxyaspartic acid showed the same 
unstable behaviour. After one week of incubation, the signals in the 1H NMR spectrum 
corresponding to N-hydroxyaspartic acid were no longer present. Ottenheijm and 
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Herscheid previously described that N-hydroxyamino acids are highly unstable (see 
2.6.1).22 Attempts towards functionalization of the N-hydroxy and carboxylic acid 



















Scheme 2.03. Enantioselective hydroxylamine addition to fumarate and hydrogenolysis to L-Asp. 
To establish the enantiomeric excess of the enzymatically produced N-hydroxyaspartic 
acid, hydrogenolysis of the N-O bond of N-hydroxyaspartic acid with a catalytic amount 
of PtO2 yielded (S)-aspartic acid in 80% yield and 97% ee (scheme 2.03). Thus, we 
could identify optically active N-hydroxyaspartic acid as the product of the AspB-
catalyzed addition of hydroxylamine to fumarate, but failed to stabilize and isolate this 
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Scheme 2.04. Enantioselective hydrazine addition to fumarate and hydrogenolysis to L-Asp. 
The enzymatic addition of hydrazine to fumarate was scaled up to 5.0 mmol. The stable 
product 2-hydrazinosuccinic acid was successfully purified in quantitative yield by ion 
exchange chromatography (IEC) on cationic Dowex 50 resin. For the determination of 
the enantiomeric excess, the crude 2-hydrazinosuccinic acid was reduced with a catalytic 
amount of PtO2 to give (S)-aspartic acid, which was purified by IEC on cationic Dowex 



















Scheme 2.05. Enantioselective addition of methoxylamine to fumarate and esterification.23 
As the enzymatic addition of methoxylamine to fumarate occurs slowly, we used a 
higher concentration of biocatalyst (1.8 mol% of AspB). The reaction was scaled up to 
1.0 mmol and was allowed to proceed for one week until fumarate was completely 
converted. The resulting N-methoxyaspartic acid could not be purified using 
chromatography on a cationic Dowex 50 resin or column chromatography on silica gel. 
Therefore, the crude N-methoxyaspartic acid was esterified using TMSCl in MeOH, 
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which yielded N-methoxyaspartic acid dimethyl ester 2.35 in 11% yield over two steps 
with an enantiomeric excess >99% (scheme 2.05). The yield of this reaction is very low 














Scheme 2.06. Enantioselective addition of methylamine to fumarate. 
The enzymatic addition of methylamine gave full conversion of fumarate after six days 
of incubation, using 1.4 mol% of AspB. The N-methylaspartic acid was purified by 
column chromatography on silica gel with a yield of 95%,[20] and the pure acid had 
>99% ee (scheme 2.06). The determination of the optical rotation gave a value of []D20 
= +24.5° (c = 0.26 in 1N aq. HCl), which corresponds to the S-(+)-configuration of the 
product according to the literature.24 
The biocatalytic production of these four N-substituted aspartic acids has previously 
been demonstrated for 3-methylaspartate ammonia lyase (methylaspartase).25 In contrast 
to that study a detailed analysis of these reactions including HPLC analysis of the 
products and the determination of kinetic parameters has been presented herein. 
2.6 Chemical synthesis of N-substituted aspartic acids 
2.6.1 N-Hydroxyaspartic acid 
N-hydroxyaspartic acid 2.32 was synthesized to compare the results of biocatalysis and 
chemical synthesis. Therefore, hydroxysuccinic acid 2.37 was first esterified to its 
benzyl ester 2.38 using benzylalcohol and catalytic p-toluenesulfonic acid (p-TsOH) in 
moderate yield (scheme 2.07). Then the hydroxy group was transformed into the triflate, 
followed by in situ addition of benzylhydroxyl amine and base to form the overall 


























Scheme 2.07. Synthesis of benzylated N-hydroxyaspartic acid. 
Upon hydrogenolysis the chemically synthesized N-hydroxyaspartic acid showed the 
same unstable behaviour as the enzymatically synthesized 2.32 (scheme 2.08) discussed 
in paragraph 2.4 (scheme 2.03). 
















Scheme 2.08. Chemical synthesis of N-hydroxyaspartic acid. 
N-hydroxyaspartic acid dimethylester 2.40 was synthesized by aza-Michael addition of 
hydroxylamine to dimethyl maleate 2.41 (scheme 2.09) for comparison with the product 












Scheme 2.09. Synthesis of N-hydroxyaspartic acid dimethylester. 
2.6.2 2-Hydrazinosuccinic acid 
The racemate of 2-hydrazinosuccinic acid 2.33 was synthesized starting from dimethyl 
succinate 2.42 which was converted to N-Boc-protected hydrazino-dimethyl succinate 
2.43 followed by saponification of the methylester with LiOH and subsequent 
deprotection of the Boc-group with trifluoroacetic acid (TFA) (scheme 2.10).28 When the 
deprotection steps were performed in reverse order no complete cleavage of both methyl 
esters was observed. 2-Hydrazinosuccinic acid prepared as described above was 





























Scheme 2.10. Synthesis of racemic 2-hydrazinosuccinic acid. 
2.6.3 N-Methoxyaspartic acid 
The racemate of N-methoxyaspartic acid dimethylester 2.35 was synthesized via 1,4-














Scheme 2.11. Synthesis of N-methyoxyaspartic acid dimethylester. 
Attempts to deprotect both methyl ester groups from 2.35 using base (NaOH or LiOH) 


















Scheme 2.12. Attempted deprotection of N-methoxyaspartic acid dimethyl ester. 
2.7 In situ functionalization of enzymatic products 
2.7.1 N-Hydroxyaspartic acid 
N-Substituted hydroxylamino acids are useful builing blocks for further transformation 
such as aziridine formation (after converting the hydroxy group into a leaving group 
such as a tosyl or trimethylsilyl group and subsequent deprotonation at the acidic -C-H-
position). Ottenheijm and Herscheid previously described that N-hydroxy-acids are 
highly unstable.22 The N-hydroxy group is readily converted to the corresponding nitroso 
compound 2.45, either by air oxidation or disproportionation, which subsequently 
undergoes rapid decarboxylation to the aldoxime 2.46 (scheme 2.13).22,30 However, the 
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Scheme 2.13. Proposed mechanism for the decomposition of N-hydroxyamino acids. 
As the decomposition of N-hydroxyaspartic acid is initiated via the oxidation of its 
hydroxy functionality, protection of the hydroxy group should give a stable compound.  
 


















Scheme 2.14. Attempted protection with pivaloyl chloride. 
First, a protection with pivaloyl chloride was attempted (scheme 2.14). This reaction was 
initially performed as a test with dimethylester 2.41. The obtained product was 55% O-
acylated and 8% N-acylated due tot the fact that both positions are good nucleophiles 
with the N-position slightly more sterically hindered.31 When this reaction was 
performed with the crude N-hydroxyaspartic acid obtained from the enzymatic reaction 

















Scheme 2.15. Attempted silyl protection. 
Next, tert-butyldimethylsilyl cloride was added to the crude N-hydroxyaspartic acid after 
water was removed in vacuum (scheme 2.15). Only decomposed starting material and no 
protection could be observed. In a control reaction, the model substrate 2.41 gave the 



















Scheme 2.16. Attempted protection as nitrone. 
N-hydroxy groups are precursors for the formation of nitrones which could undergo a 
variety of follow up reactions such as [2+3]-addition to isooxazolidines and dimerization 
(by adding base) to oxazolones to give easy access to valuable heterocycles.33 Addition 
of benzaldehyde or pentanal to the freshly prepared and dried 2.32 showed no 



















CO2, H2O  
Scheme 2.17. Attempted ketoacid-hydroxylamine ligation. 
Bode et al. published the ketoacid-hydroxylamine ligation as a new method for peptide 
synthesis.34 Hydroxylamine and -ketoacid form under acidic conditions first an unstable 
hemiaminal which decarboxylates and looses water to give an imidocarbonic acid, which 
readily tautomerizes to give the more stable amide. This decarboxylative condensation 
was tested on hydroxylamine 2.32 produced by AspB. Accordingly, the -ketoacid 
pyruvic acid or phenylpyruvic acid were added and stoichiometric amounts of oxalic 
acid to generate the oxalate salt of the hydroxylamine (scheme 2.17). In some reactions 























Scheme 2.18. Attempted benzyl protection. 
Finally, benzylation of the hydroxy group to product 2.51 was attempted (scheme 2.18). 
Treatment with benzylbromide in the presence of NaH or NEt3 did not yield any 
product35, neither did the addition of benzylbromide and potassium tert-butoxide 
(KOtBu)36. Also, a Misunobu reaction with benzyl alcohol as nucleophile did not yield 
any product 2.51.37 
In summary, no protection method for the nitrogen or oxygen functionality of the 
hydroxylamine in 2.32 could be found. Problems hereby could be that residual water is 
hydrolysing the reagents because acyl chloride, trialkylsilyl chlorides, or benzylbromide 
are sensitive towards hydrolysis. Moreover, the reactions could be not fast enough to 
overcome the rapid decomposition. Furthermore, there are still many buffer salts in the 
reaction mixture which could influence the protection reactions. 
 
In an alternative approach, the carboxylic acid groups were esterified to yield a more 
stable compound. 






























Scheme 2.19. Esterification of N-hydroxyaspartic acid. 
First, esterification under mild conditions with trimethylsilyl diazomethane was 
attempted but it was not successful since the reagent is sensitive towards hydrolysis 
(scheme 2.19). 38,39 However, a second procedure with methanol and concentrated 
sulfuric acid yielded the desired ester although in poor yield and with 40% ee.40 The low 
enantiomeric excess could result from the harsh reaction conditions which could lead to 
partial racemization of the starting material. Next under water free acidic conditions, 
HCl was generated with thionyl chloride in MeOH41 or trimethylsilyl chloride in 
MeOH42 to methylate 2.32, but these methods did not lead to the desired ester either 
(scheme 2.19). 
In summary, esterification of 2.32 was not successful and the methylester 2.41 could not 
be obtained with good enantioselectivity or yield. 
 
In order to analyze the enantiomeric excess of the N-hydroxyaspartic acid formation 
catalyzed by AspB, several methods were exploited to cleave the nitrogen-oxygen bond 
























61% ee  
Scheme 2.20. Hydrogenolysis of N-hydroxyaspartic acid. 
Compound 2.32 was first hydrogenated with Raney-Nickel as catalyst to yield aspartic 
acid (scheme 2.20). After purification with IEC, aspartic acid was analyzed by reversed 
phase HPLC revealing that the ee was 61%. This moderate enantioselectivity could 
result from partial racemization during the reduction.43 Further hydrogenolysis 
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conditions were tested such as zinc in acetic acid, 44 palladium hydroxide on carbon and 
hydrogen gas, 45 samarium iodide in aqueous THF solution, 46 and palladium on activated 
carbon and hydrogen gas,47 but none of these treatments could overcome the rapid 
decomposition of 2.32 nor it was compatible with remaining buffer salts. Finally, 
catalytic platinum oxide in water in the presence of a few drops of acetic acid yielded 
(S)-aspartic acid, which was isolated in 80% yield and 97% ee.  
2.7.2 2-Hydrazinosuccinic acid 
To analyze the enantiomeric excess of the product (2.33) of the AspB catalyzed 
hydrazine addition reaction, attempts were made to transform 2.33 into its dimethyl ester 




















Scheme 2.21. Esterification of 2-hydrazinosuccinic acid. 
Similar reactions as tested for 2.32 were performed: 1) water-free generation of HCl by 
using thionyl chloride in MeOH to esterify the carboxylic acid groups42 and 2) mild 
esterification with trimethylsilyl diazomethane38. Furthermore, under acidic conditions, 
esterification of 2.33 with methanol, generated from 2,2-dimethoxypropane in HCl, was 
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Scheme 2.22. N-Acylation with camphanoyl chloride to form diastereomeric hydrazine adducts. 
To analyse the ee of the product of the enzymatic reaction the hydrazine adduct 2.33 was 
derivatized with ()-camphanoyl chloride, a chiral derivatizing reagent (scheme 2.22).49 
The acylated hydrazine should form diastereomers with the chiral reagent. If the 
hydrazine is present in enantiomeric forms, the diastereomeric ratio can be determined 
by 1H-NMR or chiral GC. However, when using the racemic N-hydrazinyl aspartic acid 
no clear signals belonging to the expected diastereomers could be detected in the 1H-
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NMR spectrum.50 Probably the stereogenic center on the aspartic acid core is too far 




















Scheme 2.23. Hydrogenolysis of 2-hydrazinosuccinic acid. 
Finally, cleavage of the nitrogen-nitrogen bond of 2.33 was tested to give aspartic acid 
for which a separation on reversed phase HPLC was established in order to determine 
the ee of 2.33. 2-Hydrazinosuccinic acid was first hydrogenated with Raney-Nickel as 
catalyst to yield aspartic acid revealing that the ee was 68% (scheme 2.23). The 
moderate enantioselectivity most probably results from partial racemization during the 
reduction. Accordingly, hydrogenolysis with a catalytic amount of platinumoxide and a 
few drops of acetic acid produces (S)-aspartic acid with 99% ee.  
2.8 Conclusion 
The nucleophile promiscuity of aspartase (AspB) from Bacillus sp. YM55-1 was 
exploited for catalyzing stereoselective amination reactions to produce the N-substituted 
aspartic acids (S)-N-hydroxyaspartic acid, (S)-2-hydrazinosuccinic acid, (S)-N-
methylaspartic acid, and N-methoxyaspartic acid with excellent enantioselectivities. 
These non-proteinogenic -amino acids are interesting building blocks for 
peptidomimetics, synthetic enzymes and pharmaceuticals. For example, 2-
hydrazinosuccinic acid is an important structural unit because it represents a turnmimic 
in peptides,51 and several peptides containing this structural motif show antibiotic 
activity.52 When included in peptides, N-methylaspartic acid leads to enhanced 
proteolytic stability and an increase in lipophilicity. However, problems ocurred in the 
further transformation of (S)-N-hydroxyaspartic acid and (S)-2-hydrazinosuccinic acid. 
While this investigation has set the stage for the development of a biocatalytic process 
for the stereoselective synthesis of N-substituted aspartic acid derivatives, the 
biocatalytic scope of AspB is rather limited. Based on the structural characterization of 
the enzyme, protein engineering experiments have started that aim at evolving AspB 
activity towards a broader range of amino compounds.18 The isolation of the N-
hydroxyaspartic acid proved to be difficult due to its instability. An in situ protection of 
the hydroxy group or the acid functionality (as ester) were investigated, but no 
successful procedure could be developed so far. 
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2.9 Experimental  
This project was performed in collaboration with Gerrit J. Poelarends from the 
Department of Pharmaceutical Biology. 
 
General methods. Reagents were purchased from Aldrich, Acros, ABCR, AlfaAesar, 
Merck or Fluka and were used as provided, unless stated otherwise. All solvents were 
reagent grade. THF and Et2O were distilled over Na, CH2Cl2, toluene and n-hexane over 
CaH2. EtOAc for column chromatography was distilled prior to use. Enzymes used for 
the molecular biology procedures, DNA ladders, protein molecular weight standards, 
deoxynucleotide triphosphates (dNTPs), the high pure plasmid isolation kit, the high 
pure PCR product purification kit, and multipurpose agarose were purchased from F. 
Hoffmann-La Roche, Ltd. Oligonucleotides for DNA amplification and sequencing were 
synthesized by Sigma-Aldrich. All biocatalytic reactions were performed in 50 mL 
Greiner tubes, which were shaken at ~100 rpm in a waterbath at 37°C. Buffer and stock 
solutions of fumarate were prepared in distilled water and stored at 4°C. The pH of the 
solutions was adjusted with a Professional Meter PP-15 pH-meter from Sartorius. All 
moisture sensitive reactions were performed in round bottomed or modified Schlenk 
flasks, previously heated with a heatgun under oil pump vacuum, which were fitted with 
rubber septa under a positive pressure of nitrogen. Air- and moisture-sensitive liquids 
and solutions were transferred via syringe. Low temperature reactions were performed 
with a cryostat or in an EtOH/solid CO2 bath. Organic solutions were concentrated by 
rotary evaporation at 40–60°C. Lyophilization was performed with a ALPHA 2-4 LD 
plus freeze dryer from Christ. Flash column chromatography was performed as described 
by Still et al.53 As stationary phase, Silica-P flash silica gel from Silicycle, size 40-63 
m, was used. For TLC analysis silica gel 60 from Merck (0.25 mm) impregnated with a 
fluorescent indicator (254 nm) was used. TLC plates were visualized by exposure to 
phosphomolybdic acid (PMA) stain followed by brief heating with a heatgun. Ion 
exchange chromatography was performed with either Dowex 50 (H+ form) activated 
with 1N HCl and rinsed with distilled water until a neutral pH was obtained (as assessed 
with pH indicator paper), or Amberlite IRA 140 (Cl form) activated with 1N NaOH 
until chloride free and washed with distilled water until a neutral pH was obtained. SPE 
SCX columns were purchased from IST. Optical rotations were recorded with a 
Polartronic MH8 polarimeter from Schmidt + Haensch. The concentrations are given in 
g/100 mL. 1H and 13C NMR spectra were recorded on a Varian VXR-300 (300 MHz), a 
Varian Mercury Plus (400 MHz) or a Varian (500 MHz) spectrometer. Chemical shifts 
for protons are reported in parts per million scale ( scale) downfield from 
tetramethylsilane and are referenced to residual protium in the NMR solvents (CHCl3:  
= 7.25, H2O:  = 4.67). Chemical shifts for carbon are calibrated to the middle signal of 
the 13C-triplet of  the solvent CDCl3 ( = 77.0). HPLC spectra were obtained using a 
Shimadzu LC-20AD equipped with a Chiralcel columns. Reversed phase HPLC was 
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performed on a Shimadzu LC-10AD VP using either a C6 Crownpack column or an 
Astec CLC-L column. Kinetic data were obtained on a Jasko V-550, V-560, or V-570 
UV-spectrophotometer.  
 
Construction of the expression vector for the production of AspB: The aspB gene 
was amplified by PCR using two synthetic primers, the coding sequence for the 
aspartase in plasmid pUCBA5 as the template (a kind gift Dr. Y. Kawata, Tottori 
University, Japan), and PCR reagents supplied in the Expand High Fidelity PCR system 
following the protocol supplied with the system (F. Hoffman-La Roche, Ltd.). The 
forward primer (5’-ATACCATGGATACCGATGTTCG-3’) contains a NcoI restriction 
site (in bold) followed by 13 bases corresponding to the coding sequence of the aspB 
gene. The reverse primer (5’-CATAAGCTTTTTTCTTCCAGCAATTCC-3’) contains a 
HindIII restriction site (in bold) followed by 18 bases corresponding to the 
complementary sequence of the aspB gene. The resulting PCR product and the 
pBAD/Myc-His A vector (Invitrogen) were digested with NcoI and HindIII restriction 
enzymes, purified, and ligated using T4 DNA ligase. Aliquots of the ligation mixture 
were transformed into competent E. coli TOP10 cells. Transformants were selected at 
37°C on LB/ampicillin plates. Plasmid DNA was isolated from several colonies and 
analyzed by restriction analysis for the presence of the insert. The cloned aspB gene was 
sequenced to verify that no mutations had been introduced during the amplification of 
the gene. The newly constructed expression vector was named pBAD(AspB-His) 
 
Expression and purification of AspB-His: The AspB enzyme was produced in E. coli 
TOP10 cells using the pBAD expression system. Fresh TOP10 cells containing 
pBAD(AspB-His) were collected from a LB/ampicillin plate using a sterile loop and 
used to inoculate 1 L of LB/ampicillin medium that contained 0.04% (w/v) arabinose. 
After overnight growth at 37°C and 200 rpm, the cells were harvested by centrifugation 
(10 min at 6000 rpm at 4°C in a JA-10 rotor) and stored at 20 °C until further  use.  
In a typical purification experiment, cells of three 1 L-cultures were thawed, combined, 
and suspended in 15 mL lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 
pH 8.0). Cells were disrupted by sonication for 10x1 min (with 3-5 min rest in between 
each cycle) at 60 W output, after which unbroken cells and debris were removed by 
centrifugation (30 min at 15000 rpm at 4°C in a JA17 rotor). The supernatant was 
filtered through a 0.45 μM-pore diameter filter and incubated with Ni-NTA (4x1 mL 
slurry in small columns at 4°C for two nights), which had previously been equilibrated 
with lysis buffer. The non-bound proteins were eluted from the column by gravity flow. 
The columns were first washed with lysis buffer (10 mL per column) and then with 
buffer A (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0; 10 mL per 
column). Retained proteins were eluted with buffer B (50 mM NaH2PO4, 300 mM NaCl, 
250 mM imidazole, pH 8.0; 3.0 mL per column). Fractions (~0.5 mL) were analyzed by 
SDS-PAGE on gels containing 12% acrylamide, and those that contained purified 
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aspartase were pooled and concentrated to a protein concentration of about 9.4 mg/mL in 
50 mM NaH2PO4 (pH 8.0) using an Amicon stirred cell equipped with a YM30 (30.000 
MW cutoff) ultrafiltration membrane. The purified enzyme was stored at 80°C until 
further use. Protein was analyzed by polyacrylamide gel electrophoresis (PAGE) under 
either denaturing conditions using sodium dodecyl sulfate (SDS) or native conditions on 
gels containing 12% polyacrylamide. The gels were stained with Coomassie brilliant 
blue. Protein concentrations were measured using the Waddell method.54 DNA 
sequencing was performed by GATC Biotech. Melting points were determined on a 
Büchi Melting Point B-545. GC-MS data were recorded on a Hewlett Packard HP6890 
equipped with a HP1 column and an HP 5973 mass selective detector 
 
Colorimetric assay for ammonia detection: The deamination of potential amino acid 
substrates was monitored by following ammonia production upon incubation with the 
different compounds. Accordingly, an appropriate amount of enzyme was incubated in a 
microtiter plate with an amino acid (150 μL of a 25 mM solution) in 100 mM Na2HPO4 
buffer (pH 9.0). After incubation of the plate at 37°C for 18 h, a drop of 1.5 M 
trichloroacetic acid followed by 100 μL of Nessler’s reagent were added. A red-brown 
color indicated the presence of AspB activity. 
 
Kinetic studies: For determining the kinetic parameters for the AspB-catalyzed 
deamination of L-aspartate, the kinetic assays were performed at 25°C by following the 
increase in absorbance at 240 nm, which corresponds to the formation of fumarate 
(=2530 M-1 cm-1). An aliquot of AspB was diluted into 50 mM NaH2PO4 buffer (pH 8.5), 
yielding a final enzyme concentration of 0.08 μM, and incubated for 60 min at 25°C. 
Subsequently, a 1 mL portion was transferred to a 10 mm quartz cuvette and the enzyme 
activity was assayed by the addition of a small quantity (1-10 μL) of sodium-L-aspartate 
from a stock solution. The stock solution was made up in 50 mM NaH2PO4 buffer (pH 
8.5). The concentrations of L-aspartate used in the assay ranged from 5 to 100 mM. 
For determining the kinetic parameters for the AspB-catalyzed addition of amines to 
fumarate, the kinetic assays were performed at 22°C and the decrease in absorbance was 
followed at 270 nm, which corresponds to the depletion of fumarate (=555 M-1 cm-1).[27] 
To determine the Km for fumarate, an aliquot of AspB was diluted into 50 mM NaH2PO4 
buffer (pH 8.0) containing a fixed concentration of amine (ammonia 200 mM, 
hydroxylamine 400 mM, hydrazine 750 mM, all titrated to pH 8.0) yielding a final 
enzyme concentration of 0.0179 μM (0.0358 μM when using hydrazine). Subsequently, a 
1 mL portion was transferred to a 10 mm quartz cuvette and the enzyme activity was 
assayed by the addition of a small quantity of fumarate from a stock solution made up in 
50 mM NaH2PO4 buffer (pH 8.0). The concentrations of fumarate used in the assay 
ranged from 0.10 to 3.75 mM. To determine the Km for the amine nucleophile, the 
incubation mixtures contained various concentrations of nucleophiles ranging from 
20571 mM, 0.041 μM of AspB (0.081 μM when using hydrazine) and 50 mM phosphate 
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buffer (pH 8.0). A 350 μL portion of this solution was transferred to a 1 mm quartz 
cuvette, and reactions were started by adding 20 mM of fumarate. The kinetic data were 
fitted by nonlinear regression data analysis using the Grafit program (Erithacus Software 
Ltd.). 
 
General procedure for nucleophile screening: The nucleophile screening was 
recorded on a Varian Inova 500 NMR spectrometer using a pulse sequence for selective 
presaturation of the water signal. The reactions were performed in a NMR tube with a 
volume of 550 μL at room temperature, and 1H-NMR spectra were recorded after 1 day, 
1 week, 2 weeks and 3 weeks. A sample contained initially 9.34 μmol or 8.95 μmol of 
AspB, 25 mmol of fumarate and 10 eq. of nucleophile. The nucleophile was dissolved in 
50 mM phosphate buffer containing D2O in order to decrease the water signal in the 
spectrum. The total volume was adjusted to 550 μL using buffer in D2O. At the same 
time a blank sample without AspB was monitored. The reactions were monitored at 
different pH values (pH 7.0, 8.0, and 9.5). 
 
N-Hydroxyaspartic acid 2.32. To a solution of hydroxylamine hydrochloride (0.69 g, 
10.0 mmol) in 5 mM phosphate buffer, 5N aq. NaOH was added until 
pH 8.0 was reached. 1 mL of a 1M stock solution of fumarate (1.00 
mmol) at pH 8.0 were added, and the Greiner tube was filled up to 15 
mL with 5 mM phosphate buffer at pH 8.0. After addition of AspB (50 
μL, 0.009 mmol) from a frozen stock, the tube was shaken at 100 rpm at 37°C for 30 
min. The solvent was evaporated, and a white gum obtained. 1H NMR (400 MHz, D2O) 
=2.29 (dd, 2J=15.8 Hz, 3J=9.0 Hz, 1H; CH2), 2.50 (dd, 2J=15.8 Hz, 3J=4.2 Hz, 1H; 
CH2) 3.65 (dd, 3J=8.6 Hz, 3J=4.6 Hz, 1H; CH). Attempts to purify the product by ion 
exchange chromatography lead to decomposition of the material. 
 
2-Hydrazinosuccinic acid 2.33. To a solution of hydrazine (35% in water, 5.20 mL, 
50.0 mmol) in 5 mM phosphate buffer 6N aq. HCl was added till pH 
8.0 was reached. 10 mL of a 500 mM stock solution of fumarate (5.00 
mmol) at pH 8.0 were added, and the Greiner tube was filled up to 25 
mL with 5 mM phosphate buffer (pH 8.0). After addition of AspB 
(80.0 μL, 0.014 mmol) from a frozen stock, the tube was shaken at 95 rpm at 37°C. The 
reaction was continued to completion, as confirmed spectrophotometrically by 
disappearance of absorption at 240-270 nm. The solvent was evaporated and the oily 
residue was purified by ion exchange column chromatography on a cationic Dowex 50 
(H+, 20-50 mesh, washed with water) by elution with 2.5% aq. NH3-solution. After 
evaporation of the solvent and lyophilization, the product (0.741 g, 5.00 mmol, 100%)55 
was obtained quantitatively as colourless gum. []D20= 16.1 (c=0.557 in 1N HCl); 1H 
NMR (500 MHz, D2O) =2.31 (dd, 2J=16.1 Hz, 3J=8.3 Hz, 1H; CH2), 2.49 (dd, 2J=16.1 













MHz, D2O) =36.9 (CH2), 62.8 (CH), 175.8 (CO2H), 178.4 (CO2H); m/z (ESI): 149.1 
(M+1), 171.1 (M+Na+), 147.1 (M1). 
 
N-Methoxyaspartic acid 2.34. O-Methylhydroxylamine hydrochloride (4.18 g, 50.0 
mmol) was dissolved in 5 mM phosphate buffer (10 mL) and 5N NaOH 
was added until pH 8.0 was reached. 10 mL of a 500 mM stock 
solution of fumarate (5.00 mmol) at pH 8.0 were added, and the 
Greiner tube was filled up to 50 mL with 5 mM phosphate buffer (pH 
8.0). After addition of AspB (500 μL, 0.090 mmol) from a frozen stock, the tube was 
shaken at 100 rpm at 37°C. The progress of the reaction was monitored 
spectrophotometrically. After 9 d, no absorption at 240-270 nm was observed, indicating 
that the reaction was completed. The solvent was evaporated and the white residue 
lyophilized, and used without further purifcation. 1H NMR (400 MHz, D2O) =2.39 (dd, 
2J=15.2 Hz, 3J=8.0 Hz, 1H; CH2), 2.58 (d, 2J=15.2 Hz, 3J=5.2 Hz, 1H; CH2), 3.59 (s, 3H; 
OCH3), 3.85 (dd, 3J=7.6 Hz, 3J=5.2 Hz, 1H; CH); 13C NMR (75.4 MHz, D2O) =34.5 
(CH2), 61.5, 63.0, 179.9 (CO2H), 180.2 (CO2H). 
 
N-Methoxyaspartic acid dimethylester 2.35. A suspension of the crude lyophilized N-
methoxyaspartic acid (5.00 mmol) containing buffer salts in MeOH 
(18 mL) was cooled on ice and TMSCl (4.00 mL, 31.5 mmol, 6.3 
eq.) was added dropwise. A precipitate occurred, and the solution 
was stirred at room temperature over night. After removal of the 
solvent, the product was purified by flash chromatography on silica gel (n-pentane : 
EtOAc = 2:1) yielding a colorless oil (0.107 g, 0.560 mmol, 11%). []D20= 3.6 (c=1.4 in 
CHCl3); 1H NMR (300 MHz, CDCl3) =2.71 (dd, 2J=16.3 Hz, 3J=7.3 Hz, 1H; CH2), 2.83 
(dd, 2J=16.3 Hz, 3J=6.0 Hz, 1H; CH2), 3.51 (s, 3H; OCH3), 3.71 (s, 3H; CO2CH3), 3.76 
(s, 3H; CO2CH3), 4.03 (dd, 3J=6.8 Hz, 3J=6.8 Hz, 1H; CH), 6.26 (bs, 1H; NH); 13C NMR 
(75.0 MHz, D2O) =34.0 (CH2), 52.0 (OCH3), 52.4 (OCH3), 59.8 (CH3), 62.4 (CH), 
171.2 (CO2Me), 172.0 (CO2Me); m/z (EI) 191 (M+), 160 (MOMe), 132 (MCO2Me); 
HRMS calcd. for C6H10NO4: 160.0610; found: 160.0612; HPLC (Chiralpak OD-H, 
heptane: i-PrOH 95:5, flow 0.5 mL/min) 19.1 (minor), 21.9 min (major), 99% ee. 
 
N-Methylaspartic acid 2.36. To a solution of methylamine (40% in water, 4.20 mL, 
50.0 mmol) in 5 mM phosphate buffer 6N aq. HCl was added until pH 
8.0 was reached. 10 mL of a 500 mM stock solution of fumarate (5.00 
mmol) at pH 8.0 were added, and the Greiner tube was filled up to 50 
mL with 5 mM phosphate buffer (pH 8.0). After addition of AspB (400 
μL, 0.072 mmol) from a frozen stock, the tube was shaken at 100 rpm at 37°C for 7 
days. The reaction was followed to completion, as confirmed spectrophotometrically 
until no absorption at 240-270 nm was observed. The solvent was evaporated and the 
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H2O = 3:3:3:2). After evaporation of the solvent and lyophilization, the product (95%)55 
was obtained as white gum. []D20= +24.6 (c=0.256 in 1N aq. HCl); 1H NMR (300 MHz, 
D2O) =2.62 (s, 3H; CH3), 2.88 (d, 3J=8.5 Hz, 2H; CH2), 3.75 (dd, 3J=8.8 Hz, 3J=8.8 Hz, 
1H; CH); 13C NMR (125 MHz, D2O) =31.2 (CH2), 34.7 (CH3), 60.1 (CH), 172.9 
(CO2H), 176.8 (CO2H); m/z (ESI) 146.2 (M1). HPLC (Astec CLC-L, 2 mM CuSO4 in 
H2O : MeOH = 90 : 10, flow 1.0 mL/min, 40°C) 9.2 min (L-N-MeAsp), 11.4 min (D-N-
MeAsp), 99.5% ee. 
 
(S)-Aspartic acid from N-hydrazinosuccinic acid. The crude 2-hydrazinosuccinic acid 
(5.0 mmol) was dissolved in H2O (12 mL), and a catalytic amount of PtO2, followed by 
3 drops of concentrated acetic acid, were added. A hydrogen balloon was placed on top 
of the Schlenck flask and the solution stirred vigorously over night. The mixture was 
filtered over celite and the filtrate was evaporated. The crude aspartic acid was purified 
by IEC on cationic Dowex 50 (H+, 20-50 mesh, washed with water) by elution with 5% 
NH3-solution and lyophilized. From 2-hydrazinosuccinic acid: HPLC (Astec CLC-L, 
2mM CuSO4 in H2O : MeOH 90 = 10, flow 1.0 mL/min, 40°C) 6.3 min (D-Asp), 7.4 min 
(L-Asp), 99.5% ee. From N-hydroxyaspartic acid: HPLC (C6 Crownpack, HClO4, pH 
2.0, flow 0.3 mL/min, 0°C) 4.33 min (D-Asp), 6.23 (L-Asp), 97% ee. 
 
(S)-Aspartic acid 2.02. Data according to literature: 1H NMR (300 MHz, D2O) =2.55 
(dd, 2J=17.4 Hz, 3J=8.7 Hz, 1H; CH2), 2.69 (dd, 2J=17.5 Hz, 3J=4.1 
Hz, 1H; CH2), 3.76 (dd, 3J=9.0 Hz, 3J=3.6 Hz, 1H; CH). HPLC (C6 
Crownpack, HClO4, pH 2.0, flow 0.3 mL/min, 0°C) 4.33 min (D-Asp), 
6.23 (L-Asp), 99% ee. 
 
2-Hydroxysuccinic acid dibenzylester 2.38. 
p-TsOH (1.47 g, 7.74 mmol, 10.0 mol%) was added to benzylalcohol 
(15.5 mL, 155 mmol, 2.00 eq.) and DL-malic acid (10.0 g, 75.6 
mmol, 1.00 eq.) in benzene (150 mL) and heated to reflux using a 
Dean-Stark condensor for 4h. After cooling to room temperature the 
mixture was washed with H2O, 5% aqueous Na2CO3 solution, saturated aqueous 
NaHCO3 solution and brine. After drying over MgSO4 the solvent was evaporated in 
vacuum, and the residue purified by flash column chromatography on silica gel (CH2Cl2 
: MeOH 2% -> 5%) to yield a yellow oil (12.6 g, 40.0 mmol, 53%). Spectral data were 












N-Benzyloxyaspartic acid dibenzylester 2.39. To benzylester 2.38 (3.28 g, 20.6 mmol, 
2.00 eq.) in anhydrous CH2Cl2 (30.0 mL) at 78°C, triflic anhydride 
(2.66 mL, 16.0 mmol, 1.53 eq.) was added, and the mixture stirred 
for 5 min. Then, 2,6-lutidine (1.40 mL, 12.0 mmol, 1.15 eq.) was 
added. After stirring, O-benzylhydroxylamine (2.54 g, 20.6 mmol, 
2.00 eq.) in anhydrous CH2Cl2 (10 mL) was added dropwise, the mixture warmed to 
room temperature and stirred for 2 h. The solvent was removed in vacuum, and the crude 
product purified by flash column chromatography on silica gel (n-hexane : EtOAc 80:20) 
to a coulourless oil (0.77 g, 1.80 mmol, 18%).26 1H NMR (300 MHz, CDCl3) =2.75 (dd, 
2J= 16.3 Hz, 3J=7.3 Hz, 1H: CH2), 2.89 (dd, 2J= 16.3 Hz, 3J=5.8 Hz, 1H: CH2), 4.05-
4.15 (m, 1H; CH), 2.63-2.67 (m, 2H; CH2), 5.09 (d, 3J=4.8 Hz, 2H: CH2), 5.17 (d, 3J=4.5 
Hz, 1H: CH2), 7.23-7.36 (m, 15H; CH). 13C NMR (75 MHz, CDCl3) =34.3 (CH2), 60.2 
(CH2), 66.6 (CH2), 67.1 (CH2), 76.6 (CH), 127.8 (CH), 128.2 (CH), 128.3 (CH), 128.3 
(CH), 128.3 (CH), 128.4 (CH), 128.5 (CH), 135.3 (C), 135.6 (C), 137.3 (C), 170.5 (CO), 
171.4 (CO). 
 
N-Hydroxyaspartic acid dimethylester 2.41. Hydroxylamino hydrochloride ( 0.49 g, 
7.0 mmol, 1.2 eq.) was stirred in 1M aq. NaOH (7.0 mL, 7.0 
mmol, 1.2 eq.) for 5 min and then added dropwise to dimethyl 
maleate (0.72 mL, 5.8 mmol, 1.0 eq.). After stirring for 5 min, 
CH2Cl2 was added, the organic layer dried over MgSO4 and the 
solvent evaporated in vacuum. The crude ester was purified by flash column 
chromatography on silica gel (CH2Cl2 : Et2O, 1:3) to give the product as a coulourless oil 
(0.45 g, 2.5 mmol, 44%).27 1H NMR (400 MHz, CDCl3) =2.60(dd, 2J=16.0 Hz, 3J=7.2 
Hz, 1H; CH2), 2.73 (dd, 2J=16.0 Hz, 3J=6.0 Hz, 1H; CH2), 3.67 (s, 3H; CH3), 3.74 (s, 
3H; CH3), 3.93 (dd, 3J=6.6 Hz, 1H; CH), 5.65 (bs, 1H; OH). 13C NMR (100 MHz, 
CDCl3) =26.0 (CH3), 33.9 (CH2), 61.6 (CH), 171.0 (CO), 172.4 (CO). 
 
N-tert-Butoxycarbonyl-2-hydrazinosuccinic acid dimethylester 2.43. Triflic 
anhydride (1.70 mL, 11.4 mmol, 1.15 eq.) was added to dimethyl 
hydroxysuccinate (1.62 g, 9.99 mmol, 1.00 eq.) in dry CH2Cl2 (25 
mL) at 0°C. After stirring for 5 min, 2,6-lutidine (1.60 mL, 13.7 
mmol, 1.37 eq.) was added. After stirring for 5 min, Boc-hydrazine 
(2.64 g, 20.0 mmol, 2.00 eq.) in dry CH2Cl2 (10 mL) was added dropwise, and the 
mixture stirred for 2h at room temperature. The solvent was evaporated and the product 
purified by flash column chromatography (CH2Cl2 . Et2O 3:1) to a colourless liquid (1.92 
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Chapter 3 
Synthesis of - and -aryl-amino acids 
catalyzed by phenylalanine amino mutase 
 
Phenylalanine amino mutase (PAM) from Taxus chinensis catalyzes the stereoselective 
isomerization of -phenylalanine to -phenyalanine. Mechanistic studies show that 
trans-cinnamic acid is an intermediate in this transformation. The synthetic strategy 
described here shows that the addition of ammonia to cinnamic acid derivates gives - 
and -amino acids with excellent enantioselectivities of >99%. The / distribution is 
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Phenylalanine aminomutase (PAM) from Taxus chinensis, a Pacific Yew tree, catalyzes 
the key step in the biosynthesis of the phenylisoserin side chain of the antitumor drug 
paclitaxel 3.01 (Taxol, figure 3.1).1,2 Current commercially available Taxol is made 
semi-synthetically; the side chain is synthesized by a chemical route and is subsequently 
attached to 10-deacetyl-baccatin III, which is a more abundant metabolite from Taxus 
chinensis.3 In the biosynthetic pathway, the phenylisoserine side chain is constructed in 
five steps: 1) conversion of (S)--phenylalanine to (R)--phenylalanine catalyzed by 
PAM,4 2) ligase catalyzed activation to the corresponding CoA ester,5 3) transfer of the 
activated -phenylalanine to the C-13 hydroxy group of baccatin III catalyzed by CoA 
acyltransferase,6 4) hydroxylation at the C-2 of the side chain catalyzed by cytochrome 
















Figure 3.1. Structure of Taxol. 
One key step in the Taxol-biosynthesis is the isomerization of (S)--phenylalanine to 
(R)--phenylalanine first demonstrated in cell-free extracts from Taxus brevifolia 
(scheme 3.01).4 By deuterium labeling and kinetic isotope measurements, the 
mechanism of this hydrogen transfer has been elucidated. It turns out that the same 
hydrogen shifts from the C-3 to the C-2 position via elimination and addition (scheme 
3.01).8 The shift of the amino group from C-3 of the substrate to C-2 of the product 
proceeds also with retention of configuration, and the pro-3S hydrogen shifts to C-2 of 
(R)--Phe with retention of configuration. A primary kinetic isotope effect calculated for 
the C-H bond of the substrate indicates that C-H bond cleavage is rate limiting. From 
these data, Walker et. al have proposed that PAM binds the carboxylate and phenyl ring 
in a syn-periplanar orientation in the active site.8 The amino group and the pro-3S 
hydrogen of -Phe are therefore positioned on the same side of the molecule, and 
exchange and reattachment can occur from this side with retention of configuration. This 
orientation should show (Z)-cinnamic acid as intermediate, however, (Z)-cinnamic acid 
was not identified as substrate or inhibitor for PAM (see paragraph 2.4).9 The 
stereochemistry observed in the reaction of PAM should be related to another 
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mechanism, which could include rotation or distortion of the intermediate cinnamate. Up 















Scheme 3.01. Isomerization of -Phe to -Phe catalyzed by PAM. 
Walker has shown that various aromatic -amino acids can be synthesized from their 
corresponding -amino acids using PAM.10 Studies with fluorine substituents in o-, m- 
and p-position of these amino acids reveal that electron withdrawing substituents 
enhance the activity.  
PAM relies on the internal cofactor 4-methylideneimidazol-5-one (MIO) 3.07 in its 
active site. MIO is formed by posttranslational modification from the internal tripeptide 
Ala-Ser-Gly 3.04 by executing mechanical pressure during protein folding (scheme 
3.02).11,12 PAM belongs to a family of enzymes, which also includes the recently 
characterized tyrosine aminomutase (TAM) from Strepteomyces globiporus13 and shows 
high sequence similarity to the family of phenylalanine ammonia lyase (PAL)14 and 
histidine ammonia lyase (HAL)15. All members of that family contain the MIO cofactor. 
MIO, which is a more electrophilic version of dehydroalanine, is formed by cyclization 
of glycine with alanine to give intermediate 3.05, from which then two molecules of 









































Scheme 3.02. Mechanism for the formation of MIO. 
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The catalytic mechanism of this enzyme family has been extensively investigated and 
debated.11 Even with crystal structures of PAL14 and HAL15 available no agreement has 
yet been achieved.  
Two mechanisms were suggested for PAL/HAL and aminomutases (PAM and TAM), 
both of them are E1cb-like.9,11 In the suggested Friedel-Crafts mechanism the aromatic 
ring is involved in a nucleophilic attack from the o-position on the terminal carbon of 
MIO forming a MIO-phenylalanine adduct with a positive charge delocalized in the 
former phenyl ring (scheme 3.03).16 A base abstracts the -proton and from the resulting 
intermediate ammonia and MIO are released, gaining back the aromaticity of the phenyl 
ring and leading to cinnamic acid. In the PAL catalyzed reaction cinnamic acid and 
ammonia are now released, while PAM catalyzes a hydroamination adding ammonia to 








































Scheme 3.03. Friedel-Crafts mechanism for PAM . 
The alternative carbanion mechanism starts with conjugate addition of the amino group 
at C-2 to the terminal ,-unsaturated alkene of MIO giving a protonated ammonia-MIO 
adduct (scheme 3.04).14 The acidity of the C-3 proton is thus increased,17 and it is 
deprotonated to give a carbanion intermediate which is further stabilized through the 
inductive effect of the phenyl ring. Then, the ammonia-MIO adduct is eliminated and in 
a reverse conjugate amine addition added to C-3 while C-2 is protonated giving a MIO-
-phenylalanine adduct. Finally, MIO is released and -Phe is formed.  
 




















































Scheme 3.04. Carbanion-mechanism for PAM . 
Poppe and Rétey have favoured the Friedel-Crafts mechanism because they argue that 
stabilization of the carbanion through the protonated amino group and the phenyl ring 
would not be sufficient because the C-3 proton has a pKa of >40.11 On the other hand the 
energy to eliminate the aromaticity at the expense of 36 kcal/mol is also high.18 The 
enzyme shows 10-20% higher activity with m-tyrosine as substrate than with -Phe, and 
with p-tyrosine lower activity is observed which the authors explain through enhanced 
nucleophilicity of the phenyl ring through resonance with an attack from the o-position if 
the Friedel-Crafts mechanism plays a role.19 However, x-ray analysis of cocrystals of 
,-difluoro--tyrosin with TAM revealed an electron density that fits with an amine-
bound-MIO-adduct, therefore supporting the carbanion mechanism.20 Furthermore, the 
crystal structure of PAL supports the carbanion mechanism.14 MIO is not the only 
responsible factor for lowering the pKa of the C-3 proton. The carbanion can be 
stabilized through the influence of dipole moments of six -helices which point with 
their positive poles towards the environment of the active site. This observation would 
strongly disfavour a mechanism with a cationic intermediate. The basicity of the general 
histidine base that deprotonates the C-3 group is also enhanced by a nearby negative 
dipole of a helix. The observation by Walker and co-workers, that electron withdrawing 
substituents on the phenyl ring enhance the activity, also supports the carbanion 
mechanism through increased acidity on C-3.10 
PAL (EC 4.3.1.5) from Rhodosporidium toruloides is a homotetramer with four active 
sites, which catalyzes the reversible deamination of (S)--phenylalanine to cinnamic acid 
(scheme 3.05).14 This enzyme plays a key role in the secondary phenylpropanoid 
metabolism in plants,21 and is important in plant stress reponses.22 Trans-cinnamate is a 
precursor for compounds which are essential for mechanical support such as lignin.23 
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PAL from parsley24 has been used in the biocatalytic production of -amino acids in the 
reverse reaction, i.e. by the addition of high concentrations of ammonia to cinnamic acid 
derivatives. A variety of aryl substituted (2-fluoro, 3-fluoro, 4-fluoro, 2,5-difluoro, 3,5-
difluoro, pentafluoro, 2-chloro, 3-chloro, 4-chloro, 2,5-dichloro, 3-bromo, 3-cyano, 4-
cyano, 3-hydroxy, 4-hydroxy, 2-nitro, 3-nitro, 2-naphthyl phenylalanine)25, 2-naphthyl 
phenylalanine and heteroaromatic (2-pyridyl, 3-pyridyl, 4-pyridyl, and 3-thienyl)26 -










Scheme 3.05. Deamination of -Phe catalyzed by PAL. 
In contrast to ammonia lyases, aminomutases do not release the ,-unsaturated 
carboxylic acid but catalyze the re-addition of ammonia to the -position, thus 
preventing ammonia lyase activity (scheme 3.01). It is shown in this chapter that the 
addition of ammonia to cinnamic acids can be used to produce enantioenriched - and -
amino acids. For the investigation of the scope of the PAM catalyzed reaction, a series of 
cinnamic acids were synthesized as well as the corresponding - and -substituted amino 
acids.  
Chapter 3: Synthesis of - and -aryl-amino acids catalyzed by phenylalanine amino mutase 
 93
2.2 Synthesis of cinnamic acid derivatives 
Cinnamic acid derivatives were synthesized via Knoevenagel condensation of 
benzaldehyde derivatives with malonic acid and catalytic amounts of piperidine (table 
3.1). All compounds were obtained in very good yields. 











entry R compound yield [%] 
1 2-F  3.10 99 
2 2-Cl  3.11 93 
3 2-Br  3.12 73 
4 3-F  3.13 99 
5 3-Cl  3.14 96 
6 3-Br  3.15 92 
7 4-Br  3.16 88 
8 4-Et  3.17 96 
9 4-n-Pr  3.18 92 
10 4-NO2  3.19 95 
11 4-tert-Bu  3.20 99 
 
By hydrogenation of the corresponding alkyne with Lindlar’s catalyst and hydrogen gas, 
(Z)-ethyl cinnamate 3.21 was synthesized, and subsequently hydrolyzed with base to 










48% 97%  
Scheme 3.06. Synthesis of (Z)-cinnamic acid. 
2.3 Synthesis of amino acids 
2.3.1 Synthesis of -amino acids  
A sequence involving Knoevenagel condensation with methyl isocyanoacetate and 
substituted benzaldehyde derivatives as electrophiles, followed by homogeneous or 
heterogeneous hydrogenation, and deprotection of both the amine and the ester moiety 




























Scheme 3.07. Synthesis of racemic -amino acids. 
Methyl isocyanoacetate 3.24 reacts with catalytic amounts of copper(I) to form an 
organocopper-isocyanide adduct where the acidic -hydrogen is replaced by Cu(I).27 
This intermediate adds to the aldehyde to form a tetrahedral intermediate, which cyclizes 
to a 2-oxazoline releasing the copper catalyst. Upon addition of the base t-BuOK, ring 
opening yields the N-formyl-dehydroamino acid ester.27,28 All products were obtained as 
a mixture of (E)- and (Z)-isomers in moderate to good yields ranging from 35-74% (table 
















Table 3.2. Synthesis of N-formyl-dehydroamino acid esters. 
entry R compound yield [%] 
1 2-F  3.25 42 
2 2-Cl  3.26 53 
3 2-Br  3.27 39 
4 3-F  3.28 67 
5 3-Cl  3.29 48 
6 3-Br  3.30 35 
7 3-Me  3.31 74 
8 4-Br 3.32 57 
9 4-CF3  3.33 70 
10 4-Et  3.34 55 
11 4-n-Pr 3.35 58 
 
In order to avoid dehalogenation, halogen substituted N-formyl-dehydroamino esters 
were homogeneously hydrogenated employing 1 mol% of Rh(COD)2BF4 and 2 mol% of 
triphenylphosphine as catalyst with 20 bar of hydrogen gas in an autoclave (table 3.3).28b 
The N-formylamino esters were obtained in very good yields. Due to their low solubility 
in CH2Cl2, 2-bromo- and 3-bromo-substituted dehydroamino esters 3.38 and 3.41 were 
dissolved in CHCl3 and the hydrogenation was performed at 60°C (table 3.3, entry 3, 6), 
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leading in case of 2-bromo substrate 3.38 to lower yield. Alkyl substituted substrates 
3.42, 3.45 and 3.46 could be hydrogenated using Pd on activated carbon as a 




















Table 3.3. Hydrogenation of dehydroamino esters. 
entry R compound yield [%] 
1 2-F  3.36a 97 
2 2-Cl  3.37a 86 
3 2-Br  3.38a 58 
4 3-F  3.39a 91 
5 3-Cl  3.40a 84 
6 3-Br  3.41a 91 
7 3-Me b 3.42 85 
8 4-Br  3.43a 83 
9 4-CF3  3.44a 80 
10 4-Et  3.45b 94 
11 4-n-Pr  3.46b 83 
a homogeneous hydrogenation using Rh(COD)2BF4 and 
PPh3; b heterogeneous hydrogenation using Pd/C. 
Deprotection of the amino group was achieved using 6N aq. HCl in methanol but the 
esters were only partly hydrolyzed. The crude amino acid esters were deprotected using 
aqueous LiOH, and the corresponding amino acids were crystallized as their 













2) LiOH, MeCN, H2O
 
Table 3.4. Synthesis of -amino acids. 
entry R compound yield [%] 
1 2-F  3.47 54 
2 2-Cl  3.48 34 
3 2-Br  3.49 84 
4 3-F  3.50 91 
5 3-Cl  3.51 34 
6 3-Br  3.52 88 
7 3-Me  3.53 99 
8 4-Br  3.54 80 
9 4-CF3  3.55 87 
10 4-Et  3.56 99 
11 4-n-Pr 3.57 37 
 
The -amino acids were used for the chromatographic separation of - and -
regioisomers and for the analysis, identification and characterization of the enantiomers 
of the - and -amino acids produced by PAM. 
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2.3.2 Synthesis of -amino acids 
The racemic -amino acids were synthesized via the Rodionov reaction (table 3.5).30 
Ammonia is produced in situ from ammonium acetate, and forms an imine with the 
aldehyde at which malonic acid is attacking. A subsequent decarboxylation provided the 












Table 3.5. Synthesis of -amino acids. 
entry R compound yield [%] 
1 2-F  3.58 41 
2 2-Cl  3.59 31 
3 2-Br  3.60 13 
4 3-F  3.61 67 
5 3-Cl  3.62 56 
6 3-Br  3.63 55 
7 3-Me  3.64 56 
8 4-Br  3.65 29 
9 4-Et  3.66 60 
10 4-n-Pr  3.67 31 
11 4-i-Pr 3.68 60 
12 4-NO2  3.69 21 
 
The -amino acids were used for separation of - and -regioisomers and for the 
analysis, identification and characterization of the enantiomers of the - and -amino 
acids produced by PAM. 
2.4 Synthesis of - and -amino acids using PAM 
PAM exhibits ammonia lyase activity as previously discussed (paragraph 3.1). The use 
of the reverse lyase reaction, i.e. the addition of ammonia to cinnamic acid derivatives, 
to synthesize enantiopure - and -amino acids was investigated (scheme 3.08). The 
gene for PAM from Taxus chinensis was cloned in the pBAD-His expression plasmid, 
and the recombinant enzyme expressed in E. coli as an N-terminal hexahistidine protein.9 











R RR NH3  
Scheme 3.08. Synthesis of - and -amino acids using PAM. 
After having establishing that PAM catalyzes the addition of ammonia to cinnamic acid,9 
a variety of cinnamic acid derivatives was studied as potential substrates. For every 
accepted substrate kinetic parameters were determined with UV-Vis spectroscopy 
employing the Michaelis-Menten equation to explore the influence on binding affinity 
and catalytic activity. Initial ratios for the formation of - and -isomers were 
determined by HPLC to analyze the parameters influencing their formation.  
Table 3.6. PAM catalyzed addition of ammonia to ortho-substituted cinnamic acids. 








entry R Km 
[mM] 
kcat [s1]  
x 103 
kcat/Km  
[l mol1 s1] 
 x 103 
initial 
: ratio 
 ee  
[%] 
 ee  
[%] 
1 H 24±1 1.8±0.1 13 51:49 >99 (S) >99 (R) 
2 F 226±11 13±1 17 98:2 >99 (S) nd 
3 Cl 359±20 8.6±1 42 >99:1 >99 (S) nd 
4 Br 145±11 6.9±1 21 99:1 >99 (S) nd 
5 Me 110±8 9.3±1.4 12 >99:1 >99 (S) nd 
6 OMe - - <0.1 - - - 
7 OH - - <0.1 - - - 
nd = not determined. 
- And -phenylalanine are formed in a 1:1 ratio (table 3.6, entry 1), both with >99% ee. 
2-Methoxy- and 2-hydroxy cinnamic acid did not show any conversion (table 3.6, entry 
6-7). Substrates with fluoro, chloro, bromo and methyl substituents in ortho-position 
were accepted by PAM, and lead to almost exclusive formation of the -isomer (table 
3.6, entry 2-5). This selectivity is likely due to steric hindrance resulting in effectively 
shielding of the -position. One assumption is that the affinity of PAM (expressed as Km) 
towards -substituted cinnamic acids depends on the hydrophobicity of the substituent. 
Considering the halogen substitution, the lowest Km-value, so the highest affinity, is 
observed for the bromo substituted substrate, while the more hydrophilic fluoro 
substituted substrate has a 2-fold higher Km-value (table 3.6, entry 2 and 4). This could 
suggest that a hydrophobic pocket exists around the ortho position. However, the chloro 
substituted substrate does not fit this pattern of reactivity. It seems that size does not 
matter for accepting a substrate in the active site of PAM, because the Km value for the 
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bromo substituted substrate is smaller than the Km value for the smaller fluoro-
substituted substrate. The catalytic activity kcat is increased for all substituted cinnamic 
acids, the highest for fluoro cinnamic acid, indicating that stronger electron withdrawing 
substituents might influence the acidity at C-3 (see paragraph 3.1). However, the 
electron donating methyl substituted phenyl ring does not match with this observation, 
because its activity is higher than for substrates bearing electron withdrawing bromo and 
chloro substituents (table 3.6, entry 5) 
Table 3.7. PAM catalyzed addition of ammonia to meta-substituted cinnamic acids. 




R R R  
 
entry R Km 
[mM] 
kcat [s1]  
x 103 
kcat/Km  
[l mol1 s1] 
 x 103 
initial 
: ratio 
 ee  
[%] 
 ee  
[%] 
1 H 24±1 1.8±0.1 13 51:49 >99 (S) >99 (R) 
2 F 68±2 5.6±0.5 10 86:14 92 nd 
3 Cl 111±6 9.4±1.1 12 94:6 >99 (S) nd 
4 Br nda nda nda 94:6 >99 (S) nd 
5 Me 10±2 7.6±2.9 1.3 20:80 >99 (S) >99 (R) 
6 OMe - - <0.1 - - - 
7 OH - - <0.1 - - - 
a Kinetic parameters were not determined due to insufficient solubility. nd = not determined. 
Addition of ammonia to meta-substituted cinnamic acids gives a mixture of - and -
amino acids (table 3.7). For halogen substituents the -isomer dominates (table 3.7, entry 
2-4), but the substrate with the electron donating methyl substituent yields 80% of the -
isomer (table 3.7, entry 5). The affinity of PAM for 3-methyl cinnamic acid is higher 
than for its natural substrate -Phe. The catalytic activity is in all cases higher than for 
cinnamic acid. 3-Methoxy and 3-hydroxy cinnamic acid showed no detectable activity 
(table 3.7, entry 6-7).  
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Table 3.8. PAM-catalyzed addition of ammonia to para-substituted cinnamic acids. 




R R R  
 
entry R Km 
[mM] 




s1] x 103 
initial 
: ratio 
 ee  
[%] 
 ee  
[%] 
1 H 24±1 1.8±0.1 13 51:49 >99 (S) >99 (R) 
2 F 37±1 2.5±0.2 15 35:65 >99 (S) >99 (R) 
3 Cl 46±1 0.40±0.01 115 41:59 >99 (S) >99 (R) 
4 Br 29±1 0.20±0.01 161 52:48 85 (S) >99 (R) 
5 Me 35±1 0.89±0.06 39 4:96 >99 (S) >99 (R) 
6 OMe 27±1 0.79±0.04 34 14:86 >99 (S) >99 (R) 
7 OH - - <0.1 - - - 
8 Et 38±3 0.44±0.10 86 12:88 nd >99a 
9 n-Pr 18±1 0.11±0.01 164 9:91 nd >99a 
10 i-Pr 46±3 2.1±0.6 22 9:91 nd >99a 
11 NO2 133±1 1.0±0.10 12 98:2 >99 (S) nd 
12 CF3 81±4 - 81 83:17 43 (S) nd 
13 t-Bu - - <0.1 - - - 
a The absolute configuration was not determined. nd = not determined. 
The catalytic efficiency is generally lower for cinnamic acids substituted in the para-
position compared to those in the meta- or ortho-position (table 3.8, entry 2-6 and 8-11). 
As Km values are lower, the affinity of PAM for these substrates is higher, they seem to 
fit better into the active site. 4-Methoxycinnamic acid is accepted by PAM in contrast to 
m- and o-methoxy substituted substrates (table 3.8, entry 6). Therefore, a larger range of 
p-substituted cinnamic acids was studied. The affinity of PAM seems to be influenced by 
three parameters: 1) hydrophobicity, 2) steric effects, and 3) electronic effects of the 
substituents. Lower Km values are observed for lipophilic groups, as they decrease in the 
order methyl > propyl (table 3.8, entry 5+9), while they increase in the order bromo < 
fluoro < trifluoromethyl < nitro (table 3.8, entry 2-3 and 11-12). Steric effects disturb 
this trend, because the affinity in the series methyl, n-propyl, iso-propyl and tert-butyl 
initially rises until n-propyl, and then decreases for the bulkier branched substituent iso-
propyl, while the sterically more demanding substrate tert-butylcinnamic acid is not 
accepted by PAM (table 3.8, entry 5, 8-10, 13). The ratio for - and -amino acids is 
dominated by electronic properties of the respective substituents: cinnamic acids with 
electron donating substituents, such as methyl, ethyl, propyl, iso-propyl and methoxy 
(table 3.8, entry 5-6 and 8-10), are predominantly converted to their -amino acids while 
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cinnamic acids with strongly electron withdrawing trifluoromethyl- and nitro- 
substituents give mostly their -amino acids (table 3.8, entry 11-12). Bromo-substituted 
cinnamic acid gives an approximate ratio of 1:1, chloro-cinnamic acid a ratio of 40:60 of 
- to -amino acid, and fluoro-cinnamic acid displays a 2:1 ratio in favour of the -
isomer (table 3.8, entry 2-4). 
Both the aromatic ring and the carboxylate group are activating the double bond for a 
conjugate addition, so the tendency for - or -amino acid formation should be 
influenced by the electronic properties of the substituents on the aromatic ring. Cinnamic 
acids with electron donating groups in the para-position are activated towards conjugate 
addition to the ,-unsaturated carboxylic acid because the electronrich aromatic ring 
cannot stabilize a negative charge (scheme 3.09). This could be the same reason for the 
preferred formation of -amino acids with electron donating substituents in the meta-
position (table 3.7). The strongly electron withdrawing substituted para-nitrocinnamic 
acid gave exclusively -amino acids, which could suggest that a conjugate addition to C-
2 is occurring and the produced negative charge can be delocalized to the nitro group 
(scheme 3.09). Deviations from this trend could result from steric effects that might 
influence the enzyme-substrate complex and thus the / ratio, as for example, observed 
























Scheme 3.09. Electronic effects on the regioselectivity of PAM catalyzed addition reactions. 
A Hammett plot32 of the initial percentage of -isomer formation for meta-substituted 
cinnamic acids vs. the Hammett constants33 p for the respective substituents shows a 
linear behaviour, and therefore, a good correlation (figure 3.2). However, it should be 
















Figure 3.2. Correlation between the Hammett constant p and the 
initial percentage of -isomer formation for meta-substituted 
substrates of table 3.7. 
For para--amino acids more data points were available to display the initial percentage 
of -isomer formation for meta-substituents vs. the Hammett constants p in a Hammett 
plot. The graph shows a linear behaviour, and therefore, a good correlation of -isomer 
formation and electronic effects of the subsituents in para-position (figure 3.3). These 
observations show that the initial / ratio is dominated by electronic properties of m- 















Figure 3.3. Correlation between the Hammett constant p and the 
initial percentage of -isomer formation for para-substituted 
substrates of table 3.8. 
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Although kinetic efficiencies (kcat) were collected for 18 substrates, no definitive trend in 
























Figure 3.4. Substrates not accepted by PAM. 
Additional cinnamic acids were investigated in the addition of ammonia-catalyzed by 
PAM (figure 3.4). The -Dopa35 precursor 3.70 was not accepted by PAM, and neither 
substrates with trisubstituted double bonds with methylgroups in C-2 position (3.71 and 
3.73) or at C-3 (3.72). (Z)-Cinnamic acid is also not a substrate for PAM. PAM did not 
accept substrates where the phenyl ring was replaced with a furyl- (3.74), cyclohexyl-
residue (3.75), an olefin (3.76) or a phenyl-substituted olefin (3.77).  
 
2.5 Conclusion 
Enantiopure - and -amino acids can be synthesized by PAM-catalyzed addition of 
ammonia to cinnamic acid derivatives. The substrate scope of PAM is rather broad 
which makes it an interesting enzyme for the biocatalytic synthesis of 3-aryl-amino 
acids. However, the catalytic activity (kcat) of 0.0001-0.0076 s1 is yet too low to use this 
enzyme in industrial applications. Studies towards the affinity of the enzyme for its 
substrates (Km) indicate that a small hydrophobic pocket exists around the ortho-position 
of the substrate, and a larger hydrophobic groove around the para-position which 
tolerates non-branched aliphatic chains. Substrates with substituents in ortho-position 
lead to the selective formation of -amino acids which is attributed to steric hindrance at 
C-3. Synthetic applications of this biocatalyst are depending on enantioselectivities and 
regioselectivities of /-formation. -Amino acids are formed in excess (>90%) from 
cinnamic acids with electron donating groups in the para-position and to a smaller 
extend with these substituents in meta-position, all of them with excellent 
enantioselectivities. For substrates with electron withdrawing substituents the formation 
of -amino acids is preferred. In most cases the enantioselectivities exceed 99%. 
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Concerning the debate about the mechanism involving PAM and PAL (see paragraph 
3.1), the observed rates for the amination of the substituted cinnamic acids favor the 
carbanion mechanism. Substrates with electron withdrawing substituents in meta-
position show a rate acceleration compared to cinnamic acid. This would strongly 
disfavor the Friedel-Crafts mechanism because the intermediate positive charge would 
partially be located in meta-position. Also, electron withdrawing substituents in ortho- 
and para position enhance the catalytic activity, which is in agreement with a 
stabilization of a carbanion-intermediate. This catalytic system represents a new addition 
to the biocatalytic synthesis of enantiopure -amino acids. 
2.6 Experimental  
This project was performed in collaboration with Wiktor Szymanski and Bian Wu from 
the Department of Biochemistry. The PAM gene (T. chinensis) was ligated into a pBAD-
His vector, expressed in E. coli TOP10 cells, and purified by metal-based affinity 
column chromatography by Wu Bian as described in reference 9. 
 
General methods. see chapter 2. 
 
Determination of kinetic parameters for the amination activity of PAM. Kinetic 
parameters of the PAM-catalyzed ammonia addition reaction were measured with UV-
Vis spectroscopy. A 6M aq. ammonia solution was prepared and the pH was adjusted to 
pH=10 by bubbling CO2 into the solution. In a typical assay, (E)-cinnamic acid or a 
derivative was incubated at various concentrations with purified PAM (0.06 mg, 0.76 
mol) in aqueous ammonia solution (300 l). The reaction mixture was incubated at 30 
oC. The ammonia addition activity was monitored by UV-Vis spectroscopy. The initial 
rates were plotted against the substrate concentration and these data were fitted to the 
Michaelis-Menten equation to obtain the kinetic constants. 
 
Stereochemical analysis of the phenylalanine products by chiral HPLC. Purified 
PAM (0.02 mg, 0.25 mol, 0.03 mol%) was added to 5 mM of (E)-cinnamic acid (1 
mmol) or a derivative in aqueous ammonia solution (6M, pH 10, 200 l, 1.2 mmol). The 
reaction mixture was incubated for 24 h at 30oC. Subsequently, a 20-l portion was 
taken and it was quenched by heating for 5 min at 99oC. A 40-l  portion of 2M aq. 
NaOH was added, and the sample was then frozen in liquid nitrogen. Subsequently, the 
sample was lyophilized and dissolved in 55 l of 2M aq. HClO4. Analysis were carried 
out with reversed phase HPLC on a Crownpak column with UV detection at 210 nm. 
  
(E)-Cinnamic acid (3.08), (E)-4-fluoro-cinnamic acid, (E)-4-chloro-cinnamic acid, (E)-
4-methyl-cinnamic acid, (E)-4-hydroxy-cinnamic acid were purchased from Acros 
organics. (E)-2-Methyl-cinnamic acid, (E)-2-methoxy-cinnamic acid, (E)-2-hydroxy-
cinnamic acid, (E)-3-methyl-cinnamic acid, (E)-3-methoxy-cinnamic acid, (E)-3-
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hydroxy-cinnamic acid, (E)-4-iso-propyl-cinnamic acid, (E)-4-methoxy-cinnamic acid 
were obtained from Sigma-Aldrich-Fluka. (R)--Phenylalanine, (S)--phenylanine, (R)-
3-amino-3-(2-fluoro-phenyl)-propionic acid, (R)-3-amino-3-(2-chloro-phenyl)-propionic 
acid, (R)-3-amino-3-(2-bromo-phenyl)-propionic acid, (R)-3-amino-3-(2-methyl-
phenyl)-propionic acid, (S)-3-amino-3-(2-methyl-phenyl)-propionic acid, (R)-3-amino-3-
(3-fluoro-phenyl)-propionic acid, (R)-3-amino-3-(3-chloro-phenyl)-propionic acid, (R)-
3-amino-3-(3-bromo-phenyl)-propionic acid, (R)-3-amino-3-(3-methyl-phenyl)-
propionic acid, (R)-3-amino-3-(4-fluoro-phenyl)-propionic acid, (S)-3-amino-3-(4-
fluoro-phenyl)-propionic acid, (R)-3-amino-3-(4-chloro-phenyl)-propionic acid, (S)-3-
amino-3-(2-fluoro-phenyl)-propionic acid, (R)-3-amino-3-(4-bromo-phenyl)-propionic 
acid, (R)-3-amino-3-(4-nitro-phenyl)-propionic acid were synthesized by Peptech Corp. 
(±)--Phenylalanine, (±)--phenylalanine, (R)--phenylalanine, (S)--phenylalanine, (S)-
4-nitro--phenylalanine and (±)-4-nitro--phenylalanine were obtained from Sigma-
Aldrich-Fluka. (R)--Phenylalanine, (S)--phenylanine, (S)-3-amino-3-(4-fluoro-
phenyl)-propionic acid, (R)-3-amino-3-(4-fluoro-phenyl)-propionic acid, (S)-3-amino-3-
(4-chloro-phenyl)-propionic acid, (R)-3-amino-3-(4-chloro-phenyl)-propionic acid, (S)-
3-amino-3-(4-methyl-phenyl)-propionic acid, (R)-3-amino-3-(4-methyl-phenyl)-
propionic acid, (S)-3-amino-3-(4-methoxy-phenyl)-propionic acid, (R)-3-amino-3-(4-
methoxy-phenyl)-propionic acid, (S)-4-fluoro--phenylalanine, (R)-4-fluoro--
phenylalanine, (S)-4-chloro--phenylalanine, (R)-4-chloro--phenylalanine, (S)-4-
methyl--phenylalanine, (R)-4-methyl--phenylalanine, (S)-4-methoxy--phenylalanine 
and (R)-4-methoxy--phenylalanine were purchased from Peptech. Corp. 
 
General procedure for the synthesis of cinnamic acid derivatives.30b A mixture of 
substituted benzaldehyde (4.00 mmol), malonic acid (8.80 mmol) and piperidine (70 L) 
in pyridine (1.80 mL) was stirred under reflux for 80-180 min. The reaction mixture was 
cooled and slowly poured into ice-cold aqueous HCl (2N, 35 mL). The precipitate was 
filtered off and dried in vacuum. 
 
General procedure for the synthesis of N-formyl dehydroamino acid esters.28b To a 
solution of aldehyde (13.2 mmol, 1.2 eq.) and methyl isocyanoacetate (1.0 mL, 11.0 
mmol) in dry Et2O (10 mL) Cu2O (79 mg, 0.55 mmol, 5 mol%) was added. After stirring 
for 3h at room temperature the mixture was cooled to 0°C and t-BuOK (1.28 g, 11.0 
mmol) in dry THF (10 mL) was added. The mixture was stirred for 30 min at 0°C, acetic 
acid (0.65 mL, 11.0 mmol) in CH2Cl2 (27 mL) was added, and the solution slowly 
warmed to room temperature. The organic layer was washed with H2O (20 mL), dried 
over MgSO4 and concentrated in vacuum. The crude mixture was purified by flash 
column chromatography (n-pentane/EtOAc) or recrystallized from EtOAc/CH2Cl2.28b 
 
General procedure for hydrogenation of nonhalogen-substituted dehydroamino 
acids.28b In a pressure secure vial one spatula tip of Pd/C was added to the N-formyl 
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dehydroamino acid ester (2.0 mmol) in MeOH (5.0 mL). The vial was placed in an 
autoclave and 5 bar H2 was applied. After stirring over night, the mixture was filtered 
over celite, and concentrated in vacuum. The crude mixture was purified by flash 
column chromatography (pentane/EtOAc). 
 
General procedure for hydrogenation of halogen-substituted dehydroamino acid 
esters.28b In a pressure secure vial Rh(COD)2BF4 (8.1 mg, 0.02 mmol, 1 mol%) and PPh3 
(10.5 mg, 0.04 mmol, 2 mol%) were added to the N-formyl dehydroamino acid ester (2.0 
mmol) in CH2Cl2 (5.0 mL). The vial was placed in an autoclave and 20 bar H2 was 
applied. After stirring over night, the mixture was filtered over celite, and concentrated 
in vacuum. The crude mixture was purified by flash column chromatography 
(pentane/EtOAc). 
 
General procedure for the synthesis of -amino acids. To the N-formyl amino ester 
(0.5 mmol) in MeOH (2.0 mL), 5M aq. HCl (2 mL) was added. After heating to 40°C 
overnight, the solvent was evaporated in vacuum. The residue was dissolved in EtOH (2 
mL) and Et2O (5 mL) was added. The precipitated amino acid esters were filtered, and 
the crystals dried in vacuum. LiOH (0.15 g, 6.26 mmol) was added to the amino acid 
ester in MeCN (2 mL) and H2O (2 mL), and the mixture stirred for 3 d. The sample was 
concentrated in vacuum, acidified with 5M aq. HCl (5 mL), and concentrated in vacuum. 
The precipitate was redissolved in EtOH and crystallized from Et2O. The crystals were 
filtered and dried in vacuum. 
 
3-Amino-3-(2-methyl-phenyl)-propanoic acid. HPLC (Crownpack CR(+), 4 mm x 150 
mm, HClO4 in 15% MeOH, pH 2.3, flow 0.3 mL/min, 7°C) 86.6 (R-), 100.5 (S-) 
min. 
 
4-Fluoro phenylalanine. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% 
MeOH, pH 2.5, flow 0.3 mL/min, 5°C) 22.0 (R-), 35.6 (S-), 53.8 (R-), 68.3 (S-) 
min. 
 
4-Chloro phenylalanine. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% 
MeOH, pH 2.7, flow 0.3 mL/min, 6°C) 45.8 (R-), 73.9 (S-), 136.6(R-),155.1 (S-) 
min. 
 
4-Methyl phenylalanine. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% 
MeOH, pH 2.6, flow 0.3 mL/min, 5°C) 34.7 (R-), 71.5 (S-), 109.8 (R-), 126.3 (S-) 
min. 
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4-Methoxy phenylalanine. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% 
MeOH, pH 2.7, flow 0.3 mL/min, 6°C) 24.7 (R-), 41.5 (S-), 74.4 (R-), 106.2 (S-) 
min. 
4-Nitro phenylalanine. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 10% 
MeOH, pH 2.2, flow 0.3 mL/min, 6°C) 58.6 (R-), 72.1 (S-) min. 
 
4-iso-propyl phenylalanine. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 
15% MeOH, pH 1.8, flow 0.5 mL/min, 7°C) 280 (R-), 294 (S-) min. 
 
(E)-2-Fluoro-cinnamic acid 3.10. Light yellow solid; 99%; >99% (E) isomer; mp. 173-
174°C (lit. 175°C)36; 1H NMR (400 MHz, CDCl3): =6.56 (d, 3J=16.0 
Hz, 1H; CH), 7.10-7.59 (m, 4H; CH). 7.93 (d, 3J=16.0 Hz, 1H; CH). 
Spectral data consistent with literature.37 
 
 
(E)-2-Chloro-cinnamic acid 3.11. White solid, 93%; >99% (E) isomer; mp. 211°C (lit. 
208-210°C)38; 1H NMR (400 MHz, CDCl3): =6.59 (d, 3J=16.0 Hz, 
1H; CH), 7.86 (d, 3J=16.4 Hz, 1H; CH), 7.36-7.92 (m, 4H; CH). 




(E)-2-Bromo-cinnamic acid 3.12. White solid, 73%; >99% (E) isomer; mp. 220°C (lit. 
218-219°C)39; 1H NMR (400 MHz, CDCl3): =6.54 (d, 3J=16.0 Hz, 
1H; CH), 7.82 (d, 3J=15.6 Hz, 1H; CH), 7.32-7.90 (m, 4H; CH). 




(E)-3-Fluoro-cinnamic acid 3.13. White solid, 99%; >99% (E) isomer; mp. 168-169 °C 
(lit. 166-167)41; 1H NMR (400 MHz, DMSO-d6): =6.60 (d, 3J=16.0 
Hz, 1H; CH), 7.21-7.61 (m, 5H; CH). Spectral data were consistent 
with the literature.42 
 
(E)-3-Chloro-cinnamic acid 3.14. White solid, 96%; >99% (E) isomer; mp. 161-162°C 
(lit. 162-163°C)41; 1H NMR (400 MHz, CDCl3): =6.60 (d, 3J=16.0 
Hz, 1H; CH), 7.55 (d, 3J=15.6 Hz, 1H; CH), 7.40-7.80 (m, 4H; CH); 

















(E)-3-Bromo-cinnamic acid 3.15. White solid, 92%; >99% (E) isomer; mp. 175-176°C 
(lit. 176-178°C)44; 1H NMR (400 MHz, CDCl3): =6.61 (d, 3J=15.6 
Hz, 1H; CH), 7.65 (d, 3J=16.0 Hz, 1H; CH), 7.39-7.90 (m, 4H; CH). 
Spectral data were consistent with the literature. 
 
 
(E)-4-bromo-cinnamic acid 3.16. White solid, 88%; >99% (E) isomer; mp. 264-265°C 
(lit. 264-266°C)45; 1H NMR (400 MHz, CDCl3): =6.55 (d, 
3J=16.0 Hz, 1H; CH), 7.55 (d, 3J=15.6 Hz, 1H; CH), 7.58-7.65 (m, 
4H; CH). Spectral data were consistent with the literature.  
 
 
(E)-4-Ethyl-cinnamic acid 3.17. White solid, 96%; >99% (E) isomer; mp. 142-144°C 
(lit. 143°C)46; 1H NMR (400 MHz, CDCl3): =1.25 (t, 3J=7.6 Hz, 
3H; CH3), 2.68 (q, 3J=7.6 Hz, 2H; CH2), 6.42 (d, 3J=15.6 Hz, 1H; 
CH), 7.22-7.49 (m, 4H; CH). 7.78 (d, 3J=16.0 Hz, 1H; CH); 
Spectral data were consistent with the literature.47 
 
(E)-4-n-Propyl-cinnamic acid 3.18. White solid, 92%; >99% (E) isomer; mp. 176-
177°C; 1H NMR (400 MHz, CDCl3): =0.95 (t, 3J=7.2 Hz, 3H; 
CH3), 1.61-1.70 (m, 2H; CH2), 2.62 (t, 3J=8.0 Hz, 2H; CH2), 
6.42 (d, 3J=15.6 Hz, 1H; CH), 7.21-8.49 (m, 4H; CH), 7.78 (d, 
3J=15.6 Hz, 1H; CH); 13C NMR (50 MHz, CDCl3): =24.0, 
24.5, 38.2, 116.3, 128.6, 129.3, 131.8, 146.3, 147.3, 184.8.	MS (EI) m/z 190 (M+, 40), 
161 (100), 115 (75); HRMS calcd. for C12H14O2 190.0994, found 190.0996. 
 
(E)-4-Nitro-cinnamic acid 3.19. Yellow solid, 95%; >99% (E) isomer; mp. 292-293°C 
(lit. 293°C)44; 1H NMR (400 MHz, DMSO-d6): =6.74 (d, 
3J=16.4 Hz, 1H; CH), 7.68 (d, 3J=16.4 Hz, 1H; CH), 7.96-8.24 
(m, 4H; CH). Spectral data were consistent with the literature.48 
 
 
(E)-4-tert-Butyl-cinnamic acid 3.20. White solid, 99%; >99% (E) isomer; mp. 202-
204°C (lit. 201-203°C)37; 1H NMR (400 MHz, CDCl3): =1.35 (s, 
9H; (CH3)3), 6.43 (d, 3J=15.6 Hz, 1H; CH), 7.42-8.51 (m, 4H; 
CH), 7.78 (d, 3J=16.0 Hz, 1H; CH); 13C NMR (50 MHz, CDCl3): 
=31.4, 35.2, 116.4, 126.2, 128.5, 131.5, 147.1, 172.0.	 MS (EI) 
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Ethyl (Z)-cinnamate 3.21. Ethyl phenylpropionate (2.87 mmol,), quinoline (0.47 mL, 
4.00 mmol) and 1-octene (3.0 mL) were dissolved in hexane (12.0 mL). 
Lindlar’s catalyst (0.15 g) was added, and the suspension was stirred 
under H2 pressure (baloon) for 140 min. The solvent was evaporated, 
and the product was purified by flash column chromatography 
(pentane:Et2O = 99:1) to give the product as a yellow oil (0.24 g, 1.37 mmol, 48%).49 1H 
NMR (400 MHz, DMSO-d6): =1.25 (t, 3J=7.2 Hz, 4H; CH3), 4.18 (q, 3J=7.2 Hz, 1H; 
CH2), 5.95 (d, 3J=12.8 Hz, 1H; CH), 6.95 (d, 3J=12.8 Hz, 1H; CH), 7.32-7.59 (m, 5H; 
CH). Spectral data were consistent with the literature.49 
 
(Z)-Cinnamic acid 3.22. To a solution of ethyl (Z)-cinnamate 3.21 (0.23 g, 1.30 mmol) 
in ethanol (5.0 mL) was added aqueous 2N NaOH (11 mL). The mixture 
was stirred for 120 min, acidified with aqueous 4N HCl (6 mL) and 
extracted with Et2O (3 x 20 mL). The combined organic layers were 
dried (MgSO4) and the solvent was evaporated in vacuum. The residue 
was suspended in hexane (8 mL) and the solid product was filtered off, to give white 
crystals (0.19 g 1.25 mmol, 97%). Mp. 67°C (lit. 67-68)50; 1H NMR (400 MHz, DMSO-
d6): =5.98 (d, 3J=12.8 Hz, 1H; CH), 7.07 (d, 3J=12.8 Hz, 1H; CH), 7.35-7.62 (m, 5H; 
CH). Spectral data were consistent with the literature.50 
 
-Cyclohexyl-acrylic acid 3.75. The product was obtained as white solid (75 %). mp. 
56°C (lit. 56-57°C)51; 1H NMR (400 MHz, DMSO-d6): =1.14-2.18 
(m, 11H; CH2 + CH), 5.75 (d, 3J=16.0 Hz, 1H; CH), 7.02 (dd, 3J=16.4 
Hz 3J = 6.8 Hz, 1H; CH). Spectral data were consistent with the 
literature.52 
 
Methyl 3-(2-fluorophenyl)-2-formamidoacrylate 3.25. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (1.09 g, 4.67 
mmol, 42%) as a trans:cis (60:40) mixture. mp. 91°C;1H NMR (300 
MHz, CDCl3): =3.84 (s, 3H; CH3), 3.88 (s, 3H; CH3), 7.02-7.18 (m, 
4H; CH), 7.25-7.60 (m, 6H; CH), 7.66 (s, 1H; CH), 8.19 (bs, 2H; 
CHO). 13C NMR (75 MHz, CDCl3): =53.2 (CH3), 53.4 (CH3), 115.7 
(C), 116.0 (C), 116.5 (CH), 116.7 (CH), 120.4 (CH), 124.2 (CH), 125.0 (CH), 125.0 
(CH), 126.1 (C), 129.8 (CH), 130.1 (CH), 131.3 (CH), 131.3 (CH), 131.5 (CH), 131.6 
(CH), 159.0 (CO), 163.7 (CO), 164.7 (CO), 165.3 (CO). HR-ESI-MS: m/z calcd for 

















Methyl 3-(2-chlorophenyl)-2-formamidoacrylate 3.26. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (1.40 g, 5.84 
mmol, 53%) as a trans:cis (60:40) mixture. 1H NMR (400 MHz, 
CDCl3): =3.83 (s, 3H; CH3), 3.87 (s, 3H; CH3), 7.20-7.52 (m, 9H; 
CH), 7.71 (s, 1H; CH), 8.14-8.24 (m, 2H; CHO). 13C NMR (100 
MHz, CDCl3): =52.9 (CH3), 53.1 (CH3), 123.0 (C), 125.1 (C), 
127.0 (CH), 127.2 (CH), 127.8 (CH), 129.3 (CH), 129.5 (CH), 129.6 (CH), 130.4 (C), 
130.7 (CH), 134.3 (C), 134.4 (C), 135.0 (C), 135.3 (C), 159.2 (CO), 163.8 (CO), 164.5 
(CO), 165.0 (CO). HR-ESI-MS: m/z calcd for C11H11ClNO3 [M+H]+ 240.0422, found  
240.0421. 
 
Methyl 3-(2-bromophenyl)-2-formamidoacrylate 3.27. Recrystallization from 
EtOAc/CH2Cl2 yielded the product as a white solid (1.10 g, 3.87 
mmol, 39%) as a trans:cis (60:40) mixture. mp. 137°C; 1H NMR 
(400 MHz, CDCl3): =3.80 (s, 3H; CH3), 3.86 (s, 3H; CH3), 7.07-
7.49 (m, 8H; CH), 7.50-7.60 (m, 2H; CH), 7.66 (s, 1H; CH), 7.90 (s, 
1H; CH), 8.00-8.06 (m, 2H; CHO). 13C NMR (100 MHz, CDCl3): 
=52.8 (CH3), 53.0 (CH3), 124.1 (C), 124.3 (C), 124.4 (C), 125.7 (C), 125.9 (CH), 126.9 
(CH), 127.8 (CH), 129.4 (CH), 129.6 (CH), 130.0 (CH), 130.1 (CH), 130.3 (CH), 132.5 
(CH), 133.1 (CH), 133.4 (C), 134.2 (C), 159.1 (CO), 163.4 (CO), 164.2 (CO), 164.8 
(CO). HR-ESI-MS: m/z calcd for C11H11BrNO3 [M+H]+ 283.9917, found  283.9916. 
 
Methyl 3-(3-fluorophenyl)-2-formamidoacrylate 3.28. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (1.73 g, 7.42 
mmol, 67%) as a trans:cis (60:40) mixture. mp. 105°C; 1H NMR 
(300 MHz, CDCl3): =3.78 (s, 3H; CH3), 3.84 (s, 3H; CH3), 6.81-
7.02 (m, 3H; CH), 7.09-7.35 (m, 6H; CH), 7.65-7.85 (m, 1H; CH), 
7.95-8.26 (m, 3H; CH). 13C NMR (75 MHz, CDCl3): =52.7 (CH3), 
53.1 (CH3), 114.8 (C), 115.8 (C), 116.6 (CH), 123.7 (CH), 124.7 (CH), 125.4 (CH), 
127.6 (CH), 126.0. (CH), 128.1 (CH), 129.6 (CH), 130.2 (CH), 131.0 (CH), 131.6 (CH), 
135.1 (C), 135.9 (C), 137.5 (C), 160.1 (CO), 164.5 (CO), 165.4 (CO), 170.8 (CO). HR-
ESI-MS: m/z calcd for C11H11FNO3 [M+H]+ 224.0718, found  224.0718. 
 
Methyl 3-(3-chlorophenyl)-2-formamidoacrylate 3.29. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (1.26 g, 5.75 
mmol, 48%) as a trans:cis (60:40) mixture. mp. 117°C; 1H NMR 
(400 MHz, CDCl3): =3.83 (s, 3H; CH3), 3.88 (s, 3H; CH3), 7.14-
7.29 (m, 4H; CH), 7.33-7.60 (m, 6H; CH), 7.76 (s, 1H; CH), 8.05-
8.11 (m, 2H; CHO). 13C NMR (100 MHz, CDCl3): =52.8 (CH3), 
53.1 (CH3), 123.6 (CH), 124.2 (C), 125.9 (c), 126.4 (CH), 127.2 (CH), 127.9 (CH), 129. 
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158.9 (CO), 163.4 (CO), 164.2 (CO), 164.9 (CO). ). HR-ESI-MS: m/z calcd for 
C11H11ClNO3 [M+H]+ 240.0422, found  240.0422. 
 
Methyl 3-(3-bromophenyl)-2-formamidoacrylate 3.30. Recrystallization from 
EtOAc/CH2Cl2 yielded the product as a white solid (1.06 g, 3.81 
mmol, 35%) as a trans:cis (60:40) mixture. 1H NMR (400 MHz, 
CDCl3): =3.84 (s, 3H; CH3), 3.88 (s, 3H; CH3), 7.17-7.29 (m, 2H; 
CH), 7.29-7.50 (m, 6H; CH), 7.5-7.65 (m, 2H; CH), 8.14-8.26 (m, 
2H; CH). 13C NMR (100 MHz, CDCl3): =52.9 (CH3), 53.1 (CH3), 
122.4 (C), 123.0 (C), 123.2 (C), 125.1 (C), 126.7 (CH), 127.6 (CH), 128.1 (CH), 129.9 
(CH), 130.5 (CH), 130.6 (CH), 132.3 (CH), 132.4 (CH), 134.8 (C), 135.6 (C), 159.1 
(CO), 163.7 (CO), 164.5 (CO), 165.0 (CO). HR-ESI-MS: m/z calcd for C11H11BrNO3 
[M+H]+ 283.9917, found  283.9915. 
 
Methyl 3-(3-methylphenyl)-2-formamidoacrylate 3.31. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (1.78 g, 8.10 
mmol, 74%) as a trans:cis (60:40) mixture. mp. 145-147°C; 1H 
NMR (400 MHz, CDCl3): =2.27 (s, 3H; CH3), 2.29 (s, 3H; CH3), 
3.75 (s, 3H; CH3), 3.81 (s, 3H; CH3), 6.96-7.34 (m, 10H; CH), 8.09-
8.20 (m, 2H; CHO). 13C NMR (100 MHz, CDCl3): =21.0 (CH3), 
52.4 (CH3), 52.6 (CH3), 122.3 (CH), 123.6 (C), 124.9 (C), 126.4 (CH), 126.5 (CH), 
128.2 (CH), 128.7 (CH), 129.0 (CH), 130.2 (CH), 130.4 (CH), 132.3 (C), 133.4 (CH), 
134.4 (C), 137.1 (C), 138.5 (C), 159.6 (CO), 160.1 (CO), 164.2 (CO), 164.8 (CO). HR-
ESI-MS: m/z calcd for C12H14NO3 [M+H]+ 220.0968, found  220.0968. 
 
Methyl 3-(4-bromophenyl)-2-formamidoacrylate 3.32. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (1.78 g, 
6.29 mmol, 57%) as a trans:cis (60:40) mixture. mp. 125-127°C; 
1H NMR (400 MHz, CDCl3): = 3.53 (s, 3H; CH3), 3.69 (s, 3H; 
CH3), 6.91-7.58 (m, 9H; CH), 7.90-8.20 (m, 2H; CHO), 
8.30.8.60 (m, 1H; CH). 13C NMR (100 MHz, CDCl3): =52.0 
(CH3), 52.4 (CH3), 121.4 (C), 122.6 (C), 123.4 (CH), 124.2 (CH), 124.5 (CH), 125.3 (C), 
127.2 (C), 128.6 (C), 129.9 (CH), 130.6 (CH), 130.8 (CH), 130.9 (CH), 131.2 (CH), 
131.4 (CH), 131.8 (CH), 133.3 (C), 159.6 (CO), 160.0 (CO), 164.2 (CO), 164.8 (CO). 
HR-ESI-MS: m/z calcd for C11H11BrNO3 [M+H]+ 283.9917, found  283.9917. 
 
Methyl 2-formamide-3-(4-(trifluoromethyl)phenyl)acrylate 3.33. Column 
chromatography (n-pentane/EtOAc 1:1) yielded the product as a 
white solid (2.11 g, 7.73 mmol, 70%) as a trans:cis (60:40) 
mixture. 107-109°C; 1H NMR (400 MHz, CDCl3): = 3.81 (s, 































1H; CH), 7.48-7.68 (m, 6H; CH), 7.83 (s, 1H; CH), 7.96-8.08 (m, 1H; CH), 8.10-8.22 
(m, 2H; CHO). 13C NMR (100 MHz, CDCl3): =52.9 (CH3), 53.0 (CH3), 123.2 (C), 
123.7 (C), 124.6 (CH), 124.6 (CH), 125.1 (CH), 125.2 (CH), 126.8 (CH), 127.0 (C), 
128.8 (CH), 129.7 (CH), 130.2 (CH), 136.3 (C), 137.2 (CH), 138.9 (CH), 159.4 (CO), 
159.7 (CO), 164.0 (CO), 165.0 (CO). ). HR-ESI-MS: m/z calcd for C12H11F3NO3 
[M+H]+ 274.0686, found  274.0685. 
 
Methyl 3-(4-ethylphenyl)-2-formamide acrylate 3.34. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (1.41 g, 
6.05 mmol, 55%) as a trans:cis (60:40) mixture. mp. 72-74°C; 
1H NMR (300 MHz, CDCl3): = 1.23 (t, 3J=7.5 Hz, 6H; CH3), 
2.64 (q, 3J=7.5 Hz, 4H; CH2), 3.83 (s, 3H; CH3), 3.87 (s, 3H; 
CH3), 7.11-7.27 (m, 6H; CH), 7.33-7.49 (m, 4H; CH), 8.12-8.35 
(m, 2H; CO). 13C NMR (75 MHz, CDCl3): =15.1 (CH3), 15.2 (CH3), 28.5 (CH2), 28.6 
(CH2), 52.6 (CH3), 52.7 (CH3), 121.5 (C), 123.1 (CH), 124.1 (C), 127.2 (CH), 127.7 
(CH), 128.0 (CH), 128.6 (CH), 128.8 (CH), 129.4 (C), 129.8 (CH), 130.0 (CH), 130.6 
(C), 144.0 (C), 146.3 (CH), 159.4 (CO), 159.6 (CO), 164.2 (CO), 165.1 (CO). HR-ESI-
MS: m/z calcd for C13H16NO3 [M+H]+ 234.1125, found  234.1123. 
 
Methyl 3-(4-propylphenyl)-2-formamide acrylate 3.35. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (0.48 
g, 1.92 mmol, 58%) as a trans:cis (60:40) mixture. 1H NMR 
(400 MHz, CDCl3): = 0.87 (t, 3J=6.2 Hz, 6H; CH3), 1.56 
(quin, 3J=7.0 Hz, 4H; CH2), 2.50 (t, 3J=7.3 Hz, 4H; CH2), 
3.71 (s, 3H; CH3), 3.77 (s, 3H; CH3), 6.98-7.23 (m, 6H; CH), 
7.32-7.45 (m, 4H; CH), 8.06-8.32 (m, 2H; CO). 13C NMR (100 MHz, CDCl3): =13.4 
(CH3), 23.8 (CH2), 23.9 (CH2), 37.3 (CH2), 37.4 (CH2), 52.2 (CH3), 52.4 (CH3), 121.7 
(C), 122.8 (C), 125.2 (CH), 127.6 (CH), 128.2 (CH), 128.3 (CH), 128.8 (CH), 129.6 
(CH), 130.3 (CH), 129.8 (CH), 130.7 (CH), 131.6 (C), 133.5 (CH), 142.1 (C), 144.4 (C), 
144.6 (CH), 159.6 (CO), 160.3 (CO), 164.5 (CO), 165.1 (CO). HR-ESI-MS: m/z calcd 
for C14H18NO3 [M+H]+ 248.1281, found  248.1282.  
 
Methyl 3-(2-fluorophenyl)-2-formamidopropanoate 3.36. Column chromatography 
(n-pentane/EtOAc 1:1) yielded the product as a white solid (0.44 g, 
1.94 mmol, 97%). mp. 58-60°C; 1H NMR (400 MHz, CDCl3): 
=3.04-3.14 (m, 1H; CH2), 3.14-3.21 (m, 1H; CH2), 3.69 (s, 3H; 
CH3), 4.89 (mc, 1H; CH), 6.40-6.70 (m, 1H; NH), 6.93-7.06 (m, 2H; 
CH), 7.17-7.26 (m, 1H; CH), 7.08-7.14 (m, 1H; CH), 7.15-7.22 (m, 
1H; CH), 8.06 (s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =31.6 (CH3), 51.3 (CH2), 
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(CO), 171.8 (CO). ). HR-ESI-MS: m/z calcd for C11H13FNO3 [M+H]+ 226.0874, found  
226.0875. 
 
Methyl 3-(2-chlorophenyl)-2-formamidopropanoate 3.37. Column chromatography 
(n-pentane/EtOAc 1:1) yielded the product as a white solid (0.42 g, 
1.73 mmol, 86%). 1H NMR (400 MHz, CDCl3): =2.97 (dd, 2J=14.0 
Hz, 3J=6.4 Hz, 1H; CH2), 3.07 (dd, 2J=13.6 Hz, 3J=5.2 Hz, 1H; 
CH2), 3.68 (s, 3H; CH3), 4.82-4.89 (m, 1H; CH), 6.81 (bs, 1H; NH), 
6.93-7.01 (m, 1H; CH), 7.05-7.09 (m, 1H; CH), 7.11-7.20 (m, 2H; 
CH), 8.05 (s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =37.1 (CH3), 51.5 (CH2), 52.3 
(CH), 127.1 (CH), 127.2 (CH), 129.2 (CH), 129.6 (CH), 134.0 (C), 137.6 (C), 160.8 
(CO), 171.2 (CO). HR-ESI-MS: m/z calcd for C11H13ClNO3 [M+H]+ 242.0579, found  
242.0577. 
 
Methyl 3-(2-bromophenyl)-2-formamidopropanoate 3.38. The dehydroamino acid 
was dissolved in CHCl3, and the hydrogenation performed at 60°C 
and 20 bar H2. Column chromatography (n-pentane/EtOAc 1:1) 
yielded the product as a white solid (0.48 g, 1.92 mmol, 58%). mp. 
101°C; 1H NMR (400 MHz, CDCl3): =3.16 (dd, 2J=14.0 Hz, 3J=8.0 
Hz, 1H; CH2), 3.32 (dd, 2J=13.8 Hz, 3J=6.2 Hz, 1H; CH2), 3.70 (s, 
3H; CH3), 4.98 (q, 3J=8.0 Hz, 1H; CH), 6.45 (d, 3J=6.4 Hz, 1H; NH), 7.06-7.12 (m, 3H; 
CH), 7.17-7.26 (m, 1H; CH), 7.52 (d, 3J=8.0 Hz, 1H; CH), 8.09 (s, 1H; CHO). 13C NMR 
(100 MHz, CDCl3): =37.8 (CH3), 50.9 (CH2), 52.2 (CH), 124.8 (C), 127.5 (CH), 128.8 
(CH), 131.1 (CH), 132.9 (CH), 135.5 (C), 160.6 (CO), 171.5 (CO). 
 
Methyl 3-(3-fluorophenyl)-2-formamidopropanoate 3.39. Column chromatography 
(n-pentane/EtOAc 1:1) yielded the product as a white solid (0.41 g, 
1.81 mmol, 91%). 1H NMR (400 MHz, CDCl3): =3.01 (dd, 2J=13.8 
Hz, 3J=6.2 Hz, 1H; CH2), 3.30 (dd, 2J=14.0 Hz, 3J=5.4 Hz, 1H; 
CH2), 3.68 (s, 3H; CH3), 4.85-4.92 (m, 1H; CH), 6.50-6.95 (m, 4H; 
NH+CH), 7.26-7.25 (m, 1H; CH), 8.07 (s, 1H; CHO). 13C NMR (100 
MHz, CDCl3): =37.2 (CH3), 51.5 (CH2), 52.3 (CH), 114.0 (CH), 116.1 (CH), 124.7 
(CH), 129.9 (CH), 138.1 (C), , 160.8 (CO), 163.7 (C), 171.2 (CO). HR-ESI-MS m/z 
calcd for C12H11FNO3 [M+H]+ 226.0874, found 226.0874. 
 
Methyl 3-(3-chlorophenyl)-2-formamidopropanoate 3.40. Column chromatography 
(n-pentane/EtOAc 1:1) yielded the product as a white solid (0.40 g, 
1.67 mmol, 84%). mp. 88-90°C; 1H NMR (400 MHz, CDCl3): 
=3.14 (dd, 2J=13.8 Hz, 3J=7.8 Hz, 1H; CH2), 3.30 (dd, 2J=14.0 Hz, 
3J=6.0 Hz, 1H; CH2), 3.69 (s, 3H; CH3), 4.96 (q, 3J=7.2 Hz, 1H; 































(m, 1H; CH), 8.08 (s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =35.3 (CH3), 50.7 
(CH2), 52.5 (CH), 128.8 (CH), 128.5 (CH), 129.5 (CH), 131.2 (CH), 133.7 (C), 134.2 
(C), 160.7 (CO), 171.6 (CO). HR-ESI-MS: m/z calcd for C11H13ClNO3 [M+H]+ 
242.0579, found  242.0579. 
 
Methyl 3-(3-bromophenyl)-2-formamidopropanoate 3.41. The dehydroamino acid 
was dissolved in CHCl3, and the hydrogenation performed at 60°C 
and 20 bar H2. Column chromatography (n-pentane/EtOAc 1:1) 
yielded the product as a white solid (0.41 g, 1.81 mmol, 91%). 1H 
NMR (400 MHz, CDCl3): =3.01 (dd, 2J=13.8 Hz, 3J=6.2 Hz, 1H; 
CH2), 3.09 (dd, 2J=14.0 Hz, 3J=5.6 Hz, 1H; CH2), 3.70 (s, 3H; CH3), 
4.89 (q, 3J=6.5 Hz, 1H; CH), 6.58 (d, 3J=6.8 Hz, 1H; NH), 7.02 (d, 
3J=7.6 Hz, 1H; CH), 7.12 (t, 3J=7.8 Hz, 1H; CH), 7.24 (s, 1H; CH), 7.33 (d, 3J=8.0 Hz, 
1H; CH), 8.10 (s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =37.2 (CH3), 51.6 (CH2), 
52.4 (CH), 122.3 (CH), 127.7 (CH), 130.0 (CH), 130.1 (CH), 132.1 (C), 137.9 (C), 160.6 
(CO), 171.2 (CO). 
 
Methyl 2-formamido-3-m-tolylpropanoate 3.42. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (0.38 g, 1.71 
mmol, 85%). 1H NMR (400 MHz, CDCl3): =2.24 (s, 3H; CH3), 
2.90-3.10 (m, 2H; CH2), 3.63 (s, 3H; CH3), 4.79-4.89 (m, 1H; CH), 
6.84-6.94 (m, 2H; CH), 6.95-7.03 (m, 1H; CH), 7.06-7.15 (m, 1H; 
CH), 7.99 (s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =20.9 
(CH3), 37.2 (CH3), 51.6 (CH2), 51.9 (CH), 125.8 (CH), 127.4 (CH), 
128.0 (CH), 129.6 (CH), 135.3 (C), 137.7 (C), 160.8 (CO), 171.4 (CO). HR-ESI-MS m/z 
calcd for C12H16NO3 [M+H]+ 222.1125, found 222.1126. 
 
Methyl 3-(4-bromophenyl)-2-formamidopropanoate 3.43. Column chromatography 
(n-pentane/EtOAc 1:1) yielded the product as a white solid (0.48 
g, 1.67 mmol, 83%). mp. 54-55°C; 1H NMR (400 MHz, CDCl3): 
=2.97 (dd, 2J=14.0 Hz, 3J=6.4 Hz, 1H; CH2), 3.07 (dd, 2J=14.0 
Hz, 3J=5.6 Hz, 1H; CH2), 3.67 (s, 3H; CH3), 4.85 (q, 3J=6.5 Hz, 
1H; CH), 6.60-6.70 (m, 1H; NH), 6.95 (d, 2J=8.4 Hz, 1H; CH), 
7.34 (d, 2J=8.0 Hz, 1H; CH), 8.06 (s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =37.3 
(CH3), 51.9 (CH2), 52.8 (CH), 121.4 (C), 131.2 (CH), 131.8 (CH), 134.9 (C), 161.1 
(CO), 171.6 (CO). HR-ESI-MS: m/z calcd for C11H13BrNO3 [M+H]+ 286.0073, found  
286.0071. 
 
Methyl 2-formamido-3-(4-(trifluoromethyl)phenyl)propanoate 3.44. Column 
chromatography (n-pentane/EtOAc 1:1) yielded the product as a 
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CDCl3): =3.12 (dd, 2J=14.0 Hz, 3J=6.0 Hz, 1H; CH2), 3.22 (dd, 2J=14.0 Hz, 3J=5.6 Hz, 
1H; CH2), 3.72 (s, 3H; CH3), 4.95 (q, 3J=6.5 Hz, 1H; CH), 6.45 (d, 3J=6.4 Hz, 1H; NH), 
7.21 (d, 2J=8.0 Hz, 1H; CH), 7.51 (d, 2J=8.0 Hz, 1H; CH), 8.12 (s, 1H; CHO). 13C NMR 
(100 MHz, CDCl3): =37.4 (CH3), 51.6 (CH2), 52.5 (CH), 125.3 (C), 125.4 (CH), 129.6 
(CH), 129.7 (C), 139.7 (C), 160.6 (CO), 171.2 (CO). HR-ESI-MS: m/z calcd for 
C12H13F3NO3 [M+H]+ 276.0842, found  276.0844. 
 
Methyl 3-(4-ethylphenyl)-2-formamidopropanoate 3.45. Column chromatography (n-
pentane/EtOAc 1:1) yielded the product as a white solid (0.44 g, 
1.87 mmol, 94%). 1H NMR (400 MHz, CDCl3): =1.14 (t, 3H, 
3J=7.6 Hz; CH3) 2.53 (q, 2H 3J=7.5 Hz, 2H; CH2), 2.95 (dd, 
2J=14.0 Hz, 3J=6.4 Hz, 1H; CH2), 3.05 (dd, 2J=13.6 Hz, 3J=5.3 
Hz, 1H; CH2), 3.62 (s, 3H; CH3), 4.80-4.88 (m, 1H; CH), 6.97-
7.08 (m, 4H; CH), 8.00 (s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =15.0 (CH3), 27.9 
(CH2), 36.8 (CH3), 51.6 (CH2), 51.8 (CH), 127.5 (CH), 128.7 (CH), 132.5 (C), 142.5 (C), 
160.8 (CO), 171.4 (CO). HR-ESI-MS m/z calcd for C13H18NO3 [M+H]+ 236.1281, found 
236.1281. 
 
Methyl 3-(4-propylphenyl)-2-formamidopropanoate 3.46. Column chromatography 
(n-pentane/EtOAc 1:1) yielded the product as a white solid 
(0.34 g, 1.35 mmol, 83%). mp. 59-60°C; 1H NMR (400 MHz, 
CDCl3): =0.86 (t, 3J=7.4 Hz; CH3), 1.55 (sextet, 2H, 3J=7.6 
Hz; CH3) 2.48 (q, 2H 3J=6.9 Hz, 2H; CH2), 2.96 (dd, 2J=14.0 
Hz, 3J=6.4 Hz, 1H; CH2), 3.05 (dd, 2J=13.6 Hz, 3J=5.6 Hz, 
1H; CH2), 3.62 (s, 3H; CH3), 4.80-4.88 (m, 1H; CH), 6.88-7.09 (m, 5H; NH+CH), 8.00 
(s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =13.4 (CH3), 24.0 (CH2), 36.8 (CH2), 37.1 
(CH3), 51.6 (CH2), 51.8 (CH), 128.2 (CH), 128.6 (CH), 132.5 (C), 141.0 (C), 160.7 
(CO), 171.4 (CO). HR-ESI-MS m/z calcd for C14H20NO3 [M+H]+ 250.1438, found 
250.1437. 
 
2-Fluorophenylalanine hydrochloride 3.47. Precipitation yielded the product as a 
white solid (0.06 g, 0.27 mmol, 54%). 1H NMR (300 MHz, CDCl3): 
=3.09 (dd, 2J=14.7 Hz, 3J=7.5 Hz, 1H; CH2), 3.26 (dd, 2J=14.6 Hz, 
3J=5.9 Hz, 1H; CH2), 4.19 (d, 3J=6.6 Hz, 1H; CH), 6.97-7.10 (m, 2H; 
NH+CH), 7.15-7.29 (m, 1H; CH). 13C NMR (50 MHz, CDCl3): 
=22.4 (CH2), 46.3 (CH), 108.4 (CH), 113.8 (C), 114.1 (C), 117.9 
(CH), 123.1 (CH), 124.8 (CH), 164.1 (CO). HR-ESI-MS: m/z calcd for C9H11FNO2 
[M+H]+ 184.0768, found  184.0767. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 



















2-Chlorophenylalanine hydrochloride 3.48. Precipitation yielded the product as a 
white solid (0.03 g, 0.14 mmol, 34%). 1H NMR (400 MHz, CDCl3): 
=3.04 (dd, 2J=14.8 Hz, 3J=7.6 Hz, 1H; CH2), 3.17 (dd, 2J=14.4 Hz, 
3J=5.6 Hz, 1H; CH2), 4.12-4.19 (m, 1H; CH), 7.06-7.11 (m, 1H; CH), 
7.17-7.26 (m, 3H; CH). 13C NMR (50 MHz, CDCl3): =28.3 (CH2), 
47.1 (CH), 120.8 (CH), 120.9 (CH), 122.2 (CH), 123.6 (CH), 127.0 
(C), 129.3 (C), 164.2 (CO). HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% 
MeOH, pH 2.4, flow 0.3 mL/min, 7°C) 103.8 (S-), 165.6 (R-) min. 
 
2-Bromophenylalanine hydrochloride 3.49. Precipitation yielded the product as a 
white solid (0.12 g, 0.42 mmol, 84%). 1H NMR (300 MHz, CDCl3): 
=2.90-320 (m, 2H; CH2), 4.10-4.52 (m, 1H; CH), 7.04-7.18 (m, 2H; 
CH), 7.23-7.37 (m, 2H; CH). 13C NMR (75 MHz, CDCl3): =35.1 
(CH2), 53.8 (CH), 122.3 (C), 128.3 (CH), 130.9 (CH), 130.9 (CH), 
132.1 (CH), 136.2 (C), 170.9 (CO). HPLC (Crownpack CR(+), 4 mm 
x 150 mm, HClO4 in 15% MeOH, pH 2.6, flow 0.3 mL/min, 7°C) 77.6 (R-), 94.3 (S-) 
min. 
 
3-Fluorophenylalanine hydrochloride 3.50. Precipitation yielded the product as a 
white solid (0.09 g, 0.38 mmol, 91%). 1H NMR (300 MHz, CDCl3): 
=3.08 (dd, 2J=14.5 Hz, 3J=7.7 Hz, 1H; CH2), 3.22 (dd, 2J=14.7 Hz, 
3J=5.7 Hz, 1H; CH2), 4.96 (dd, 3J=7.5 Hz, 3J=5.9 Hz, 1H; CH), 6.89-
7.02 (m, 3H; CH), 7.22-7.31 (m, 1H; CH). 13C NMR (75 MHz, 
CDCl3): =35.4 (CH2), 54.2 (CH), 114.8 (C), 115.1 (CH), 116.1 (CH), 125.4 (CH), 
131.1 (CH), 136.7 (C), 171.6 (CO). HR-ESI-MS m/z calcd for C9H11FNO2 [M+H]+ 
184.0768, found 184.0768. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% 
MeOH, pH 2.0, flow 0.3 mL/min, 7°C) 57.1 (R-), 74 (S-) min. 
 
3-Chlorophenylalanine hydrochloride 3.51. Precipitation yielded the product as a 
white solid (0.03 g, 0.14 mmol, 34%). 1H NMR (400 MHz, CDCl3): 
=3.04 (dd, 2J=14.8 Hz, 3J=7.6 Hz, 1H; CH2), 3.17 (dd, 2J=14.4 Hz, 
3J=5.6 Hz, 1H; CH2), 4.12-4.19 (m, 1H; CH), 7.06-7.11 (m, 1H; CH), 
7.17-7.26 (m, 3H; CH). 13C NMR (50 MHz, CDCl3): =28.3 (CH2), 
47.1 (CH), 120.8 (CH), 120.9 (CH), 122.2 (CH), 123.6 (CH), 127.0 
(C), 129.3 (C), 164.2 (CO). HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% 
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3-Bromophenylalanine hydrochloride 3.52. Precipitation yielded the product as a 
white solid (00.23 g, 0.82 mmol, 88%). 1H NMR (300 MHz, CDCl3): 
=3.15-3.65 (m, 2H; CH2), 4.28-4.52 (m, 1H; CH), 7.15-7.52 (m, 3H; 
CH), 7.55-7.85 (m, 1H; CH). 13C NMR (75 MHz, CDCl3): =36.4 
(CH2), 52.9 (CH), 124.4 (C), 128.4 (CH), 130.0 (CH), 132.0 (CH), 
133.4 (CH), 133.7 (C), 171.3 (CO). HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 
in 15% MeOH, pH 2.6, flow 0.3 mL/min, 7°C) 114.4 (R-), 197.8 (S-) min. 
 
3-methylphenylalanine hydrochloride 3.53. Precipitation yielded the product as a 
white solid (0.09 g, 0.43 mmol, 99%). 1H NMR (300 MHz, CDCl3): 
=2.18 (s, 3H; CH3), 2.96-3.08 (m, 1H; CH2), 3.09-3.21 (m, 1H; 
CH2), 4.12-4.21 (m, 1H; CH), 6.92-7.03 (m, 2H; CH), 7.04-7.20 (m, 
1H; CH), 7.12-7.21 (m, 1H; CH). 13C NMR (75 MHz, CDCl3): =13.4 
(CH3), 28.5 (CH2), 47.2 (CH), 119.3 (CH), 121.5 (CH), 122.1 (CH), 123.0 (CH), 127.0 
(C), 132.4 (C), 154.3 (CO). HR-ESI-MS m/z calcd for C10H14NO2 [M+H]+ 180.1019, 
found 180.1020. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% MeOH, pH 
2.3, flow 0.3 mL/min, 7°C) 111.1 (S-), 123.1 (S-), 150.8 (R-), 155.8 (R-) min. 
 
4-Bromophenylalanine hydrochloride 3.54. Precipitation yielded the product as a 
white solid (0.10 g, 0.35 mmol, 80%). 1H NMR (300 MHz, 
CDCl3): =3.05-3.38 (m, 2H; CH2), 4.20-4.42 (m, 1H; CH), 7.07-
7.32 (m, 2H; CH), 7.40-7.63 (m, 2H; CH). 13C NMR (75 MHz, 
CDCl3): =35.2 (CH2), 54.0 (CH), 121.5 (C), 131.4 (CH), 132.2 
(CH), 133.2 (C), 171.4 (CO). HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 
15% MeOH, pH 2.6, flow 0.3 mL/min, 7°C) 122.5 (R-), 163.3 (S-), 198.5 (R-), 
219.7 (S-) min. 
 
4-Trifluoromethylphenylalanine hydrochloride 3.55. Precipitation yielded the product 
as white a solid (0.10 g, 0.37 mmol, 87%). 1H NMR (300 MHz, 
CDCl3): =3.13 (dd, 2J=14.6 Hz, 3J=7.3 Hz, 1H; CH2), 3.24 (dd, 
2J=14.6 Hz, 3J=5.9 Hz, 1H; CH2), 4.22 (d, 3J=6.8 Hz, 1H; CH), 
7.31 (d, 3J=7.8 Hz, 2H; CH), 7.55 (d, 3J=7.8 Hz, 2H; CH). 13C 
NMR (50 MHz, CDCl3): =28.4 (CH2), 46.9 (CH), 118.8 (C), 118.9 (CH), 122.9 (CH), 
131.5 (C), 164.0 (CO). 
 
4-Ethylphenylalanine hydrochloride 3.56. Precipitation yielded the product as a white 
solid (0.29 g, 1.27 mmol, 99%). 1H NMR (300 MHz, CD3OD): 
=1.21 (t, 3J=7.6 Hz, 3H; CH3), 2.62 (q, 3J=7.6 Hz, 2H; CH2), 
3.15 (dd, 4J=14.7 Hz, 3J=7.4 Hz, 1H; CH2), 3.28 (dd, 4J=14.8 Hz, 
3J=5.8 Hz, 1H; CH2), 4.23 (dd, 3J=7.2 Hz, 3J=6.0 Hz, 1H; CH2), 


























(CH2) 15.1 (CH), 128.4 (CH), 129.4 (CH), 131.5 (C), 143.9 (C), 170.8 (CO). HR-ESI-
MS: m/z calcd for C11H16NO2 [M+H]+ 194.1176, found  194.1174.  
 
4-Ethylphenylalanine hydrochloride 3.57. Precipitation yielded the product as a white 
solid (0.04 g, 0.15 mmol, 37%). 1H NMR (300 MHz, CDCl3): 
=0.84-1.06 (m, 3H; CH3), 1.55-1.80 (m, 2H; CH2), 2.55-2.78 
(m, 2H; CH2), 3.18-3.50 (m, 2H; CH2), 4.30-4.50 (m, 1H; CH), 
7.21-7.45 (m, 4H; CH). 13C NMR (75 MHz, CDCl3): =13.1 
(CH3), 24.2 (CH2), 35.3 (CH2), 37.0 (CH2), 54.2 (CH), 116.1 (CH), 118.8 (C), 124.3 
(CH), 126.5 (CH), 131.2 (CH), 143.2 (C), 171.5 (CO). HR-ESI-MS: m/z calcd for 
C12H18NO2 [M+H]+ 208.1332, found  208.1334.  
 
3-Amino-3-(2-fluoro-phenyl)-propanoic acid 3.58. White solid, 41%, mp. 219-220°C 
(lit. 234-236°C)53; 1H NMR (400 MHz, D2O + K2CO3): =2.46-2.53 
(m, 2H; CH2), 4.36 (t, 3J=7.2 Hz, 1H; CH), 6.96-7.31 (m, 4H; CH). 
Spectral data consistent with literature.53  
 
 
3-Amino-3-(2-chloro-phenyl)-propanoic acid 3.59. White solid, 31%; mp. 230-232°C 
(lit. 219°C)54; 1H NMR (400 MHz, D2O + K2CO3): =2.41 (dd, 
2J=15.2 Hz, 3J=8.0 Hz, 1H; CH2), 2.54 (dd, 2J=15.2, Hz 3J=6.0 Hz, 
1H; CH2), 4.54-4.60 (m, 1H; CH), 7.13-7.36 (m, 4H; CH). Spectral 
data consistent with literature.54 
 
3-Amino-3-(2-bromo-phenyl)-propanoic acid 3.60. White solid, 13%; mp. 229-230°C; 
1H NMR (400 MHz, D2O + K2CO3): =2.38 (dd, 2J=14.8 Hz, 3J=8.0 
Hz, 1H; CH2), 2.54 (dd, 2J=14.8 Hz, 3J=6.0 Hz, 1H; CH2), 4.51-4.54 
(m, 1H; CH), 7.05-7.52 (m, 4H; CH); 13C NMR (75 MHz, CDCl3): 
=46.9, 52.8, 124.9, 126.5, 127.4, 130.3, 133.8, 146.2, 167.3. HR-ESI-
MS calcd. for C9H11O2NBr 243.9968, found 243.9967. 
 
3-Amino-3-(3-chloro-phenyl)-propanoic acid 3.62. White solid, 56%; mp. 221-222°C; 
1H NMR (400 MHz, D2O + K2CO3): =2.41-2.45 (m, 2H; CH2), 4.10 
(t, 3J=7.2 Hz, 1H; CH), 7.16-7.28 (m, 4H; CH); 13C NMR (75 MHz, 
CDCl3): =46.9, 52.8, 124.9, 126.5, 127.4, 120.3, 133.8, 146.2, 167.3; 
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3-Amino-3-(3-bromo-phenyl)-propanoic acid 3.63. White solid, 55%; mp. 225-226°C 
(lit. 243-245°C);30b 1H NMR (400 MHz, D2O + K2CO3): =2.40-2.44 
(m, 2H; CH2), 4.03-4.10 (m, 1H; CH), 7.13-7.43 (m, 4H; CH). 




3-Amino-3-(3-methyl-phenyl)-propanoic acid. 3.64. White solid, 56%; mp. 219°C (lit. 
221-222°C)55; 1H NMR (400 MHz, D2O + K2CO3): =2.20 (s, 3H; 
CH3), 2.41-2.44 (m, 2H; CH2), 4.09 (t, 3J=7.2 Hz, 1H; CH), 7.02-7.19 
(m, 4H; CH); Spectral data consistent with literature.55 HPLC 
(Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% MeOH, pH 2.3, 
flow 0.3 mL/min, 7°C) 111.1 (S-), 150.8 (R-), 155.8 (R-), 123.1 
(S-) min. 
 
3-Amino-3-(4-bromo-phenyl)-propanoic acid 3.65. White solid, 29%; mp. 228-229°C 
(lit. 234°C)54; 1H NMR (400 MHz, D2O + K2CO3): =2.37-2.50 
(m, 2H; CH2), 4.08 (t, 3J=6.8 Hz, 1H; CH), 7.14-7.17 (m, 2H; 
CH), 7.39-7.42 (m, 2H; CH); Spectral data consistent with 
literature.54 HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 
15% MeOH, pH 2.6, flow 0.3 mL/min, 7°C) 122.5 (R-), 163.3 (S-), 198.5 (R-), 
219.7 (S-) min. 
 
3-Amino-3-(4-ethyl-phenyl)-propanoic acid 3.66. White solid, 60%; mp. 220-221°C; 
1H NMR (400 MHz, D2O + K2CO3): =1.04 (t, 3J=7.6 Hz, 3H; 
CH3), 2.40-2.43 (m, 2H; CH2), 2.48 (q, 3J=8.0 Hz, 2H; CH2), 
4.05-4.10 (m, 1H, CH), 7.13-7.19 (m, 4H; CH); 13C NMR (75 
MHz, CDCl3): =15.2, 28.0, 46.9, 52.8, 166.1, 126.7, 128.3, 
144.1, 167.7; MS (EI) m/z 193 (M+, 16), 134 (100); Anal. calcd. 
for C11H15NO2 C 68.37, H 7.82, N 7.25, found C 68.20, H 7.88, N 7.19. HPLC 
(Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% MeOH, pH 2.6, flow 0.3 mL/min, 
7°C) 175.0 (R-), 231.6 (S-) min. 
 
3-Amino-3-(4-propyl-phenyl)-propanoic acid 3.67. White solid, 31%, mp. 218-219°C; 
1H NMR (400 MHz, D2O + K2CO3): =0.75 (t, 3J=7.2 Hz, 3H; 
CH3), 1.42-1.50 (m, 2H; CH2), 2.41-2.47 (m, 4H; CH2), 4.10 (t, 
3J=7.2 Hz, 1H; CH), 7.12-7.20 (m, 4H; CH); 13C NMR (75 
MHz, CDCl3): =13.1, 24.2, 37.0, 47.0, 52.8, 118.8, 121.5, 




















found 208.1333; Anal. calcd. for C12H17NO2 C 69.54, H 8.27, N 6.76, found C 69.46, H 
8.27, N 6.72. HPLC (Crownpack CR(+), 4 mm x 150 mm, HClO4 in 15% MeOH, pH 
3.0, flow 0.3 mL/min, 7°C) 250.1 (R-), 387.3 (S-) min. 
 
3-Amino-3-(4-iso-propyl-phenyl)-propanoic acid 3.68. White solid, 60%, mp. 242-
243°C; 1H NMR (400 MHz, D2O + K2CO3): =1.05 (d, 3J=6.8 
Hz, 6H; CH3), 2.39 (d, 3J=7.2 Hz, 2H; CH2), 2.75 (sept, 3J=6.6 
Hz, 1H; CH), 4.07 (t, 3J=7.2 Hz, 1H; CH), 7.15-7.20 (m, 4H; 
CH); 13C NMR (75 MHz, CDCl3): =23.3, 36.7, 47.0, 51.2, 
121.5, 124.2, 126.6, 126.8, 168.1; MS (EI) m/z 207 (M+, 16), 148 
(100); Anal. calcd. for C12H17NO2 C 69.54, H 8.27, N 6.76, found C 69.40, H 8.25, N 
6.74. 
 
3-Amino-3-(4-nitrophenyl)-propanoic acid 3.69. A suspension of 4-nitrobenzaldehyde 
(1.00 g, 6.65 mmol), malonic acid (0.70 g, 6.70 mmol) and 
ammonium acetate (1.09 g, 14.2 mmol) in 2-propanol was heated 
under reflux for 22 h. The solid was filtered off, redissolved in 
aqueous 1N HCl (10 mL) and washed with Et2O (3 x 10 mL). 
The aqueous phase was evaporated in vacuum to give the product as yellow solid (0.30 
g, 1.42 mmol, 21 %).54 1H NMR (400 MHz, D2O + K2CO3): =2.44-2.50 (m, 2H; CH2), 
4.21-4.32 (m, 1H; CH), 7.41-8.10 (m, 4H; CH). Spectral data consistent with literature.54 
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Chapter 4 
Anti-Markovnikov selective Wacker 
oxidations of phthalimide protected 
allylic amines: a new catalytic route to 3-
amino acids 
 
A new method for the synthesis of 3-amino acids is presented. Phthalimide-protected 
allylic amines are oxidized under Wacker conditions selectively to aldehydes using 
PdCl2 and CuCl or Pd(MeCN)2Cl(NO2) and CuCl2 as complementary catalyst systems. 
The aldehydes are produced in excellent yields, and the new oxidation method exhibits a 
large substrate scope. -Amino acids and alcohols are synthesized by oxidation or 
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“Aldehyde Selective Wacker Oxidations of Phthalimide Protected Allylic Amines: a New Catalytic 




The Wacker oxidation is an important industrial and synthetic catalytic process for the 
conversion of olefins.1 The industrial Wacker-Hoechst process transforms ethylene to 
acetaldehyde using a homogeneous PdCl2/CuCl2 catalyst in an aqueous medium.1 This 
reaction has been widely used in natural product synthesis.1  
A simplified mechanism is depicted in scheme 4.01.2,3 PdII coordinates to the double 
bond of the alkene 4.01 to form 2-complex 4.02. Water reacts with 4.02 to form -
hydroxy alkyl palladium species 4.03 (oxypalladation). Subsequent -hydride 
elimination gives 2-complex 4.04, then H-Pd-Cl reinserts with opposite regioselectivity 
to form 4.05, which eliminates via transition state TS 1, a H-Pd-Cl species 4.06 and 
ketone 4.07. Loss of HCl results in a Pd0-species which is reoxidized to PdII using CuCl2 









































Scheme 4.01. Simplified mechanism of the Wacker oxidation. 
Usually, the oxidation of terminal alkenes via the Wacker process yields selectively 
methylketones, but there are few examples showing a preference for aldehyde 
formation.3 Until today, the palladium-catalyzed anti-Markovnikov Wacker oxidation of 
olefins remains a major challenge. In some cases the formation of aldehydes is observed 
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in the presence of directing functional groups or by using a palladium-nitro-nitroso redox 
couple.3 The first successful application of a palladium-nitro-nitroso redox couple in 
oxidations of terminal alkenes to aldehydes was reported by Feringa in 1986.4 The 
oxidation catalyst used is Pd(MeCN)2Cl(NO2) in combination with CuCl2 in a molar 
ratio of 1:4. When tert-butanol is used as a solvent linear alkenes are oxidized to an 
excess of aldehydes with selectivity up to 70% for 1-decene 4.08 with 10% conversion 
(table 4.1, entry 1).4a A change of solvent to EtOH leads to complete reversal of 
selectivity towards the ketone (table 4.1, entry 2). Branched olefin 4.09 shows a higher 
preference for ketone formation (table 4.1, entry 3). Styrene 4.10 is oxidized exclusively 
to phenylacetaldehyde at 10% conversion (table 4.1, entry 4).4a  
Table 4.1. Oxidation with Pd(MeCN)2Cl(NO2)/CuCl2. 
R
[Pd(MeCN)2Cl(NO2)] (10 mol%),













1 C8H17 (4.08) t-BuOH 1.1 10 60:40 
2 C8H17 (4.08) EtOH 20 75 0:100 
3 CHMe(C6H13) (4.09) t-BuOH 3.2 18 18:82 
4 Ph (4.10) t-BuOH 2.0 10 100:0 
 
The mechanism of this reaction is supposed to involve a 1,3-dipolar cycloaddition to 
form a heterometallocyclopentane 4.12 (scheme 4.02). Usually, palladium-dimers are 
formed; for simplification of the drawings in schemes 4.02-4.04 these are not shown. 
18O-labeling data, spectroscopic data and a crystal structure of the palladium-
metallacycle5 confirm the formation of this intermediate.6 18O-enriched 
Pd(MeCN)2Cl(N18O2) reacts with 1-decene in toluene under nitrogen atmosphere to give 
18O labeled 2-decanone.6a Therefore, the oxygen transfer proceeds from the nitro group 
compared to the mechanism of the regular Wacker oxidation where oxygen comes from 
water in the reaction mixture (scheme 4.01). Evidence for this pathway also comes from 
the high stereospecifity observed in the oxidation. It can also be regarded 
















4.11 4.12  
Scheme 4.02. Formation of the heterometallocyclopentane. 
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Andrews et al. propose a mechanism for the formation of the ketone from 
metallacyclopentane 4.12 over a hydrolytic ring opening to 4.13, where -hydride 
elimination should be favoured due to conformational flexibility to generate a Pd-C-C-H 
angle of 0°C; an appropriate orientation necessary for syn-elimination.6d The proposed 
conversion of the vinyl nitrite complex 4.14 to metallacyclobutane 4.15 might occur via 
reverse insertion of the H-Pd-X into the olefinic double bond and retro [2+2] 

























Scheme 4.03. Formation of the ketone from the heterometallocyclopentane. 
The simplified catalytic cycle proposed for the generation of aldehydes from olefins 
using the palladium-nitro-nitroso redox couple 4.17 in tert-butanol is shown in scheme 
4.04.4 Cycloaddition of olefin and catalyst lead to metallacycle 4.18, followed by -
hydrogen elimination and reoxidation of the palladium-nitroso species 4.20. The 
oxidation state of palladium is not changing during the reaction, therefore, the role of the 
CuII-salt might be different from that shown in scheme 4.01; perhaps CuII-ions are 
incorporated into a heterobimetallic (Cu-Pd) species or being involved in the oxidition of 
the nitroso to the nitro functionality.4 





























Scheme 4.04. Simplified mechanism for aldehyde formation. 
Another mechanism for the oxidation with the palladium nitro-nitroso redox couple has 
been suggested which includes the role of tert-butanol as a nucleophile (scheme 4.05).7 
With allylacetate as substrate, the solvent tert-butanol acts as a nucleophile and attacks 
the less hindered terminal position of the olefin. The intermediate alkyl-palladium 
species 4.21 has to undergo -hydrogen elimination followed by cleavage of the tert-
butyl vinyl ether. These assumptions are based on five observations: 1) the reaction is 
first order in tert-butanol in DMF as solvent, 2) the use of n- or sec-butanol lead to 
formation of acetal and ketal products, 3) the selectivity for aldehyde formation 
increases in the order n-butanol < sec-butanol < tert-butanol, 4) aldehyde selectivity is 
decreased by adding small amounts of water, but the rate is increased, 5) non-protic 













Scheme 4.05. Reaction involving tert-butanol. 
Very few examples of oxidations of allylic amines to amino aldehydes are known.3 
Cyclic N-allyl lactam 4.23 has been oxidized under Wacker conditions (table 4.2).8 In 
the presence of CuCl2 ketone 4.24 is the major product (table 4.2, entry 1). However, 
when CuCl is used, more of aldehyde 4.25 is formed along with olefin isomerization 
























4.23 4.24 4.25 4.26 4.27
 
entry CuX 4.24 [%] 4.25 [%] 4.26 [%] 4.27 [%] 
1 CuCl2 55 13 2 5 
2 CuCl 24 55 17  - 
 
The oxidation of allylic amides 4.28 and 4.29 has to be performed under water-free 
conditions to obtain good aldehyde selectivities (scheme 4.06).9 By adding water, the 
product outcome is reversed, e. g. mostly ketone is formed. Only -unsubstituted allylic 
amines were used, employing Pd(MeCN)2Cl2, CuCl, and excess of HMPA as catalyst 
system. Although an aldehyde/ketone ratio of 90/10 is achieved, the isolated yield of the 
aldehyde does not exceed 68%. The authors attribute the formation of the aldehyde to a 
coordination of the palladium species with the carbonyl oxygen of the amide.  
 
PdCl2(MeCN)2 10 mol%
















R1 = Me, R2 = Me (4.28)                85 (58%)                                  15
R1 = Me, R2 = Ph (4.29)                 90 (68%)                                  10  
Scheme 4.06. Oxidation of allylic amines under H2O-free conditions. 
Acetals are formed as major products of -unsubstituted allylic amines when Li2CO3 is 











R1 = R2 = Bn, R3 = Me (4.30)             81%    
R1 = R2 = R3 = Et (4.31)                     85%  
Scheme 4.07. Oxidation of allylic amines to acetals. 
The oxidation of allylic amine 4.32 is very sensitive to the copper source.11 Replacing 
Cu(OAc)2 with CuCl2 increases the formation of aldehyde 4.33, while better results are 
obtained using CuCl (table 4.3, entry 1-3). Optimal selectivities are achieved with 
addition of HMPA (table 4.3, entry 4), but aldehyde 4.33 was only isolated with a 
maximum yield of 64%. 
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4.32 4.33 4.34  
 
entry CuX ratio 4.33 : 4.34 
1 Cu(OAc)2 54:46 
2 CuCl2 65:35 
3 CuCl 75:25 
4 CuCl, HMPA 82:12 
 
During the natural product synthesis of tetraponerines, Blechert et al. employed the 
Wacker oxidation to yield amino aldehyde 4.36 in 76% yield (scheme 4.08).12 When the 
o-nitrobenzenesulfonyl (Ns) protecting group was used instead of the carboxybenzyl 


























Scheme 4.08. Wacker oxidation in the synthesis of the tetraponerines. 
The goal of the research described in this chapter was to find a methodology that allows 
the exclusive formation of aldehydes 4.38 from the oxidation of terminal allylic amines 
4.37 (scheme 4.09). A suitable protecting group has to be found that can direct the attack 
of the nucleophile (water) towards the terminal carbon of the double bond. So far, no 
method has been developed that gives aldehydes in yields exceeding 80%. Also the 
substrate scope has been limited to either -unsubstituted allylic amines (table 4.2, and 














4.37 4.38 4.39  
Scheme 4.09. Attempted oxidation of allylic amines. 
The new methodology presented in this chapter involves the selective anti-Markovnikov 
oxidation of various phthalimide protected allylic amines to amino aldehydes in 
excellent yields. No formation of side products, no olefin isomerization or allylic 
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substitution is observed. This method can be combined with asymmetric allylic 
amination or asymmetric imine vinylation to be applied in the synthesis of optically 
active 3-amino acids. 
4.2 Synthesis of allylic amines 
Different methods were used for the synthesis of the starting materials depending on the 
protecting group for the amino function. Literature procedures or variations thereof were 
used for these reactions. 
The p-methoxy phenyl (PMP) protected allylic amine 4.40 was synthesized at low 
temperatures by an addition of vinyllithium to the corresponding p-methoxyphenyl imine 
4.41, which was prepared from benzaldehyde and p-anisidine in 85% yield (scheme 
4.10).13 Vinyllithium freshly prepared from tetravinyltin and n-BuLi had to be used to 













Scheme 4.10. Synthesis of PMP-protected allylic amine. 
Carboxybenzyl (Cbz) protected amine 4.42 and p-toluenesulfonyl chloride (Ts) protected 
allylic amine 4.44 were synthesized from allylic amine 4.43 (scheme 4.11). 
Benzylchloroformate and aqueous saturated NaHCO3 were added to 4.43 to form 4.42 in 
good yield.15 Compound 4.44 was synthesized in moderate yield by adding p-toluene-






















Scheme 4.11. Synthesis of Cbz- and Ts-protected allylic amines. 
For the synthesis of tert-butoxycarbonyl (Boc) protected amine 4.46, a sequence of 
Swern oxidation and in situ Wittig olefination was employed (scheme 4.12).17 N-Boc-
protected amino alcohol 4.45, prepared from N-Boc-phenylalanine, was oxidized under 
mild conditions to the corresponding aldehyde. This aldehyde was reacted with prior 
deprotonated methyl triphenylphosphonium bromide providing the final product 4.46 in 
low yields. This disappointing result could have originated from insufficient aldehyde 
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formation during the Swern reaction, which also produced a large amount of salts that 





1) (COCl)2, DMSO, NEt3,
CH2Cl2, 62°C -> 20°C
2) HMDS, KH,THF, 0°C;
MePPh3Br, 0°C, 1h;





Scheme 4.12. Synthesis of Boc-protected allylic amine 4.46. 
The allylic substitution of alcohol 4.47 with sulfamic acid, catalyzed by an 
iridium/phosphoramidite catalyst developed by Carreira et al, was used to synthesize 
allylic amine 4.48.18,19 Amine 4.48 was in situ protected using benzoyl chloride under 
basic conditions to give benzoyl (Bz) protected allylic amine 4.49 in good yield over two 












3.0 mol% 4.50, DMF,




Scheme 4.13. Synthesis of Bz-protected allylic amine. 
The Mitsunobu reaction can be used for the synthesis of amines from alcohols when 
acidic amines are employed as nucleophiles.20 Starting from allylic alcohol 4.47, 
triphenylphosphine, diethyl azodicarboxylate solution (DEAD) and N-o-
nitrobenzenesulfonyl-N-tert-butoxycarbonyl amine were added, and protected alkyl-
amine 4.51 was isolated in very good yield (scheme 4.14).21 In principal, both the o-
nitrobenzenesulfonyl (o-Ns) and the Boc group can be selectively deprotected without 
affecting the other functional group. The Boc-protecting group is removed with 
trifluoroacetic acid (TFA), whereas deprotection of the o-Ns group can be achieved with 












Scheme 4.14. Synthesis of o-Ns-Boc-protected allylic amine. 
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Also a series of phthalimide-protected amines was synthesized from the corresponding 
allylic alcohols using the Mitsunobu reaction (table 4.4).22 In all substrates SN2 and SN2’ 
reactions of the nucleophile are possible, the latter leading to the usually more stable 
undesired internal olefin. Substrates with short or long alkyl chains give the branched 
allylic amines in good yields (table 4.4, entry 1-2). This is also the case for substrates 
wih benzyl- and benzyloxy-groups (table 4.4, entry 5-6) and substrate 4.61 containing a 
disubstituted alkene (table 4.4, entry 9). Branched product 4.54 (table 4.4, entry 3) and 
thienyl product 4.59 (table 4.4, entry 8) were formed in moderate yield. The yield and 
conversion of quartenary amine 4.55 is low because this substrate is sterically 
demanding and thus reacts very slow in the Mitsunobu reaction (table 4.4, entry 3). 
Phenyl-substituted allyl alcohol 4.58 gives the terminal olefin in low yields because the 
SN2’ reaction is favoured to give the more stable and conjugated internal alkene (table 
4.4, entry 7). 









THF, 16h  
 
entry substrate Yield [%] 
1 R = CH3  4.52 75 
2 R = C5H11  4.53 76 




  4.55 
12 
5 R = Bn  4.56 62 
6 R = BnOCH2  4.57 88 
7 R = Ph  4.58 16 










  4.61 
64 
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4.3 Screening for directing groups 
Three catalytic systems were employed in the initial screening for suitable protecting 
groups for the allylic amine. Method A is based on the palladium-nitro-nitroso redox 
couple and copper(II) chloride. Pd(MeCN)2Cl(NO2) was synthesized from 
Pd(MeCN)2Cl2 and AgNO2 in MeCN (scheme 4.15).6c The formation of this catalyst was 
proven by IR-spectroscopy via the absorption of the NO2-group and by NMR-
spectroscopy by a shift of the aromatic protons. 
 
Pd(MeCN)2Cl2 + AgNO2 Pd(MeCN)2Cl(NO2)
MeCN
16h  
Scheme 4.15. Synthesis of catalyst A. 
For Wacker oxidations catalyst A was activated under O2 for 2 h at 55°C. The oxidation 
was performed at 30°C in tert-butanol which is the best solvent for aldehyde selectivity 
as previously shown in the Feringa group (see paragraph 4.1).4 Method B and related 
method C were employing the standard Wacker catalysts palladium(II) chloride, and 
either copper(I) or copper(II) chloride and O2 as oxidant (table 4.5). 
Allylic amine 4.40 with the electron donating p-methoxyphenyl (PMP) protecting group 
did not show conversion with all catalytic systems (Table 4.5, entry 1-2). Substrate 4.42 
with the carboxybenzyl (Cbz) protection gave full conversion in case of method A and 
B23, with a slightly better selectivity of 66:33 for the aldehyde using method B (Table 
4.5, entry 4). The tosyl (Ts) protected amine 4.44 gave full conversion, and an 
aldehyde:ketone ratio of 43:57 with catalyst A, and high selectivity for the ketone using 
method B (Table 4.5, entry 5-6). The tert-butoxycarbonyl (Boc) protected amine 4.46 
gave only low conversion after longer reaction times of two days with method A and an 
undesired aldehyde:ketone ratio of 35:65 (Table 4.5, entry 7), whereas no conversion 
was seen with method B (Table 4.5, entry 8). The oxidation of benzoyl (Bz) protected 
allylamine 4.49 gave full conversion with an aldehyde-ketone ratio of 3:1 in case of 
method A, and 4:1 for method B (Table 4.5, entry 9-10). Substrate 4.51 with a Boc- and 
















A: Pd(MeCN)2Cl(NO2) (1-5 mol%), CuCl2 (5-20 mol%), 
     t-BuOH, O2, 16h
B: PdCl2 (10 mol%), CuCl (1.0 eq.), DMF/H2O (7:1), 
    O2, 3d
C: PdCl2 (10 mol%), CuCl2 (50 mol%), DMF/H2O (4:1), 
    O2, 3d








A : Kb 
1 R1=Ph, R2=PMP, R3=H (4.40)  Aa 72 0 - 
2 4.40 B 72 0 - 
3 R1=Ph, R2=Cbz, R3=H (4.42) Aa 16 100 61:39 
4 4.42 B 72 100 70:30 
5 R1=Ph, R2=Ts, R3=H (4.44) Aa 16 100 45:55 
6 4.44 B 72 100 3:97 
7 R1=Ph, R2=Boc, R3=H (4.46) Aa 16 10 35:65 
8 4.46 C 72 0 - 
9 R1=Me, R2=Bz, R3=H (4.49) Aa 72 12 77:23 
10 4.49 B 72 100 80:20 





O  (4.52) 
Ac 16 100 96:4 
13 4.52 B 48 100 >99:1 
14 4.52 C 72 80 94:6 
a 5 mol% Pd-cat, 20 mol% CuCl2. b Determined by 1H-NMR. c 1 mol% Pd-cat, 5 
mol% CuCl2. 
Phthalimide proved to be the optimal protecting group resulting in full conversion in 
case of method A and B (table 4.5, entry 12-13). The highest aldehyde selectivities 
(>99:1) were achieved using catalyst B, but the reaction took up to three days to 
completion. Catalyst A is more reactive, a lower catalyst loading can be used (1% of 
palladium, table 4.5, entry 12), and the oxidation is faster (16h), while aldehyde 
selectivities are only slightly lower (96:4). Lower conversion and slightly lower 
aldehyde selectivity are observed when using catalyst C (table 4.5, entry 14). This lower 
selectivity is attributed in this case to the higher chloride concentration, which could 
hamper coordination of palladium to the carbonyl oxygen of the substrate.3,8 
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4.4 Scope and limitations 
Next, the substrate scope was investigated in the oxidation of phthalimide-protected 
allylic amines (table 4.4). Reactions were usually performed on 1 mmol scale. Methyl 
substituted allylic amine 4.52 gave the aldehyde in 94% yield. Substrate 4.53 with a long 
alkyl chain was oxidized with excellent yield (91%) and selectivity (>99:1) (table 4.6, 
entry 2). Catalyst A was used to oxidize branched amine 4.54 in high yield and 
selectivity (table 4.6 entry 3). Quartenary amine 4.55 required a higher catalyst loading 
of A, and the aldehyde was isolated in good yield and a selectivity of 94:6 was found 
(table 4.6, entry 4). With a benzyl group in the side chain excellent yield and selectivity 
were achieved (table 4.6, entry 5). The benzyl-protected amino alcohol 4.57 was 
oxidized in 93% yield (table 4.6, entry 6). The aromatic substrate 4.58 as well as the 
heteroaromatic thienyl amine 4.59 gave excellent yields and selectivities (table 4.6, entry 
7-8). The internal olefin 4.60 could be converted selectively to the -ketone by using 
catalyst A (table 4.6, entry 9). However, 2-methyl-substituted olefin 4.61 could not be 




Table 4.6. Substrate scope of oxidation of phthalimide protected allylic amines. 
A: Pd(MeCN)2Cl(NO2) (1-5 mol%), CuCl2 (5-20 mol%), 
     tert-BuOH, O2, 16h
B: PdCl2 (10 mol%), CuCl (1.0 eq.), DMF/H2O (7:1), 













entry substrate cat time [h] A : Ka isolated  
yield % 
1 R = CH3 (4.52) B 48 >99:1 94  
2 R = C5H11 (4.53) B 72 >99:1 91  




A 48 94:6 74b  
5 R = Bn (4.56) B 72 >99:1 94  
6 R = BnOCH2 (4.57) B 72 >99:1 93  
7 R = Ph (4.58) B 72 >99:1 95  
8 




O  (4.60) 










a By 1H-NMR. b Pd(MeCN)2Cl(NO2) (15 mol%), CuCl2 (60 mol%).  
The Wacker oxidation presented here has a broad substrate scope of aliphatic and 
aromatic allylic amines. Furthermore, sterically more demanding substrates are oxidized, 
but reaction times have to be prolonged. Also internal unsubstituted olefins are oxidized 
to the corresponding -amino ketones and all products were isolate in high yields. 
It is assumed that the high selectivity for the anti-Markovnikov oxidation to the aldehyde 
with these catalysts results from coordination of the protecting group with the palladium 
catalyst. The mechanism for the oxidation with catalyst A has been described in 
paragraph 4.1.4,6 With this catalyst, the carbonyl oxygen of the phthalimide can stabilize 
the palladium intermediate. In this hypothesis, the palladium species can coordinate to 
the olefinic double bond and to the carbonyl oxygen to form intermediate 4.62.24,25 The 
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nucleophilic attack of water is then directed to the terminal carbon of the alkene to form 
the six membered complex 4.63 which could be a reason for the observed selectivities 








4.62 4.63  
Scheme 4.16. Proposed coordination of the palladium species with the allylic phthalimide protected amine. 
4.4.1 Catalytic asymmetric synthesis of an allylic amine and the transformation 
of -amino aldehydes 
It is envisioned that the new aldehyde-selective oxidation allows the asymmetric 
synthesis of 3-amino acids from allylic compounds using three consecutive catalytic 
transformations: 1) asymmetric allylic amination, 2) Wacker oxidation, and 3) oxidation 
of the aldehyde to the carboxylic acid. In the asymmetric allylic amination, allylic 
carbonate 4.64 reacted with phthalimide to 4.58 with 96% ee catalyzed by an 
iridium/phosphoramidite complex as described by Helmchen et al.  (scheme 4.17).26,27 
The yield of this reaction was not as high as reported (65%).28 The product 4.58 can be 
readily transformed into the primary amine which allows further functionalization, and 



































Scheme 4.17. Asymmetric synthesis of -amino aldehyde by allylic substitution and Wacker oxidation. 
Next, enantioenriched olefin 4.58 was oxidized using catalyst B to aldehyde 4.66 
(scheme 4.17). For determination of the enantiomeric excess of the oxidation product 

















Scheme 4.18. Conversion of aldehyde 4.66 to its acetal. 
The obtained -amino aldehydes (table 4.6) can be transformed into -amino acids and 
-amino alcohols which represent valuable building blocks for natural products and 
pharmaceuticals. Catalytic oxidation of 4.68 with Mn-tmtacn30 and subsequent 
deprotection with hydrazine31 gave the -amino acid 4.69 in 87% yield in two steps 
(scheme 4.19). Mn-tmtacn, which has been previously used for the synthesis of epoxides 
and diols from alkenes, proves also to be a good catalyst for the oxidation of aldehydes 
to carboxylic acids. A low catalyst loading can be used in short reaction times, using 
environmentally benign H2O2 as oxidant under aqueous conditions. Reduction with 1.0 
eq. of NaBH4 in MeOH at 0°C for 1h gave selective conversion to the corresponding 
alcohol 4.70 in 95% yield. Subsequent deprotection with hydrazine gave the -amino 







1) 0.5% Mn-tmtacn, Cl3CCO2H,






2) H2NNH2, EtOH, , 2.5h; 
100%
87%













Scheme 4.19. Transformation of -amino aldehydes to -amino acids and -amino alcohols. 
4.5 Conclusion 
In summary, it was demonstrated that aldehydes can by synthesized selectively from 
phthalimide-protected allylic amines using a catalytic Wacker-type oxidation. After an 
initial screening of protecting moieties for the amino group, phthalimide showed 
selective aldehyde formation. This unique effect is attributed to a stabilization of the 
palladium intermediate through coordination with the carbonyl oxygen of the protecting 
group. Two catalytic methods were used. Method A based on a palladium-nitro-nitroso 
redox couple needs shorter reaction times and lower catalyst loadings, however, 
selectivities for the aldehyde are slightly lower. For less reactive substrates, such as 
quaternary amine 4.55, branched amine 4.54 and internal olefin 4.60, catalyst A was 
employed. Method B, using PdCl2 and CuCl, gave excellent selectivity, but requires 
longer reaction times up to three days. This new methodology is used as a key step in a 
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new procedure for the asymmetric synthesis of a 3-amino acid involving three 
consecutive catalytic steps. It was shown that enantionenriched -amino aldehydes can 
be synthesized via asymmetric allylic amination and oxidation. Furthermore, these 
aldehydes were transformed into -amino acids and alcohols. Mn-tmtacn was used to 
oxidize the aldehyde to the corresponding carboxylic acid. The scope of this new 
catalytic oxidation method will be explored in the future. 
4.6 Experimental  
This project was performed in collaboration with Alejandro Baeza Garcia and Thomas 
Jerphagnon. 
 
General methods. see chapter 2. 
 
General procedure for oxidation reactions with Pd(MeCN)2Cl(NO2)/CuCl2 (method 
A): Pd(MeCN)2Cl(NO2) (0.05 eq) and CuCl2 (0.2 eq) were activated for 2h in tert-BuOH 
(0.4 M) at 55ºC with an oxygen-filled balloon placed on top of the flask. The catalyst 
solution was cooled to 30ºC and the substrate (1.0 eq) added. The reaction mixture was 
stirred at 30ºC under oxygen and the progress of the oxidation monitored by GC-MS. 
Full conversion was observed in most cases after 16h. EtOAc (10 mL) and H2O (10 mL) 
were added. The aqueous layer was extracted with EtOAc (3 x 10 mL), the combined 
organic layers washed with saturated aq. NaHCO3 solution and H2O, and dried over 
MgSO4. The solvent was evaporated in vacuum. 
 
General procedure for oxidation reactions with PdCl2/CuCl for screening (method 
B): PdCl2 (0.1 eq) and CuCl (1.0 eq) were placed in a Schlenk flask, and DMF and H2O 
(7:1, 0.05 M), and the protected allylic amine (1.0 eq) were added. An oxygen-filled 
balloon was placed on top of the flask, and the mixture was stirred vigorously. The 
progress of the reaction was monitored by GC-MS. After completion, CH2Cl2 (10 mL) 
and H2O (10 mL) were added. The aqueous layer was extracted with CH2Cl2 (3 x 10 
mL), the combined organic layers washed with saturated NaHCO3 solution and H2O, and 
dried over MgSO4. The solvent was evaporated in vacuum. 
 
General procedure for oxidation reactions with PdCl2/CuCl2 (method C): PdCl2 (0.1 
eq) and CuCl2 (0.5 eq) were placed in a Schlenk flask, DMF and H2O (4:1, 0.05 M), and 
the protected allylic amine (1.0 eq) were added. An oxygen filled-balloon was placed on 
top of the flask, and the mixture was stirred vigorously. The progress of the reaction was 
monitored by GC-MS. After completion, CH2Cl2 (10 mL) and H2O (10 mL) were added. 
The aqueous layer was extracted with CH2Cl2 (3 x 10 mL), the combined organic layers 
washed with saturated NaHCO3 solution and H2O, and dried over MgSO4. The solvent 




Synthesis of Pd(MeCN)2Cl(NO2): AgNO2 (0.154 g, 1.00 mmol) in MeCN (2.0 mL) 
was added to Pd(MeCN2)Cl2 (0.260 g, 1.00 mmol) in MeCN (4.4 mL). After stirring 
overnight, the precipitate was filtered and the filtrate concentrated in vacuum to yield a 
light orange solid (0.263 g, 0.97 mmol, 97%). m.p. 108-110°C; IR (KBR): =2771 (NO), 
2661 (NO). Data were according to literature6 
 
4-Methoxy-N-(1-phenylallyl)aniline 4.40. Preparation of vinyllithium14: n-BuLi (6.4 
mL, 10 mmol, 5.0 eq) was added to tetravinyltin (0.36 mL, 2.0 
mmol, 1.0 eq) in dry n-hexane. After 2h of stirring the solvent was 
removed with a  syringe, and the residue was washed four times with 
dry n-hexane. The solid was dried in vacuum and dissolved in dry 
THF. The imine (0.43 g, 2.0 mmol, 1.0 eq) was  dissolved in dry 
toluene, TMEDA (0.33 mL, 2.2 mmol, 1.1 eq) was added and the mixture was cooled to 
-72°C. The solution of vinyllithium (4.3 mmol, 2.2 eq) in dry THF (1.5 mL) was added 
dropwise over 30 min. The mixture was stirred for 24 h, quenched with MeOH, and 
warmed slowly to room temperature. The solvent was evaporated in vacuum, and the 
crude allylic amine purified by flash column chromatography (pentane:EtOAc 90:10) to 
yield a reddish oil (0.44 g, 1.83 mmol, 92%).13 Data were according to literature33: 1H 
NMR (400 MHz, CDCl3): = 3.72 (s, 3H; CH3), 3.81 (bs, 1H; NH), 4.85 (d, 3J=6.0 Hz, 
1H; CH), 5.20 (d, 3J=10.4 Hz, 1H; CH), 5.26 (d, 3J=17.2 Hz, 1H; CH), 6.03 (ddd, 
3J=16.8 Hz, 3J=10.2 Hz, 3J=6.2 Hz, 1H; CH), 6.56 (d, 3J=8.8 Hz, 2H; CHAr), 6.73 (d, 
3J=9.2 Hz, 1H; CH), 7.24-7.40 (m, 5H; CHAr). 13C NMR (100 MHz, CDCl3): 
=55.5(CH3), 55.6 (CH3), 61.6 (CH), 61.7 (CH), 114.6 (CH2), 114.8 (CH2), 115.7 (CH), 
127.0 (CH), 127.2 (CH), 128.6 (CH), 139.4 (CH), 141.3 (C), 142.0 (C), 152.0 (C). 
 
Benzyl 1-phenylallyl carbamate 4.42. To 1-phenylprop-2-en-1-amine (0.27 g, 2.0 
mmol) in EtOAc (6.15 mL) was added saturated NaHCO3 solution 
(6.15 mL) and benzyl chloroformate (0.29 mL, 2.0 mmol) at 0°C. The 
reaction was stirred over night at room temperature. The aqueous layer 
was extracted with EtOAc (3 x 10mL), the combined organic layers 
washed with 1M HCl (2 x 20 mL), dried over MgSO4, and 
concentrated in vacuum. The product was purified by flash column chromatography 
(pentane/EtOAc 3:1) to a white solid (0.50 g, 1.9 mmol, 94%).15 Data according to 
literature34: 1H NMR (300 MHz, CDCl3): = 5.08-5.20 (m, 2H; CH2),  5.22-5.23 (m, 3H; 
CH+CH2), 5.40 (bs, 1H; NH), 5.96-6.10 (m, 1H; CH), 7.28-7.42 (m, 10H; CHAr). 13C 
NMR (75 MHz, CDCl3): =57.0 (CH), 68.8 (CH2), 115.7 (CH2), 126.9 (CH), 127.6 
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4-Methyl-N-(1-phenylallyl)benzenesulfonamide 4.44. p-Toluenesulfonyl chloride 
(0.41 g, 2.12 mmol) was added to 1-phenylprop-2-en-1-amine (0.27 
g, 2.0 mmol) and NEt3 (0.64 mL, 4.59 mmol) in CH2Cl2 (1.6 mL) 
and stirred at room temperature overnight. H2O was added, and the 
aqueous layer extracted with CH2Cl2 (3 x 5 mL), the organic layer 
dried over MgSO4 and concentrated in vacuum. The product was 
purified by flash column chromatography (n-pentane/EtOAc 3:1) to a yield white solid 
(0.38 g, 1.31 mmol, 66%).16 Data according to literature35: 1H NMR (400 MHz, CDCl3): 
= 2.37 (s, 3H; CH3), 4.94 (t, 3J=6.0 Hz, 1H; CH), 5.06-5.13 (m, 2H; CH+CH), 5.59 (d, 
3J=6.8 Hz, 1H; NH),  (ddd, 3J=16.8 Hz , 3J=10.3 Hz , 3J=6.3 Hz , 1H; CH), 7.09-7.21 
(m, 7H; CHAr), 7.62-7.67 (m, 2H; CHAr). 13C NMR (100 MHz, CDCl3): =21.4 (CH), 
59.8 (CH3), 116.5 (CH2), 126.9 (CH), 127.0 (CH), 127.5 (CH), 128.4 (CH), 129.2 (CH), 
137.0 (CH), 137.5 (C), 139.3 (C), 143.0 (C).  
 
tert-Butyl 1-phenylallylcarbamate 4.46. 1) To oxalyl chloride (0.27 mL, 3.2 mmol) in 
CH2Cl2 (3 mL) was added DMSO (0.23 mL, 3.3 mmol) at -63°C, and the 
solution was stirred for 20 min at -63°C. The alcohol (0.48 g, 2.0 mmol) in 
DMSO/CH2Cl2 (0.17 mL/3 mL) was added over 5 min. The mixture was 
stirred at -35°C for 20 min. Then, NEt3 (1.72 mL, 12.3 mmol) was added 
dropwise. After stirring for 5 min at room temperature it was cooled to -78°C. 2) HMDS 
(0.87 mL, 4.2 mmol) was added dropwise to KH (30% in mineral oil, 0.50 g, 3.74 mmol) 
in dry THF (14 mL) at 0°C, and stirred for 1 h at 0°C. The mixture was added via 
cannula to MePPh3Br (1.5 g, 4.58 mmol) at 0°C, and stirred for 1h. After cooling to -
78°C the aldehyde in THF (4 mL) was added. The mixture was stirred for 5 min at -
78°C, then warmed to room temperature over 1 h and heated to 40°C overnight. MeOH 
(0.1 mL) and potassium tartrate (1.5 mL of saturated solution and 7 mL H2O) were 
added. The aqueous layer was extracted with EtOAc (3 x 10 mL), the combined organic 
layers washed with H2O and brine, and dried over MgSO4. The crude allylic amine was 
purified by flash column chromatography (n-pentane/EtOAc 6:1) to a colourless oil 
(0.09 g, 0.4 mmol, 20%).17 Data according to literature17: 1H NMR (400 MHz, CDCl3): 
=1.44 (s, 9H; CH3), 4.85 (bs, 1H; NH), 5.15-5.34 (m, 3H; CH+CH+CH), 5.99 (ddd, 
3J=15.6 Hz, 3J=10.1 Hz, 3J=5.5 Hz, 1H; CH), 7.22-7.38 (m, 5H: CHAr). 13C NMR (75 
MHz, CDCl3): =28.3 (CH)3, 56.6 (CH), 79.7 (C), 115.4 (CH2), 127.0 (CH), 127.5 (CH), 
128.6 (CH), 137.9 (CH), 141.0 (C), 155.0 (CO) 
 
N-(But-3-en-2-yl)benzamide 4.49. Bis(1,5-cyclooctadiene)diiridium(I) dichloride (0.02 
g, 0.03 mmol, 1.5 mol%) and phosphoramidite 4.50 (0.02 g, 0.06 mmol, 3.0 
mol%) were stirred in DMF for 15 min. Then, the allylic alcohol (0.17 mL, 
2.0 mmol) and sulfamic acid (0.19 g, 2.00 mmol) were added. The sealed 
tube was heated to 50°C over night. After cooling to room temperature NEt3 














mmol) were added. The mixture was stirred for 3.5 h, CH2Cl2 (40 mL) and H2O added, 
and the aqueous layer extracted with CH2Cl2 (3 x 30 mL). The combined organic layers 
were dried over MgSO4, concentrated in vacuum, and the product was purified by flash 
column chromatography (n-pentane/EtOAc 3:1) to a white solid (0.27 g, 1.5 mmol, 
76%).18 Data according to literature18: mp. 55-57°C; 1H NMR (300 MHz, CDCl3): 
=1.35 (d, 3J=6.6 Hz, 3H; CH3), 4.73-4.86 (m, 1H; CH), 5.14 (d, 3J=10.2 Hz, 1H; CH), 
5.24 (d, 3J=17.4 Hz, 1H; CH), 5.86-6.04 (m, 2H; NH+CH), 7.40-7.53 (m, 3H; CHAr), 
7.72-7.80 (m, 2H; CHAr). 13C NMR (75 MHz, CDCl3): =20.3 (CH)3, 47.1 (CH), 114.4 
(CH2), 126.8 (CH), 128.5 (CH), 131.4 (CH), 134.7 (C), 139.4 (CH), 166.6 (CO). 
 
tert-Butyl 2-nitrophenylsulfonyl(phenylallyl)carbamate 4.51. To PPh3 (0.79 g, 3.01 
mmol), amine (0.60 g, 2.0 mmol) and allylic alcohol (0.18 mL, 2.0 
mmol) in dry THF (8 mL) was added DEAD (40% in toluene, 1.4 mL) 
at 0°C. After stirring overnight at room temperature the mixture was 
concentrated in vacuum. The product was purified by flash column 
chromatography (n-pentane/EtOAc 3:1) to a colourless oil (0.65 g, 1.82 
mmol, 91%).21 1H NMR (400 MHz, CDCl3): = 1.35 (s, 9H; CH3), 1.59 (d, 3J=6.8 Hz, 
3H; CH3), 4.97 (quin, 3J=6.4 Hz, 1H; CH), 5.18 (d, 3J=10.4 Hz, 1H; CH), 5.26 (d, 
3J=17.2 Hz, 1H; CH), 6.12 (ddd, 3J=16.9 Hz, 3J=10.9 Hz, 3J=5.7 Hz, 1H; CH), 7.70-7.76 
(m, 3H; CHAr), 8.25-8.30 (m, 1H; CHAr). 13C NMR (100 MHz, CDCl3): =18.7 (CH3), 
27.8 (CH3), 56.6 (CH), 84.9 (C), 115.9 (CH2), 124.3 (CH), 131.8 (CH), 132.9 (CH), 
133.9 (CH), 134.1 (C), 138.0 (C), 147.7 (C), 150.2 (CO). HR-ESI-MS: m/z calcd for 
C15H21N2O6S [M+H]+ 357.1115, found  357.1115. 
 
General procedure for the Mitsunobu-reaction. The corresponding allylic alcohol 
(1.0 eq) was dissolved in dry THF (0.25M), triphenylphosphine (1.5 eq), and phthalimide 
(1.0 eq) were added. DEAD (40% in toluene, 1.5 eq) was added dropwise to the ice-
cooled mixture. After stirring overnight at room temperature, the solvent was removed in 
vacuum. The crude product was purified by flash column chromatography (n-
pentane/EtOAc) on silica gel.22  
 
2-(1-Methyl-allyl)-isoindole-1,3-dione 4.52. Column chromatography (n-
pentane/EtOAc 4:1) yielded the phthalimide as white solid (75%). m.p. 86-
87ºC; 1H NMR (400 MHz, CDCl3): =1.58 (d, 3J=7.2 Hz, 3H; CH3), 4.93 
(quin, 3J=7.0 Hz, 1H; CH), 5.16 (d, 3J=10.0 Hz, 1H; CH), 5.23 (d, 3J=17.2 
Hz, 1H; CH), 6.20 (ddd, 3J=17.1 Hz, 3J=10.3 Hz, 3J=6.7 Hz, 1H; CH), 7.70 
(dd, 3J=5.2 Hz, 4J=3.2 Hz,  2H; CHAr),  7.83 (dd, 3J=6.4 Hz, 4J=3.2 Hz,  2H; 
CHAr). 13C NMR (75 MHz, CDCl3): =18.2 (CH3), 48.9 (CH), 116.3 (CH2), 
123.1 (CH), 132 (C), 133.8 (CH), 136.8 (CH), 167.9 (CO). HRMS calcd for C12H11NO2 
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2-(1-Vinyl-hexyl)-isoindole-1,3-dione 4.53. Column chromatography (n-
pentane/EtOAc 5:1) yielded the phthalimide as colourless oil (76%). 
1H NMR (400 MHz, CDCl3): =0.80-0.88 (m, 3H; CH3), 1.20-1.34 
(m, 6H, CH2), 1.86-1.93 (m, 1H, CH2), 2.02-2.12 (m, 1H, CH2), 4.72 
(q, 3J=7.7 Hz, 1H; CH), 5.16 (dt, 3J=10.5 Hz, 2J=0.8 Hz, 1H; CH), 
5.22 (d, 3J=17.2 Hz, 2J=1.2 Hz, 1H; CH), 6.21 (ddd, 3J=17.4 Hz, 
3J=9.9 Hz, 3J=7.5 Hz, 1H; CH), 7.0 (dd, 3J=5.6 Hz, 4J=3.2 Hz,  2H; 
CHAr),  7.82 (dd, 3J=5.4 Hz, 4J=3.0 Hz,  2H; CHAr). 13C NMR (75 MHz, CDCl3): =13.9 
(CH3), 22.4 (CH2), 26.0 (CH2), 31.2 (CH2), 31.9 (CH2), 54.1 (CH), 117.2 (CH2), 123.1 
(CH), 131.9 (C), 133.8 (CH), 135.8 (CH), 168.0 (CO). HR-ESI-MS: m/z calcd for 
C16H20NO2 [M+H]+ 258.1489, found 258.1489. 
 
2-(4-Methylhex-1-en-3-yl)isoindoline-1,3-dione 4.54. Column chromatography (n-
pentane/EtOAc 9:1) gave the aldehyde as a 60:40 mixture of 
diastereomers (52%). 1H NMR (400 MHz, CDCl3): = 0.80-0.87 (m, 6H; 
2 x CH3), 0.90-0.96 (m, 6H; 2 x CH3), 0.97-1.17 (m, 2H; 2 x CH2), 1.32-
1.43 (m, 1H; CH2), 1.59-1.71 (m, 1H; CH2), 2.24-2.38 (m, 2H; 2 x CH), 
4.33-4.40  (m, 2H; 2 x CH), 5.16-5.29  (m, 2H; 2 x CH2), 6.24-6. (m, 2H; 
2 x CH), 7.68-7.73 (m, 4H; 2 x CHAr), 7.80-7.85 (m, 4H; 2 x CHAr). 13C 
NMR (100 MHz, CDCl3): = 10.5 (CH3), 10.7 (CH3) , 15.4 (CH3) , 16.1 (CH3) , 25.5 
(CH2) , 26.0 (CH2) , 36.9 (CH) , 35.2 (CH), 59.7 (CH), 59.8 (CH), 118.8 (CH2), 118.9 
(CH2), 123.0 (CH), 131.8 (C), 133.9 (CH), 135.0 (CH), 135.1 (CH), 168.0 (C). HR-ESI-
MS: m/z calcd for C15H18NO2 [M+H]+ 244.1328, found  244.1332.  
 
2-(1,1-Dimethyl-allyl)-isoindole-1,3-dione 4.55. Column chromatography (n-
pentane/EtOAc 3:1) yielded the phthalimide as colourless oil (12%). 1H 
NMR (300 MHz, CDCl3): =1.70-1.75 (m, 6H; CH3), 4.99-5.13 (m, 2H; 
CH+CH), 6.12-6.26 (m, 1H; CH), 7.58-7.65 (m, 2H; CHAr), 7.66-7.75 (m, 
2H; CHAr). 13C NMR (75 MHz, CDCl3): =26.7 (CH3), 59.8 (CH), 111.1 
(CH2), 122.5 (CH), 131.8 (C), 133.6 (CH), 143.2 (CH), 168.9 (CO). ESI-
MS: m/z calcd for C13H14NO2 [M+H]+ 216.1017, found  216.1019. 
 
2-(1-Benzyl-allyl)-isoindole-1,3-dione 4.56. Column chromatography (n-
pentane/EtOAc 95:5) yielded the phthalimide as white solid (62%). m.p. 
92-93°; 1H NMR (300 MHz, CDCl3): =3.20 (dd, , 2J=13.8 Hz, 3J=6.6 Hz, 
1H; CH2), 3.42 (dd, , 2J=13.8 Hz, 3J=9.9 Hz, 1H; CH2), 4.99-5.09 (m, 1H; 
CH), 5.16-5.27 (m, 2H; CH2), 6.27 (ddd, 3J=17.4 Hz, 3J=10.1 Hz, 3J=7.1 
Hz, 1H; CH), 7.07-7.23 (m, 5H; CHAr), 7.62-7.70 (m, 2H; CHAr), 7.71-












(CH), 117.6 (CH2), 123.1 (CH), 126.6 (CH), 128.4 (CH), 129.0 (CH), 131.7 (C), 133.8 
(CH), 135.1 (CH), 137.5 (C), 167.9 (CO). HR-ESI-MS: m/z calcd for C18H16NO2 
[M+H]+ 278.1171, found  278.1176. 
 
2-(1-Benzyloxymethyl-allyl)-isoindole-1,3-dione 4.57. Column chromatography (n-
pentane/EtOAc 9:1) yielded the phthalimide as colourless oil (88%). 
1H NMR (300 MHz, CDCl3): =3.77 (dd, , 2J=9.9 Hz, 3J=5.7 Hz, 1H; 
CH2), 4.13 (dd, , 2J=9.8 Hz, 3J=9.8 Hz, 1H; CH2), 4.49 (d, , 2J=12.3 
Hz, 1H; CH2), 4.58 (dd, , 2J=12.3 Hz, 1H; CH2), 5.05-5.15 (m, 1H; 
CH), 5.26 (d, 3J=10.5 Hz, 1H; CH2), 5.26 (d, 3J=16.2 Hz, 1H; CH2), 
6.17 (ddd, 3J=17.1 Hz, 3J=10.1 Hz, 3J=7.1 Hz, 1H; CH), 7.21-7.30 
(m, 5H; CHAr), 7.67-7.74 (m, 2H; CHAr), 7.79-7.86 (m, 2H; CHAr). 13C NMR (75 MHz, 
CDCl3): =53.1 (CH), 68.8 (CH2), 72.7 (CH2), 118.9 (CH2), 123.1 (CH), 127.5 (CH), 
128.2 (CH), 131.8 (C), 132.2 (CH), 133.8 (CH), 137.8 (C), 168.0 (CO). HR-ESI-MS: 
m/z calcd for C19H18NO3 [M+H]+ 308.1276, found  308.1281. 
 
2-(1-Phenyl-allyl)-isoindole-1,3-dione 4.58. Column chromatography (n-
pentane/EtOAc 4:1) yielded the phthalimide as white solid (16%). m.p. 59-
61ºC; 1H NMR (300 MHz, CDCl3): =5.36 (d, 3J=17.7 Hz, 1H; CH), 5.38 
(d, 3J=10.2 Hz, 1H; CH), 5.97 (d, 3J=7.5 Hz, 1H; CH), 6.66 (ddd, 3J=17.4 
Hz, 3J=10.1 Hz, 3J=7.4 Hz, 1H; CH), 7.24-7.37 (m, 3H; CHAr), 7.43-7.48 
(m, 2H; CHAr), 7.70 (dd, 3J=5.2 Hz, 4J=3.2 Hz,  2H; CHAr),  7.83 (dd, 
3J=6.4 Hz, 4J=3.2 Hz,  2H; CHAr). 13C NMR (75 MHz, CDCl3): =56.8 
(CH), 119.0 (CH2), 123.3 (CH), 127.6 (CH), 127.7 (CH), 128.5 (CH), 131.8 (C), 133.9 
(CH), 134.1 (CH), 138.4 (C), 167.6 (CO). HR-ESI-MS: m/z calcd for C17H14NO2 
[M+H]+ 264.1019, found  264.1019. 
 
2-(1-(Thiophen-2-yl)allyl)isoindoline-1,3-dione 4.59. Column chromatography (n-
pentane/EtOAc 10:1) yielded the phthalimide as yellow oil (45%). 1H 
NMR (400 MHz, CDCl3): =5.35 (d, 3J=10.8 Hz, 1H; CH), 5.38 (d, 
3J=18.4 Hz, 1H; CH), 6.17 (d, 3J=7.6 Hz, 1H; CH), 6.64 (ddd, 3J=17.4 Hz, 
3J=9.8 Hz, 3J=7.6 Hz, 1H; CH), 6.94 (dd, 3J=4.8 Hz, 3J=3.6 Hz; 1H; CH), 
7.10 (d, 3J=2.8 Hz, 1H; CH), 7.23 (d, 3J=5.2 Hz, 1H; CH), 7.66-7.72 (m, 
2H; CH), 7.79-7.85 (m, 2H; CH). 13C NMR (100 MHz, CDCl3): =52.2 
(CH), 119.0 (CH2), 123.3 (CH), 125.4 (CH), 126.3 (CH), 126.7 (CH), 131.7 (C), 134.0 
(CH), 141.3 (C), 167.1 (CO). HR-ESI-MS: m/z calcd for C15H12NO2S [M+H]+ 270.0583, 
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2-(E)-1-Methyl-but-2-enyl)-isoindole-1,3-dione 4.60. Column chromatography (n-
pentane/EtOAc 3:1) yielded the phthalimide as colourless oil (49%). 1H 
NMR (300 MHz, CDCl3): =1.50 (d, 3J=7.2 Hz, 3H; CH3), 1.63 (d, 
3J=6.6 Hz, 3H; CH3), 4.84 (quin, 3J=7.2 Hz, 1H; CH), 5.65 (dq, 3J=15.3 
Hz, 3J=6.5 Hz, 1H; CH), 5.85 (ddq, 3J=15.3 Hz, 3J=7.5 Hz, 4J=1.5 Hz, 
1H; CH), 7.63-7.67 (m, 2H; CHAr),  7.73-7.78 (m, 2H; CHAr). 13C NMR 
(75 MHz, CDCl3): =17.5 (CH3), 18.8 (CH3), 48.7 (CH), 122.9 (CH), 
127.8 (CH), 129.8 (C), 132.0 (CH), 133.6 (CH), 167.9 (CO). ESI-MS: m/z calcd for 
C13H14NO2 [M+H]+ 216.1019, found  216.1019.  
 
2-(1,2-Dimethyl-allyl)-isoindole-1,3-dione 4.61. Column chromatography (n-
pentane/EtOAc 4:1) yielded the phthalimide as colourless oil (64%). 1H 
NMR (400 MHz, CDCl3): =1.64 (d, 3J=7.2 Hz, 3H; CH3), 1.74 (s, 3H; 
CH3) 4.85 (q, 3J=7.1 Hz, 1H; CH), 4.99 (s, 1H; CH), 5.01 (s, 1H; CH), 7.71 
(dd, 3J= 5.4 Hz, 4J=3.0 Hz,  2H; CHAr),  7.83 (dd, 3J=5.4 Hz, 4J=3.0 Hz,  
2H; CHAr). 13C NMR (75 MHz, CDCl3): =16.0 (CH3), 20.3 (CH3), 50.3 
(CH), 112.0 (CH2), 122.9 (CH), 131.7 (C), 133.7 (CH), 142.7 (CH), 167.9 
(CO). HR-ESI-MS: m/z calcd for C13H14NO2 [M+H]+ 216.1019, found  
216.1019.  
 
3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-butyraldehyde 4.68. Column chromatography 
(n-pentane/EtOAc 1:1) gave the aldehyde as white solid (94%). m.p. 
106-107ºC; 1H NMR (300 MHz, CDCl3): =1.47 (dd, 3J=7.2 Hz, 4J=1.2 
Hz, 3H; CH3), 2.99 (dd, 2J=18.0 Hz, 3J=6.0 Hz, 1H; CH2), 3.28 (dd, 
2J=18.0 Hz, 3J=8.1 Hz, 1H; CH2), 4.89 (sextet, 3J=6.9 Hz, 1H; CH), 
7.65-7.72 (m, 2H; CHAr),  7.76-7.81 (m, 2H; CHAr), 9.73 (s, 1H; CHO). 
13C NMR (75 MHz, CDCl3): =18.8 (CH3), 42.3 (CH2), 47.3 (CH), 123.2 
(CHAr), 131.8 (C), 134.0 (C), 168.0 (CO), 199.2 (CHO). ESI-MS: m/z calcd for 
C12H12NO3 [M+H]+ 218.0809, found  218.0812. 
 
3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-octanal 4.69. Column chromatography (n-
pentane/EtOAc 2:1) gave the aldehyde as colourless oil (91%). 1H 
NMR (400 MHz, CDCl3): =0.83 (t, 3J=6.8 Hz, 3H; CH3), 1.20-
1.31 (m, 6H; CH2), 1.66-1.75 (m, 1H; CH2), 2.00-2.11 (m, 1H; 
CH3), 2.95 (2J=18.0 Hz, 3J=5.6 Hz, 2J=1.1 Hz, 1H; CH2), 3.30 
(ddd, 2J=17.6 Hz, 3J=8.8 Hz, 2J=1.5 Hz, 1H; CH2), 4.76 (mc, 1H; 
CH), 7.70 (dd, 3J=5.6 Hz, 4J=3.2 Hz, 2H; CHAr),  7.82 (dd, 3J=5.4 Hz, 4J=3.0 Hz, 2H; 
CHAr), 9.74 (s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =13.8 (CH3), 22.3 (CH2), 25.8 
(CH2), 31.1 (CH2), 32.3 (CH2), 45.7 (CH2), 46.3 (CH), 123.2 (CHAr), 131.6 (C), 133.9 
(C), 168.2 (CO), 199.4 (CHO). HR-ESI-MS: m/z calcd for C16H20NO3 [M+H]+ 













3-(1,3-Dioxoisoindolin-2-yl)-4-methylhexanal 4.70. Column chromatography (n-
pentane/EtOAc 9:1) gave the aldehyde as a 60:40 mixture of 
diastereomers (88%). 1H NMR (300 MHz, CDCl3): = 0.79-0.86 (m, 
6H; 2 x CH3), 0.89-1.00 (m, 6H; 2 x CH3), 1.01-1.24 (m, 2H; 2 x CH2), 
1.29-1.44 (m, 1H; 2 x CH), 1.48-1.64 (m, 1H; 2 x CH), 2.01-2.21 (m, 
2H; 2 x CH), 2.84-2.96  (m, 2H; 2 x CH2), 3.35-3.49  (m, 2H; 2 x CH2), 
4.43-4.50 (m, 2H; 2 x CH), 7.65-7.72 (m, 4H; 2 x CH), 7.75-7.82 (m, 
4H; 2 x CH), 9.71 (s, 2H; 2 x CHO). 13C NMR (75 MHz, CDCl3): = 
10.7 (CH3), 10.9 (CH3), 15.4 (CH3), 16.0 (CH3), 25.6 (CH2), 26.1 (CH2), 36.4 (CH), 36.8 
(CH), 43.7 (CH2), 43.8 (CH2), 50.3 (CH), 50.5 (CH), 123.2 (CH), 131.5 (C), 134.0 (CH), 
168.4 (CO), 168.5 (CO), 199.7 (CHO), 199.8 (CHO). HR-ESI-MS: m/z calcd for 
C15H18NO3 [M+H]+ 260.1282, found  260.1281.  
 
3-(1,3-Dioxoisoindolin-2-yl)-3-methylbutanal 4.71. The reaction was completed after 2 
days. Column chromatography (n-pentane/EtOAc 2:1) gave the aldehyde 
as colourless oil (74%). 1H NMR (300 MHz, CDCl3): =1.77 (s, 6H; 
CH3), 3.18 (s, 2H; CH2), 7.66 (dd, 3J=5.4 Hz, 4J=3.0 Hz, 2H; CHAr),  
7.76 (dd, 3J=5.3 Hz, 4J=3.2 Hz, 2H; CHAr), 9.78 (s, 1H; CHO). 13C NMR 
(75 MHz, CDCl3): =27.7 (CH3), 53.0 (CH2), 57.1 (CH), 122.8 (CH), 
131.8 (C), 133.9 (C), 169.4 (CO), 199.5 (CHO). HR-ESI-MS: m/z calcd 
for C12H14NO3 [M+H]+ 232.0967, found  232.0968. 
 
3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-4-phenyl-butyraldehyde 4.72. Column 
chromatography (n-pentane/EtOAc 95:5) gave the aldehyde as 
coulourless oil (94%). 1H NMR (400 MHz, CDCl3): =3.00 (dd, 
2J=18.0 Hz, 3J=5.2 Hz, 1H; CH2), 3.13 (dd, 2J=13.6 Hz, 3J=6.8 Hz, 1H; 
CH2),  3.25 (dd, 2J=13.4 Hz, 3J=9.0 Hz, 1H; CH2),  3.39 (ddd, 2J=18.1 
Hz, 3J=9.0 Hz, 4J=1.5 Hz 1H; CH2), 4.99-5.08 (m, 1H; CH), 7.11-7.25 
(m, 5H; CHAr), 7.63-7.71 (m, 2H; CHAr),  7.72-7.78 (m, 2H; CHAr), 9.71 
(s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =38.5 (CH2), 45.5 (CH2), 47.0 (CH), 
123.2 (CH), 126.9 (CH), 128.6 (CH), 129.0 (CH), 131.5 (C), 134.0 (CH), 138.4 (C), 
170.0 (CO), 199.0 (CHO). HR-ESI-MS: m/z calcd for C18H16NO3 [M+H]+ 294.1130, 
found  294.1125. 
 
4-Benzyloxy-3-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyraldehyde 4.73. Column 
chromatography (n-pentane/EtOAc 9:1) gave the aldehyde as 
colourless oil (93%). 1H NMR (400 MHz, CDCl3): =3.04 (ddd, 
2J=18.0 Hz, 3J=5.8 Hz, 3J=1.0 Hz, 1H; CH2), 3.27 (ddd, 2J=18.0 
Hz, 3J=8.6 Hz, 3J=1.4 Hz, 1H; CH2), 3.74 (dd, 2J=9.6 Hz, 3J=6.6 
Hz, 1H; CH2),  3.86 (dd, 2J=9.6 Hz, 3J=8.0 Hz, 1H; CH2),  4.48 (d, 
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CHAr), 7.70 (dd, 3J=5.4 Hz, 4J=3.0 Hz, 2H; CHAr), 7.81 (dd, 3J=5.4 Hz, 4J=3.0 Hz, 2H; 
CHAr) , 9.71 (dd, 3J=1.4, 3J=1.4, 1H; CHO). 13C NMR (100 MHz, CDCl3): = 43.0 
(CH2), 44.9 (CH), 68.9 (CH2), 72.9 (CH2), 123.3 (CH), 127.6 (CH), 127.7 (CH), 128.3 
(CH), 131.7 (C), 134.0 (CH), 137.6 (C), 168.1 (CO), 198.8 (CHO). HR-ESI-MS: m/z 
calcd for C19H17NO4Na [M+Na]+ 346.1045, found  346.1050. 
 
3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-3-phenyl-propionaldehyde 4.66. Column 
chromatography (n-pentane/EtOAc 1:1) gave the aldehyde as colourless 
oil (95 %). 1H NMR (400 MHz, CDCl3): =3.39 (dd, 2J=18.4 Hz, 3J=5.6 
Hz, 1H; CH2), 3.96 (dd, 2J=18.4 Hz, 3J=9.6 Hz, 1H; CH2), 4.89 (dd, 
3J=9.6 Hz, 3J=5.6 Hz, 1H; CH), 7.24-7.35 (m, 2H; CHAr), 7.51 (d, 3J=7.6 
Hz, 2H; CHAr), 7.6-7.68 (m, 2H; CHAr),  7.71-7.80 (m, 2H; CHAr), 9.78 
(s, 1H; CHO). 13C NMR (100 MHz, CDCl3): =45.0 (CH2), 48.7 (CH), 
123.2 (CH), 127.6 (CH), 128.1 (CH), 128.7 (CH), 131.5 (C), 134.0 (CH), 138.4 (C), 
167.9 (CO), 198.7 (CHO). HR-ESI-MS: m/z calcd for C17H14NO3 [M+H]+ 280.0968, 
found  280.0968. 
 
3(1,3-Dioxoisoindolin-2-yl)-3-(thiophen-2-yl)propanal 4.74. Column chromatography 
(n-pentane/EtOAc 3:1) gave the aldehyde as a yellow oil (77%). 1H 
NMR (400 MHz, CDCl3): =3.48 (dd, 2J=18.4 Hz, 3J=6.0 Hz, 1H; 
CH2), 3.92 (dd, 2J=18.4 Hz, 3J=9.2 Hz, 1H; CH2), 6.17 (dd, 3J=9.2 Hz, 
3J=6.0 Hz, 1H; CH), 6.93 (dd, 3J=4.8 Hz, 3J=4.0 Hz, 1H; CH), 7.16 (d, 
3J=2.8 Hz, 1H; CH), 7.22 (d, 3J=5.2 Hz, 1H; CH), 7.66-7.72 (m, 2H; 
CH), 7.78-7.84 (m, 2H; CH), 9.76 (s, 1H; CHO). 13C NMR (75 MHz, 
CDCl3): =43.8 (CH2), 46.3 (CH), 123.4 (CH), 125.6 (CH), 126.6 (CH), 126.7 (CH), 
131.6 (C), 134.1 (CH), 141.0 (C), 198.0 (CHO). m/z calcd for C15H12NO3S [M+H]+ 
286.0534, found  286.0532. 
 
2-(1-Methyl-3-oxo-butyl)-isoindole-1,3-dione 4.75. The reaction was completed after 2 
days. Column chromatography (n-pentane/EtOAc 1:1) gave the 
product as white solid (89%). m.p. 74-76 ºC; 1H NMR (400 MHz, 
CDCl3): =1.41 (d, 3J=6.8 Hz, 3H;CH3), 2.11 (s, 3H; CH3), 2.98 (dd, 
2J=17.6 Hz, 3J=6.4 Hz, 1H; CH2), 3.27 (dd, 2J=17.6 Hz, 3J=8.0 Hz, 
1H; CH2), 4.81 (sextett, 3J=7.0 Hz, 1H; CH2), 7.64-7.69 (m, 2H; 
CHAr),  7.75-7.80 (m, 2H; CHAr). 13C NMR (100 MHz, CDCl3): =18.8 (CH3), 
30.1(CH3), 42.5 (CH2), 46.7 (CH), 123.1 (CH), 131.9 (C), 133.8 (CH), 168.1 (CO), 
















2-(1-Phenyl-allyl)-isoindole-1,3-dione 4.66. Under Argon, TBD (0.011 g, 0.08 mmol) 
was added to a solution of ([Ir(COD)Cl]2) (0.013, 0.02 mmol) and (R,R,R)-
4.65 (0.022, 0.04 mmol) in dry and degassed THF (0.5 mL). After stirring 
for 2 h at room temperature cinnamyl carbonate 4.6436 (0.140 g, 1.0 mmol) 
was added, and the mixture was stirred for 5 min at room temperature. 
Then the phthalimide was added (0.177 g, 1.2 mmol) and the mixture was 
stirred for 24 h at room temperature. The reaction mixture was concentrated 
in vacuum and the residue was purified by flash column chromatography (n-
pentane/EtOAc 95:5), yielding the product as a colorless oil (0.108 g, 4.10 mmol, 
41%).26 HPLC Chiralcel OD-H, n-hexane/i-PrOH 95:5, Tr = 18.5 min (major), 22.5 min 
(minor). 96% ee.  
 
3-(1,3-Dioxoisoindolin-2-yl)-3-phenylpropane-1,1-diyl diacetate 4.67. Aldehyde 4.66 
(0.08 g, 0.30 mmol) was dissolved in acetic anhydride (1.0 mL, 13.6 
mmol) at 0oC. Then anhydrous FeCl3 (2.43 g, 0.015 mmol) was added 
and the reaction mixture was stirred for 15 min at 0oC and subsequently 
12 h at room temperature. The solvent was removed in vacuum and the 
residue was purified by flash column chromatography (n-pentane/EtOAc 
9:1) yielding the product as colorless oil (0.09 g, 0.24 mmol, 83%).29 1H 
NMR (400 MHz, CDCl3): =1.94 (s, 3H; CH3), 1.99 (s, 3H; CH3), 2.68 
(ddd, 2J=14.3 Hz, 3J=6.0 Hz, 3J=6.0 Hz, 1H; CH2), 3.29 (ddd, 2J=14.5 Hz, 3J=10.5 Hz, 
3J=3.9 Hz, 1H; CH2), 5.55 (dd, 3J=10.4 Hz, 3J=5.2 Hz, 1H; CH), 6.95 (dd, 3J=6.0 Hz, 
3J=4.4 Hz, 1H; CH), 7.24-7.36 (m, 3H; CHAr), 7.53 (d, 3J=7.2 Hz, 2H; CHAr), 7.69 (dd, 
3J=5.0 Hz, 4J=3.0 Hz, 2H; CHAr), 7.81 (dd, 3J=5.2 Hz, 4J=3.2 Hz, 2H; CHAr). 13C NMR 
(50 MHz, CDCl3): =20.5 (CH3), 20.6 (CH3),  34.0 (CH2), 49.7 (CH), 88.2 (CH), 123.3 
(CH), 127.9 (CH), 128.1 (CH), 128.7 (CH), 131.8 (C),134.0 (CH), 138.5 (C), 168.0 
(CO), 168.5 (CO), 168.6 (CO). HR-ESI-MS: m/z calcd for C21H19NO6 [M+H]+ 
404.1105, found  404.1102. HPLC Chiralcel AS-H, n-heptane/i-PrOH 98:2, Tr = 30.0 
min (minor), 31.8 min (major). 
 
3-(1,3-Dioxoisoindolin-2-yl)butanoic acid 4.76. Mn-tmtacn (1.92 mg, 0.0026 mmol, 
0.5 mol%), trichloroacetic acid (6 mg, 0.031 mmol, 6.23 mol%), H2O 
(0.046 mL) and H2O2 (50% in H2O, 0.020 mL) in MeCN (6.40 mL) 
were stirred at 0°C for 20 min. The aldehyde 4.68 (0.108 g, 0.497 
mmol) and additional H2O2 (50% in H2O, 0.020 mL) were added. The 
reaction mixture was stirred at 0°C, and four portions of H2O2 (50% in 
H2O, 4 x 0.020 mL) were added every 30 min. After warming to room 
temperature, EtOAc (20 mL) and H2O (10 mL) were added. The aqueous layer was 
extracted with EtOAc (3 x 10 mL), the combined organic layers were dried over MgSO4, 
and concentrated in vacuum. The crude acid was purified by flash column 
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NMR (300 MHz, CDCl3): =1.49 (d, 3J=6.9 Hz, 3H; CH3), 2.85 (dd, 2J=16.7 Hz, 3J=6.2 
Hz, 1H; CH2), 3.21 (dd, 2J=16.7 Hz, 3J=8.6 Hz, 1H; CH2), 4.78 (dqd, 3J=8.4 Hz, 3J=6.8 
Hz, 3J=6.8 Hz, 1H; CH), 7.71 (dd, 3J=5.4 Hz, 4J=3.0 Hz, 2H; CHAr), 7.81 (dd, 3J=5.6 Hz, 
4J=3.2 Hz, 2H; CHAr). 13C NMR (75 MHz, CDCl3): =19.0 (CH3), 37.8 (CH2), 43.4 
(CH), 123.5 (CH), 132.0 (C), 134.2 (C), 168.3 (CO), 167.3 (CO2H). HR-ESI-MS: m/z 
calcd for C12H12NO4 [M+H]+ 234.0761, found  234.0761. 
 
3-Aminobutanoic acid 4.69. Hydrazine monohydrate was added to the phthalimide 
protected acid 4.76 (20 mg, 0.09 mmol) in EtOH (1.5 mL). After heating to 
110°C for 2.5 h, the solvent was evaporated in vacuum. Aqueous 4M HCl 
(1 mL) was added, the resulting precipitate was filtered, and the filtrate 
concentrated in vacuum. The solid was dissolved in EtOH and Et2O added 
to precipitate the amino acid. After standing overnight at 4°C the precipitate was filtered 
and dried in vacuum (12 mg, 0.09 mmol, 100%).31 Spectral data were according to the 
literature37: 1H NMR (400 MHz, CDCl3): =1.06 (d, 3J=6.4 Hz, 3H, CH3), 2.42-2.51 (m, 
2H; CH2), 3.40-3.50 (m, 1H; CH). 13C NMR (75 MHz, CDCl3): =17.7 (CH3), 37.7 
(CH2), 44.4 (CH), 164.1 (CO).  
 
2-(4-Hydroxybutan-2-yl)isoindoline-1,3-dione 4.77. To a solution of the corresponding 
aldehyde 4.68 (0.065 g, 0.300 mmol) in MeOH (1.5 mL) at 0oC sodium 
borohydride (0.011 g, 0.3 mmol) was added. After stirring for 1 h at 0oC 
the reaction was quenched with a saturated solution of ammonium 
chloride (10 mL) and extracted with CH2Cl2 (3 x 5 mL). The organic 
layers were dried over Mg2SO4, the solvent was removed in vacuum 
and the residue was purified by flash column chromatography 
(CH2Cl2/acetone 95:5), yielding the product as white solid (0.062 g, 0.285 mmol, 
95%).32 Spectral data were according to the literature38: m.p. 72-74°C; 1H NMR (300 
MHz, CDCl3): =1.51 (d, 3J=6.9 Hz, 3H; CH3), 1.82-2.00 (m, 2H; CH2), 2.12-2.29 (m, 
2H; CH2), 3.46-3.66 (m, 2H; CH2),  4.48-4.61 (m, 1H; CH), 7.68 (dd, 3J=5.4 Hz, 4J=3.0 
Hz, 2H; CHAr),  7.78 (dd, 3J=5.5 Hz, 4J=3.2 Hz, 2H; CHAr). 13C NMR (75 MHz, CDCl3): 
=18.8 (CH3), 36.6 (CH2), 44.4 (CH2), 59.9 (CH), 123.4 (CH), 132.1 (C), 134.2 (CH), 
169.0 (CO). HR-ESI-MS: m/z calcd for C12H14NO3 [M+H]+ 220.0968, found  220.0968. 
 
3-Aminobutan-1-ol 4.70. Hydrazine monohydrate (56 L, 1.3 mmol) was added to the 
corresponding protected alcohol 4.77 (30 mg g, 0.13 mmol) in EtOH (2.0 
mL). After heating to reflux for 3 h, the solvent was evaporated in vacuum. 
1M aq. HCl (5 mL) was added, and the suspension stirred for 1h. The 
resulting precipitate was filtered, and aq. NaOH (40%) added until the solution was 
basic. The solution was extracted with hot CHCl3 (4 x 5 mL), dried over MgSO4, and 
concentrated in vacuum to a colourless oil (11 mg, 0.12 mmol, 90%).31 Spectral data 












3H; CH3), 1.58-1.69 (m, 1H; CH2), 1.70-1.81 (m, 1H; CH2), 3.19 (bs, 1H; OH), 3.29-
3.40 (s, 1H; CH), 3.53-3.69 (m, 2H; CH2). 13C NMR (75 MHz, CDCl3): =25.0 (CH3), 
39.2 (CH2), 46.9 (CH), 61.3 (CH2). 
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Studies towards the Curtius 
rearrangement of thioesters for the 
synthesis of -amino acids 
 
The goal of this project was to perform a Curtius rearrangement of thioesters to 
synthesize the corresponding amines without prior hydrolysis. In combination with the 
catalytic asymmetric conjugate addition of Grignard reagents to fumarate derivatives 
(see chapter 6), this approach would represent a two-step procedure towards 
enantiomerically enriched 2- and 3-amino acids. Unfortunately, we failed so far to 

















5.1.1 Curtius rearrangement 
The Curtius rearrangement is an important synthetic method for the preparation of 
amines from carboxylic acids.1 It has been included in the preparation of many natural 
products and has also been used to synthesize -amino acids (see chapter 1). In the 
general process, an acyl azide is converted by heating into the corresponding isocyanate. 
During the thermolysis, N2 is eliminated and at the same time a [1,2]-shift of the 
substituent next to the carbonyl group takes place with retention of configuration 
(scheme 5.01).2 The isocyanates 5.02 can be transformed into (protected) amines by 
hydrolysis and alcoholysis after workup or in situ by performing the rearrangement in 




























Scheme 5.01. General mechanism for the Curtius rearrangement. 
In general, acyl azides are prepared from activated carboxylic acid derivatives such as 
acyl chlorides3 or anhydrides4.5 Direct conversion of carboxylic acids has been reported 
using diphenylphosphoryl azide (dppa) in a one pot procedure.6 This method has the 
advantage that the generally explosive acyl azides do not have to be isolated. First, a 
mixed anhydride of carboxylic acid/phosphoric acid 5.07 is formed and azide is 
eliminated. Anhydride 5.07 acylates the azide anion to form acyl azide 5.01 which then 
rearranges to the corresponding isocyanate 5.02 (scheme 5.02). With tert-butanol as 
solvent, the isocyanate 5.02 was solvolized to the N-Boc-protected amine 5.08. 



































Scheme 5.02. General mechanism for the Curtius rearrangement with dppa. 
Aldehydes can also be converted directly to acyl azides using oxidative conditions7 or 
radical azidation (scheme 5.03).8 Using Dess-Martin periodinane 5.10 or tert-butyl 
hypochlorite, aromatic and aliphatic aldehydes 5.09 were transformed to the 
corresponding acyl azides 5.01 in high yield (scheme 5.03a). The radical azidation of 
aromatic and aliphatic aldehydes with iodine azide IN3 gave upon heating the 
corresponding isocyanates. With more than one equivalent of IN3 (formed from two 
equivalents of ICl and three equivalents of NaN3) the carbamoyl azide 5.11 was formed 


































Scheme 5.03. Acyl azide formation and Curtius rearrangement of aldehydes. 
Up to date, there has been no procedure reported for the direct conversion of thioesters 
or oxoesters to acyl azides and subsequent Curtius rearrangement.  
5.1.2 Conversion of thioesters to carboxylic acids and esters 
The activation of thioesters using thiophilic metal ions such as Cu(II), Ag(I), Hg(II), and 
Zn(II) has been described for transesterification reactions. Furthermore, hydrolysis rates 
for thioesters are increased upon oxidation of the thioester residue with 
peroxymonosulfate.9 The final products are the corresponding carboxylic acid and 
sulfonic acid (scheme 5.04). The authors propose that initially the thiol is oxidized to the 
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acyl sulfoxide which then breaks down to give the carboxylic acid and a sulfenic acid 














Scheme 5.04. Accelerated hydrolysis of thioesters by oxidation. 
Ti(Oi-Pr)4 was used to activate ethylthio ester 5.15 for the transesterification with 
ethanol (scheme 5.05).10 The equilibrium was shifted to the oxoester due to the volatility 
of the released ethanethiol. 
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Scheme 5.05. Transesterification mediated by TiIV. 
Several examples have been reported in which CuI- and CuII-salts were employed to 
activate thioesters (scheme 5.06).11 The transesterification of 2-pyridyl thioates 5.17 to 
the corresponding esters 5.18 was mediated by CuBr2 (scheme 5.06a).11a Several 
aliphatic and aromatic esters were synthesized with this method. For the intramolecular 
synthesis of -lactams, the amino-thioester 5.19 was treated with CuOTf and CaCO3 to 
give the amides in good yield (scheme 5.06b).11b The alcohol group of compound 5.21, 
obtained from a hetero Diels-Alder reaction followed by a subsequent conjugate addition 
and reduction of the carbonyl group, was cyclized in the presence of Cu(OTf)2 (scheme 
5.06c).11c The product 5.22 was further converted into (+)-9-deoxygoniopyrone, which 
shows cytotoxic activity against tumor cells. 
 



































95%5.21 5.22  
Scheme 5.06. Cu-mediated transesterification and -lactam formation. 
Mercury(II)-salts have been used to facilitate the transesterification of thioesters 
(Scheme 5.07).12 For the synthesis of galbonolide B, the macrocycle 5.24 was formed 
through bond formation between the alcohol and the thioester moiety assisted by 
Hg(OAc)2 (scheme 5.07a).12a Compound 5.25 was formed by 1,4-addition to 4-OTBS-2-
cyclohexenone followed by quenching with NH4Cl at room temperature. The thioacetal 
was cleaved mediated by HgO in methanol to give 5.26 (scheme 5.07b).12b The 
4[(bismethylthio)ethylidene] functionality present in 5.27 was transformed to the 









































Scheme 5.07. Hg-mediated transesterification. 
Silver triflate was also used to facilitate macrolactonizations or transesterification of 
thioesters and alcohols (Scheme 5.08).13 Sodeoka and coworkers used AgOTf to mediate 
macrolactonization of 5.29 to form 5.30 (scheme 5.08a).13a Transesterification of 5.31 
was facilitated with AgOTf to give ester 5.32 in good yield (scheme 5.08b). The 
products are intermediates in the synthesis of a tetronic acid library as inhibitors for 
protein phosphatases.13b During the synthesis of RK-682, Sodeoka and coworkers 
transesterified thioester 5.33 with alcohol 5.34 to give ester 5.35 (scheme 5.08c).13c 
 



























1) AgCO2CF3, ROH, THF
2) Bu4NF, THF




































Scheme 5.08. Ag-mediated transesterifications. 
The objective of the project described here was to find conditions for the Curtius 
rearrangement of thioesters and to integrate it in a synthetic route to -amino acids 
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Scheme 5.09. Amine synthesis from thioesters. 
5.2 Curtius rearrangement starting from thioesters 
Thioester 5.41 was synthesized from ethanethiol and octanoic acid 5.40 by activation 
with dicylohexylcarbodiimide (DCC) and catalytic amounts of (dimethylamino)pyridine 
(DMAP) in good yield (scheme 5.09). This thioester with a long alkyl chain was chosen 
for screening purposes. Azides are generally accepted to be safe for isolation on 
multigram scale if the sum of the oxygen and carbon atoms is greater than three times 














Scheme 5.09. Synthesis of the thioester for screening. 
First, only NaN3 was used as a nucleophile in various solvents but no reaction was 
observed (table 5.1, entry 1-6). Phase transfer reagent tetra-n-butylammonium bromide 
was used to improve the solubility of the nucleophile, but no acyl azide was formed 
either (table 5.1, entry 7, 9, 11). DMAP was used to activate and transform the thioester, 
and different solvents were screened, as well as the combination of DMAP and the phase 
transfer reagent (table 5.1, entry 8-11). However, no conversion was observed. 
Activating the thioester with the Lewis acid BF3·OEt2 did not yield the acyl azide either 
(table 5.1, entry 12). Using Meerwein salt (trimethyloxonium tetrafluoroborate) to 
methylate the thioester or to methylate the released ethanethiol was also not successful to 
synthesize the acyl azide (table 5.1, entry 13). A procedure based on the addition of 18-
crown-6 to encapsulate the sodium ion, and therefore produce a ‘naked’ azide ion, did 
not show any conversion of the thioester (table 5.1, entry 14). With DBU as basic 
additive in acetonitrile or toluene, no reaction of the thioester was observed (table 5.1, 
entry 15-16).  
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entry additive [eq.] NaN3 
[eq.] 




1 -  2.0 H2O/acetone 70 - 
2 -  1.0 H2O/CH2Cl2 40 - 
3 -  1.0 H2O/1,2-
dichloroethane 
40 - 
4 -  10 H2O/THF 40 - 
5 -  3.5 H2O/MeCN 40 - 
6 -  3.5 H2O/DMF 40 - 
7 Bu4NBr  0.05 1.2 H2O/CH2Cl2 40 - 





3.4 THF 80 - 
10 DMAP  0.15 3.1 MeCN 80 - 




3.1 MeCN 80 - 
12 BF3 OEt2 2.00 4.0 toluene 95 - 
13 Me3O+BF4  2.40 1.2 toluene 100 - 
14 10-Crown-6 7.56 7.6 CH2Cl2 25 - 
15 DBU  1.20 1.5 MeCN 50 - 
16 DBU  1.20 1.5 toluene 50 - 
a Monitored by GC-MS. 
Next, various metal salts were screened, some of them thiophilic and some strong Lewis 
acids, sometimes in combination with the Lewis acid BF3·OEt2 to activate the carbonyl 
oxygen. Thiophilic metals, Hg2+, Cd2+, Pb2+, Ni2+, Ag+, As3+, Sb3+, Co2+, Bi3+, Cu2+, 
Zn2+, Fe3+, Mn2+, Pd2+, form strong complexes with thiols or sulfides. The precipitation 
of metal sulfides is used in analytical chemistry for the qualitative separation of 
cations.15 However, some of these metal salts are highly toxic, such as those based on 














entry additives [eq.] NaN3 
[eq.] 

























4.0 toluene 90 - - 
5 HgCl2 6.0 3.6 CH2Cl2 25 100 mixture of 
productse 
6 HgCl2 2.1 1.5 toluene 120 100 mixture 
productse 
7 AgOTf 3.0 4.0 benzene 80b 100 mixture 
productse 
8 AgOAc 6.0 3.6 CH2Cl2/ 
H2O 
25b - - 





4.6 toluene 95 - - 
11 CuTC 1.8 1.8 THF 40 - - 




































3.6 Et2O 90 - 
 
- 
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entry additives [eq.] NaN3 
[eq.] 






























3.6 toluene 90 100 
 
octanoic acid 



















1.8 THFc 50 -  - 
27 Cs2CO3 1.2 1.5 toluene 25 - - 
28 Cs2CO3 1.2 1.5 MeCN 25 - - 
29 Ti(Oi-Pr)4 1.5 1.8 MeCN 50 - - 
30 Ti(Oi-Pr)4 1.5 1.8 1,2-
dichloro- 
ethane 
50 90 octanoic acid 
31 FeCl3  
6 H2O 
1.5 1.5 toluene 100 100 octanoic 
acid; mixture 
of products 
32 FeCl3 1.2 1.5 toluene 110 100 octanoic 
acid; mixture 
of products 
33 FeCl3 2.0 1.5 toluene 110 100 mixture of 
products 
34 FeCl3 1.3 1.8 MeCN 90 100 mixture of 
products 
35 FeCl3 1.3 1.8 1,2-
dichloro- 
ethane 
90 100 mixture of 
products 
36 FeCl3 1.3 1.8 DMF 90 100 mixture of 
products 
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entry additives [eq.] NaN3 
[eq.] 





37 FeCl3 1.8 4.2 1,2-
dichloro- 
ethane 
90 100d mixture of 
products 
38 FeCl3 3.0 7.7 1,2-
dichloro- 
ethane 






1.5 toluene 110 100 mixture of 
products 
40 FeCl2  
4 H2O 
1.2 1.5 toluene 110 100 mixture of 
products 
a Monitored by GC-MS. b Reaction performed in the dark. c Degassed, sealed tube. d Stirred after 
evaporation of the solvent in 2M aq. NAOH. e A mixture of unidentified products was formed. 
Catalytic amounts of Zn(II)-triflate in combination with phase transfer reagent tetra-n-
butylammonium bromide did not yield a reaction of thioester 5.41 (table 5.2, entry 1).4d 
A large excess of HgCl2 (10 eq.) and NaN3 (22 eq.) in benzene as solvent gave the 
desired isocyanate in ~20% yield (table 5.2, entry 2). Attempts to reduce the amount of 
mercury salt and sodium azide to 2 and 4 equivalents, respectively, or replacing the 
solvent benzene with toluene, did not lead to conversion (table 5.2, entry 3-4). HgCl2 
alone (2-6 eq.) showed conversion of the thioester but many products were formed 
according to GC-MS and 1H NMR of whom none was the desired acyl azide or 
isocyanate (table 5.2, entry 5-6). Addition of AgOTf resulted in full conversion of the 
thioester but after treatment with tert-butanol, no Boc-protected amine was formed, nor 
could the free amine or the isocyanate be seen (table 5.2, entry 7).16 With AgOAc, no 
conversion was observed (table 5.2, entry 8). Copper(II)-triflate as additive showed only 
very low conversion of the thioester (<5%) after a reaction time of 3 days (table 5.2, 
entry 9). Copper(I)-bromide did not lead to the formation of products neither did Cu(I)-
thienylcarboxylate (table 5.2, entry 10-11) Neither Raney-Nickel nor nickel(II)-chloride 
showed conversion of the thioester (table 5.2, entry 12-13). Cadmium(II)-chloride and 
tin(II)-chloride as additives showed mainly starting material after three days (table 5.2, 
entry 14-15). Adding the strong Lewis acid SbCl5 to the reaction mixture lead to an 
immediate reaction that was indicated by a change of colour and increase of the 
temperature of the mixture. Performing the reaction in toluene, the crude 1H NMR and 
GC-MS showed that the solvent had reacted and that the thioester was hydrolyzed (table 
5.2, entry 16). In CH2Cl2 and Et2O, only the thioester was isolated after column 
chromatography, although GC-MS showed the formation of several unidentified 
products (table 5.2, entry 17-18). InCl3 as additive gave no conversion of thioester 5.41 
as identified by 1H NMR (table 5.2, entry 19). Studying SbCl3 as additive, almost no 
conversion of the thioester was observed within a reaction time of 3 days (table 5.2, 
entry 20). BiBr3 and Yb(OTf)3 gave only conversion to octanoic acid (table 5.2, entry 
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21-22). PalladiumII-chloride added to the reaction mixture did not lead to conversion of 
the thioester neither did palladium0-species17, in combination with PPh3 and/or CuTC 
(table 5.2, entry 23-26). By adding Cs2CO3 as additive, the thioester did not show 
conversion (table 5.2, entry 27-28). Ti(Oi-Pr)4 as Lewis acid in acetonitrile as solvent did 
not yield the isocyanate or the acyl azide, but in 1,2-dichloroethane the thioester showed 
conversion. The results were irrespoducible, however, and only octanoic acid could be 
isolated (table 5.2, entry 29-30). Iron(III)-salts showed conversion of the thioester, but 
no conclusion could be drawn from the GC-MS data. Upon column chromatography, 
octanoic acid was isolated, even in a reaction under anhydrous conditions. This could 
indicate that a hydrolysis step occurred during workup. Using FeCl3 hexahydrate, 
octanoic acid was formed along with other unidentified products (table 5.2, entry 31).16 
Anhydrous FeCl3 gave full conversion of the thioester, however, many products were 
formed, among them octanoic acid (table 5.2, entry 32). The same results were obtained 
when higher loadings of FeCl3 were tested and acetonitrile, DMF, or 1,2-dichloroethane 
were used as solvents (table 5.2, entry 33-36). Adding aqueous NaOH in order to 
hydrolyze the isocyanate or carbamoyl azide did not give n-heptyl amine, indicating that 
neither an acyl azide nor an isocyanate was formed, e.g. a Curtius rearrangement had not 
taken place (table 5.2, entry 37-38). Additionally, BF3 OEt2 and FeCl3 were combined, 
which led to very complex 1H NMR and GC-MS spectra (table 5.2, entry 39). Iron(II)-
salts showed no conversion of the thioester (table 5.2, entry 40). 
The isocyanate obtained from thioester 5.41 with HgCl2 and BF3 OEt2 as additives (table 
5.2, entry 2) was heated at reflux in tert-butanol and toluene. After purification by 
column chromatography only 17% of N-Boc-n-heptylamine 5.44 was obtained (scheme 
5.10). The reaction conditions were not further optimized because the isocyanate was 
only obtained when 10 eq. of highly toxic HgCl2 in benzene as solvent were used. The 






17% over two steps5.43
5.44
 
Scheme 5.10. Conversion of potential isocyanates. 
Tetra-n-butylammonium azide was synthesized from sodium azide and tetra-n-
butylammonium hydroxide (scheme 5.11).18 It is soluble in organic solvents and was 
studied for the conversion of thioester 5.41 to acyl azide 5.42. Using HgCl2 or FeCl3 as 



















Scheme 5.11. Synthesis of tetrabutylammonium azide and formation of the acyl azide. 
Sulfinyl- or sulfonyl groups are more electrophilic than regular thioesters; therefore, 
oxidizing reagents were investigated for the conversion of thioesters to acyl azides 












5.41 5.45 5.46  
Scheme 5.12. Oxidation of thioesters. 
Addition of MCPBA did not give the desired oxidation products of the thioester but GC-
MS and 1H NMR spectroscopy showed that octanoic acid 5.40 and mixed anhydride 
5.47 were formed (scheme 5.13). The second product could result from an attack of 
residual m-chlorobenzoic acid. This means that the thioester might indeed be oxidized 
and that the intermediate oxidation product is very reactive. However, no nucleophilic 
oxidizing reagent nor aqueous conditions can be used because the oxidized thioester is 












45% 42%  
Scheme 5.13. Oxidation of the thioester using MCPBA. 
Using Oxone (2 KHSO5, KHSO4, K2SO4) in methanol to oxidize the thioester, only 
methanolysis to methyl ester 5.48 was observed (scheme 5.14). However, in other 










Scheme 5.14. Oxidation of the thioester using Oxone. 
Tetra-n-butylammonium Oxone was prepared via a procedure reported by Trost and 
coworkers to use this more soluble reagent instead of Oxone to oxidize the thioester 
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(scheme 5.15).19 The oxidation of sulfides to sulfones was reported with this reagent.19 
Tetra-n-butylammonium Oxone is readily soluble in anhydrous organic solvents and was 
investigated instead of NaN3 in the oxidation of thioester 5.41 due to the fact that NaN3 
is insoluble in organic solvents. Tetra-n-butylammonium hydroxide and Oxone gave the 





(n-Bu4N)5+ (HSO5-)2 HSO4- SO42-
Oxone = KHSO5, 0.5 KHSO4, 0.5 K2SO4
48%
 
Scheme 5.15. Synthesis of tetra-n-butylammonium oxone. 
This oxidant was used in the oxidation of thioester 5.41 (scheme 5.16). No conversion 
was observed in CH2Cl2 as solvent. Also, when triethylamine as base was added, no 
reaction of the thioester took place.  
 







b) DCM, NEt3, 20-50°C  
Scheme 5.16. Oxidation ot the thioester with Oxone and tetra-n-butylammonium Oxone. 
In summary, we did not succeed in finding a suitable method to synthesize acyl azides or 
the rearranged isocyanates in good yield directly from thioesters. Metal salts as additives 
or oxidation of the thioester to activate it for azide substitution did not give the 
corresponding acyl azide or isocyanate. In some cases the hydrolyzed product, octanoic 
acid, was formed. 
5.3 Conclusion 
No procedure to successfully transform thioesters to acyl azides or isocyanates was 
found during this research. Many metal salt were investigated as additives. Moreover, 
activating reagents such as DMAP were studied. Only with ten equivalents of HgCl2 
followed by subsequent hydrolysis of the isocyanate, the corresponding N-Boc protected 
amine was isolated in low yield. Decreasing the amount of mercury salts or changing the 
solvent to the less toxic toluene did not show sufficient conversion. This conditions were 
not further optimized because of the high toxicity of mercury and benzene. 
Investigations to use tetra-n-butylammonium azide, which is better soluble in organic 
solvents compared to sodium azide, did not lead to successful conversion of the thioester 
either. Oxidation of the thioester to a sulfinyl or sulfone moiety in order to increase the 
electrophilicity gave only nucleophilic displacement of the thioester with the solvent or 
oxidizing reagent. In general, thioesters are regarded as more reactive compared to their 
oxoester analogues. However, a substitution of the thioester with azide could not be 
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achieved. That could either result from thermodynamic properties, i. e. the equilibrium 
of the thioester cleavage, or have a kinetic origin due to a lack of reactivity. If the 
equilibrium of this substitution is on the side of the thioester, the formation of an acyl 
azide should be disfavored. However, attempts to trap the thiolates for example with 
methylating reagents or by forming complexes with thiophilic metals to influence the 
equilibrium failed. Heating should start the Curtius rearrangement so that the acyl azide 
would be consumed to the isocyanate. That should also influence the equilibrium of an 
acyl azide formation from a thioester and drive it to the side of the acyl azide. Moreover, 
in those cases many side products were formed. Another reason for a failure of this 
reaction could be kinetic factors. The activation Gibbs energy of the transformation of 
the thioester to the acyl azide could be too high to overcome, for example compared to 
hydrolysis. In conclusion, we did not succeed to develop a direct route from thioesters to 
isocyanates. The thioester has to be hydrolyzed first to the corresponding carboxylic acid 
wich then can undergo a Curtius rearrangement to give the respective amines. 
5.4 Experimental  
All reactions with NaN3 were performed on small scale (0.25-0.50 mmol of the reagent) 
and with a safety screen in front of the reaction setup. 
 
General methods. see chapter 2. 
 
General procedure for the Curtius rearrangement. Thioester 5.41 (95 mg, 0.50 
mmol, 1.0 eq.) was placed into a flask, and solvents (2-5 mL) and additives were added 
as indicated (see table 5.1 and 5.2), and the reaction mixture was stirred at the indicated 
temperature for up to 48h. Conversion and product formation was monitored by GC-MS.  
 
Octanoic acid S-ethyl ester 5.41. N,N-Dicyclohexylcarbodiimide (13.0 g, 63.0 mmol, 
1.27 eq.) was added to octanoic acid 7.90 mL, 49.8 mmol, 1.00 
eq.), ethanethiol (11.1 mL, 150 mmol, 3.01 eq.) and 4-N,N-
dimethylaminopyridine (0.44 g, 6.63 mmol, 7.30 mol%) in 
anhydrous CH2Cl2 (50 mL) at 0°C. The reaction mixture was 
stirred for 4h at room temperature, and filtered. The solvent was removed in vacuum, 
and CH2Cl2 (50 mL) was added. The organic layer was washed with aq. 0.5N aq. NaOH 
(30 mL) and aq. sat. NaHCO3 (30 mL), dried over MgSO4 and concentrated in vacuum. 
The crude product was purified by flash column chromatography (n-pentane/Et2O 99/1) 
on silica gel to yield a colourless oil (7.97 g, 37.5 mmol, 75%).20 1H NMR (400 MHz, 
CDCl3): =0.84 (t, 3J=6.8 Hz, 3H; CH3), 1.17-1.31 (m, 11H; CH2), 1.62 (t, 3J=6.6 Hz, 
2H; CH2), 2.50 (t, 3J=7.4 Hz, 2H; CH2), 2.83 (q, 3J=7.5 Hz, 3H; CH2). 13C NMR (100 
MHz, CDCl3): =14.3 (CH3), 15.0 (CH3), 22.8 (CH2), 23.4 (CH2), 25.9 (CH2), 29.1 
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Synthesis of tetra-n-butylammonium azide.18 A 40% solution of tetra-n-
butylammonium hydroxide (67.0 mL, 100 mmol) and sodium azide (13.0 g, 200 mmol, 
2.00 eq.) were stirred in H2O (30 mL) for 5 min. Then, CH2Cl2 (150 mL) was added and 
the aqueous layer extracted three times with CH2Cl2 (3 x 25 mL). After drying over 
MgSO4, the solvent was evaporated in vacuum and the remaining solid dried in vacuum 
(27.0 g, 95.0 mmol, 95%). Data were according to the literature.18 
 
Synthesis of tetra-n-butylammonium Oxone (Bu4N)5 (HSO5) HSO4 SO42.19 Tetra-
n-butylammonium hydrogen sulfate (30 g, 88 mmol, 2.5 eq.) was added to Oxone (11 g, 
35 mmol) in H2O (45 mL). The mixture was stirred for 3h at room temperature. The 
aqueous layer was extracted three times with CH2Cl2 (3 x 50 mL), dried over MgSO4 
and concentrated in vacuum. The residual solid was dried in vacuum to give the pure 
product (27 g, 17.0 mmol, 48%). Data were according to the literature.19 
 
Heptyl-carbamic acid tert-butyl ester 5.44. The crude isocyanate (max. 0.5 mmol) was 
dissolved in toluene (5 mL) and tert-butanol (0.18 g, 2.4 mmol) 
was added. After reflux overnight, the reaction mixture was 
cooled to room temperature, and H2O and EtOAc were added. 
The organic layer was washed with aq. 1N HCl, aq. sat. NaHCO3 and brine, dried over 
MgSO4 and concentrated in vacuum. Column chromatography (n-pentane) gave the pure 
product (0.02 g, 0.08 mmol, 17%).22 1H NMR (400 MHz, CDCl3): =0.88 (t, 3J=6.8 Hz, 
3H; CH3), 1.12-1.38 (m, 8H; CH2), 1-48-1.50 (m, 2H; CH2), 3.45-3.49 (m, H; CH2). 
Data were according to the literature.23  
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Chapter 6 
Copper-catalyzed asymmetric conjugate 
addition of Grignard reagents to 
bifunctional building blocks 
 
The goal of this research was to sudy the copper-catalyzed asymmetric 1,4-addition to 
,-unsaturated fumarate derivatives, such as diesters, thioester-esters and acetal-
esters. The products are valuable building blocks for natural products and 
pharmaceuticals. Subsequent Curtius rearrangement of either the acetal or thioester 



















Among the most important reactions in organic synthesis are catalytic asymmetric C-C-
bond formations using organometallic reagents.1 The copper-catalyzed conjugate 
addition has been used as a key step in the synthesis of many biologically active 
compounds. This reaction shows a broad scope due to the large variety of acceptors (,-
unsaturated aldehydes, esters, ketones, phosphates, sulfones, thioesters and nitroalkenes) 
and nucleophiles (organometallic reagents, Michael donors, other carbanions) that can be 
employed.2 In the conjugate addition, the organometallic reagent reacts with the sp2-
carbon of the electron-deficient alkene converting it to an sp3-carbon and the subsequent 
enolate protonation gives a -substituted product bearing a stereogenic center at the -
carbon.2 Achieving both regio- and stereocontrol has been challenging: a regioselectivity 
issue is the 1,2- vs. 1,4-addition which depends on the hard/soft nature of the 










1,4-addition 1,2-addition  
Scheme 6.01. Competing reactions for the addition of organometallic reagents to ,-unsaturated carbonyl 
compounds. 
Much effort has been devoted to develop asymmetric variants of the conjugate addition 
using organometallic reagents as nucleophiles.2 Organozinc species have been 
successfully applied in copper-catalyzed 1,4-additions. Phosphoramidites derived from 
2,2’-binaphthol ligands4,5 provided the breakthrough showing high activity and excellent 
chemo- and regio-selectivity. The combination of phosphoramidite 6.03 (1 mol%), 
which bears a C2-symmetric binaphthyl and a C2-symmetric amine moiety, and 
Cu(OTf)2 (0.5 mol%) as catalyst system resulted in >98% ee in the conjugate addition of 















>98% ee  
Scheme 6.02. Conjugate addition of diethyl zinc to cyclohexenone. 
Bisalkylzinc reagents show lower reactivity in the non-catalyzed reactions and offer a 
higher tolerance towards functional groups than Grignard reagents.,4,5 However, 
Grignard reagents are more readily available and atom-economic because all alkyl 
groups are transferred. The potential in the addition of Grignard reagent to ,-
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unsaturated substrates has motivated extensive research into this area. The first use of 
Grignard reagents in the copper-catalyzed enantioselective conjugate addition to enones 
has been reported by Lippard and co-workers.6 The authors used chiral amide catalyst 
6.04 (2-4 mol%), based on chiral bidentate N,N’-dialkyl substituted 
aminotroponeiminate ligands with CuBr·SMe2 as the metal source and PhLi or n-BuLi to 
form the active catalyst in the addition of n-BuMgBr to cyclohexenone 6.01 (scheme 

























Scheme 6.03. a) Chiral Cu-catalyst preparation according to Lippard; b) First example of a copper-catalyzed 
asymmetric conjugate addition of Grignard reagents. 
Chiral diphosphine ligands have dominated the field of asymmetric catalysis.1 
Ferrocenyl diphosphine ligands formed the basis for the breakthrough in the copper 
catalyzed enantioselective addition of Grignard reagents (figure 6.1).7 Excellent 
enantioselectivities were achieved with catalytic amounts of Taniaphos 6.06 (6 mol%) 


















Figure 6.1. Ferrocenyl diphosphine ligands used in the addition of Grignard reagents to enones. 
The conjugate addition of Grignard reagents to acyclic ,-unsaturated esters is highly 
attractive due to the synthetic potential of the chiral ester products. However, progress 
with this substrate class was until recently scarce. The lower intrinsic reactivity of ,-
unsaturated esters compared to enones may account for this lack of methodologies.8 
Recently, Josiphos 6.07 and reversed-Josiphos 6.08 and CuBr SMe2 have been used in 
the addition of alkylMgBr to linear ,-unsaturated esters to give products with high 
regio- and enantioselectivity in high yields (table 6.01).9 Low catalyst loadings of the 
6.07-Cu-complex (0.5 mol%) can be used to catalyze the addition of n-butyl, i-pentyl 
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and homoallyl magnesium bromide to ,-unsaturated methyl esters. For less hindered 
electrophiles, ligand 6.07 shows the best results regarding enantioselectivity whereas for 
-branched and aryl substituted ,-unsaturated esters ligand 6.08 gives higher 
enantioselectivities.3 The copper-ligand-complex could be recovered from the reaction 
mixture and reused without loss of activity.9 t-BuOMe is the preferred solvent as with 
for instance THF lower enantioselectivities were observed. 








6.10 6.11  
 
R yield [%] ee [%] 
n-butyl 92 95 
homoallyl 67 85 
i-pentyl 90 96 
 
A second catalyst system has been published by Loh and coworkers (table 6.02).10 The 
catalyst is based on copper iodide (1.0 mol%) and Tol-Binap 6.09 (1.5 mol%); high 
enantioselectivities are obtained with a range of Grignard reagents. Major difference to 
the system based on ferrocenyl diphosphine ligands9 is that higher enantioselectivities in 
the addition of sterically hindered nucleophiles, e.g. i-PrMgBr, are observed. Decreased 
enantioselectivity was observed as compared with the Josiphos-based system with 
aliphatic ,-unsaturated esters and linear Grignard reagents (table 6.01 vs. 6.02).  














R1 R2 yield [%] ee [%] 
CH2Bn Et 88 93 
CH2Bn n-Bu 90 92 
CH2Bn i-Bu 91 86 
Me Et 83 74 
Ph Et 90 93 
CH2OBn Et 83 73 
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A limitation in the addition of Grignard reagents to ,-unsaturated esters is that the less 
reactive methylmagnesium bromide shows only low conversion (but high 
enantioselectivity).9 The introduction of a methyl group is, however, important in view 
of the synthesis of numerous biologically active compounds. Therefore, the more 
reactive ,-unsaturated thioesters were employed in the copper-Josiphos-catalyzed 
addition of MeMgBr to a variety of ,-unsaturated thioesters (table 6.03).11 The -
methyl substituted products were obtained with high enantioselectivity when linear 
alkyl-Grignard reagents were used, but only low ee was achieved with branched and 
bulky i-BuMgBr. Regioselectivities were in all cases excellent (>99%). The reaction rate 
observed for the addition of Grignard reagents to ,-unsaturated thioesters is 
comparable to that with their respective enone analogues and probably results from 
electronic properties.12 















R1 R2 ee [%] yield [%] 
n-Pent Me 96 90 
n-Pent Et 85 97 
n-Pent i-Bu 15 80 
Et Me 92 92 
(CH2)3OBn Me 95 84 
Ph Me 95 65 
 
The copper-catalyzed addition of Grignard reagents to ,-unsaturated thioesters 
employing the Josiphos and the TolBinap system were compared (table 6.04 shows 
results for thioester with Tol-Binap).13 Tol-Binap/CuI was identified as the more active 
catalyst. Furthermore, this system shows improved enantioselectivities in the addition of 
secondary and bulky Grignard reagents and in the addition of methylmagnesium 
bromide to bulkier -substituted substrates. Josiphos/CuBr SMe2 shows superior results 


















R1 R2 ee [%] yield [%] 
n-Pent Et 93 90 
n-Pent i-Bu 94 95 
Me n-Bu 74 94 
CH2OTBDPS Et 83 95 
i-Pr Me 99 82 
 
With both described catalytic systems, the addition to - and -disubstituted ,-
unsaturated carbonyl compounds to generate quarternary stereogenic centers was not 
successful. Alexakis and coworkers reported that diaminocarbene based ligands can be 
used with Cu(OTf)2 to accelerate the addition of Grignard reagents to these substrates.14  
The mechanism of the enantioselective copper-catalyzed conjugate addition of 
organometallics is similar to the mechanism of the noncatalyzed addition of 
organocuprates.15 Feringa and co-workers have investigated aspects of this mechanism 
using electrochemical and NMR studies.16 X-ray analysis revealed the structure of the 
dimeric Cu(I)-complex 6.14. The use of THF as solvent instead of t-BuOMe results in a 
decrease of the rate and enantioselectivity. Also the presence of bromide in the Grignard 
reagent is essential to achieve good regio- and enantioselectivities. NMR studies of the 
catalytic reaction mixture have shown that species 6.15 is formed via transmetallation of 
the Grignard reagent (scheme 6.04). 
Kinetic studies also indicate that the rate is dependent on the concentrations of the 
Grignard reagent, the substrate and the catalyst. With respect to the catalyst a first order 
dependence is observed which is in agreement with the linear dependance of the ee of 
the product on the ee of the catalyst. Moreover, studies using E- and Z-isomers as 
substrates show that the same enantiomers are formed with high ee from both isomers. 
When the reaction mixture was quenched before achieving completion it was observed 
that the Z-isomer had partially isomerized to the E-isomer.17 This suggests that the active 
catalyst interacts reversibly with the double bond of the alkene, because no isomerization 
was observed when either copper-complex or Grignard reagent were not present. 
According to these observations, a catalytic cycle was proposed (scheme 6.04).16  
 











































Scheme 6.04. Proposed catalytic cycle for the copper-catalyzed addition of Grignard reagents to ,-
unsaturated carbonyl compounds. 
The mechanism involves an intermediate -complexed species followed by formation of 
the magnesium enolate via a Cu(III)-intermediate. The first step is the formation of the 
active catalytic species 6.15 which is formed from the dimeric precatalyst 6.14 via 
transmetallation with the Grignard reagent. Complex 6.15 bears a chiral phosphine 
ligand which leads to acceleration of the reaction and stabilization of the intermediates. 
The first step in the catalytic cycle is the reversible formation of the -complex 6.17 
from complex 6.15 and the alkene moiety of the substrate 6.16. In this intermediate, 
copper coordinates to the olefin, while the Mg2+-ion interacts with the carbonyl oxygen 
of the substrate. The importance of the Mg2+-ion is reflected by a low enantiomeric 
excess when different solvents (e.g. THF) are used. The halide source, e.g. the presence 
of Br, is important for conversion and regioselectivity. The Mg2+-ion is proposed to 
activate the carbonyl group as a Lewis acid and the bromide ion forms a halide bridge. 
An intramolecular rearrangement to form a Cu(III)--intermediate 6.18 may follow, in 
which step copper binds to the -position of the enoate through a -bond. The complex 
6.18 is in fast equilibrium with complex 6.17, and its rate constant depends on the 
stability of the -complex 6.18. Calculations indicate that the Cu(III)-intermediate is 
unstable, and its thermodynamic stabilization could be achieved with soft donor ligands, 
while its kinetic lability might depend on the geometry of the species. In this system, this 
is realized through a combination of the Grignard reagent and the diphosphine ligand 
which provides donor ability and the necessary geometry in the  -complex to afford 
high regio- and enantioselectivity. The rate limiting step is the reductive elimination 
which leads to the release of the magnesium enolate 6.19 and the regeneration of 
catalytic species 6.15 for which a second equivalent of RMgBr is used. The mechanism 
is supported by the observation that substitution on - or -carbon prevent the formation 
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of the conjugate addition product. The presence of substituents in these positions might 
prevent coordination of the Cu-complex to the double bond.  
The aim of the project presented in this chapter was to perform the copper-catalyzed 
asymmetric conjugate addition of Grignard reagents to ,-unsaturated fumarate 
derivatives 6.20 (scheme 6.05). The thioester moiety should direct the conjugate addition 
due to the fact that it is more electrophilic than the ester group. The addition should, 
therefore, proceed in a regioselective and enantioselective manner to give adduct 6.21. 
The products are valuable building blocks for the synthesis of natural products and 
pharmaceuticals. In particluar, 2- and 3-amino acids can be synthesized by subsequent 

























Scheme 6.05. 1,4-Addition to fumarate mono-thioesters and Curtius rearrangement towards -amino acids. 
6.2 Synthesis of ,-unsaturated esters and thioesters 
Several ,-unsaturated thioesters and esters were synthesized using literature 
procedures or modifications thereof. Compound 6.25 was prepared via thioesterification 
of mono-ethyl fumarate 6.24 using ethanethiol, DCC and catalytic amounts of DMAP 
(scheme 6.06).18 The yield of this reaction was only moderate due to competing 
conjugate addition of the thiol. From the same starting material (6.24) tert-butyl ethyl 
fumarate 6.26 was synthesized using the Steglich esterification with DCC and DMAP in 








X = SEt (6.25) 56%




Scheme 6.06. Synthesis of a mono-thioester and a mono-tert-butyl ester of ethyl fumarate. 
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Furthermore, starting from mono-ethyl fumarate 6.24 and using N-benzyl-N-methyl 
amine as nucleophile, the amide-ester 6.27 was obtained in excellent yield (scheme 
6.07).20 Hereby, EDC in combination with HOBt were used as activating reagents for the 













Scheme 6.07. Synthesis of an amide-ester of fumarate. 
The activated ester 6.32 and thioester 6.33 were synthesized in a two step procedure 
(scheme 6.08).21 The orthoester-group is a protecting group for a carboxylic acid and can 
be hydrolyzed using acid. First, an ester was formed from mono-ethyl fumarate and 
mono-thioethyl fumarate, activated with DCC and catalytic amounts of DMAP, and 2-
methyl-2-oxetane methanol. The intermediate diester was isolated and purified, and 
subsequently treated with BF3·OEt2. The Lewis acid activates the oxetane oxygen for a 
nucleophilic attack on the carbonyl oxygen. The formed alcoholate now attacks the 




















X = O (6.32)  33%
X = S (6.33) 56%
X = O (6.28) 
X = S (6.29) X = O (6.30) 
X = S (6.31)
 
Scheme 6.08. Synthesis of activated ,-unsaturated esters and thioesters. 
Diacetal-ester 6.36 was synthesized in two consecutive steps from glyoxaldehyde 
dimethylacetal, e. g. a Swern oxidation and Horner-Wadsworth-Emmons olefination, 
respectively.22 The aldehyde was not isolated but the solution of the in situ prepared 
aldehyde was cooled to 60°C, and the olefin was formed by addition of diethyl 
phosphonoacetate (table 6.05). Several attempts had to be made to produce the trans-
alkene in good yield. When NaH was added one hour after the addition of the 
phosphonate, olefin 6.36 was obtained in low yield (table 6.05, entry 1). The alkene 6.36 
was obtained with a cis-trans ratio of 5:95, but the isomers could not be separated by 
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column chromatography. Following the literature procedure22 and deprotonating the 
phosphonate with NaH one hour before its addition, the alkene was again obtained in 
low yield and even more cis-isomer was formed (table 6.05, entry 2). Deprotonating the 
phosphonate with n-BuLi gave the product in a 60:30 ratio of the trans:cis isomers (table 
6.05, entry 3). Davies and co-workers recently reported, that deprotonating the 
phosphonate with MeMgBr yields more trans-isomer, and also provides the product in 
higher yields than n-BuLi.23 Following this procedure, and deprotonating the 
phosphonate prior to addition of the aldehyde, gave low yields (26%) of 6.36 and a 95:5 
ratio of the trans : cis-isomers (table 6.05, entry 4). Finally, when first the phosphonate 
and immediatly NaH were added to aldehyde 6.35, solely the trans-olefin was provided 
in acceptable yield (table 6.05, entry 5).  














NaH, 60°C -> rt
6.34 6.35 6.36  
 
entry base yield [%] trans : cis ratio 
1 NaHa 34 95:5 
2 NaHb 34 90:10 
3 n-BuLib nd 60:30 
4 MeMgBrb 26 95:5 
5 NaHc 62 99:1 
a NaH added 1h after the phosphonate. b Phosphonate 
deprotonated prior to addition, and the solution stirred for 30 
min. c First phosphonate, then NaH added. 
As an alternative substrate, the cyclic acetal 6.38, derived from 2,2-dimethyl-1,3-
propanediol, was synthesized from dimethoxyacetal ester 6.36 catalyzed by the Lewis 
acid BF3·OEt2 (scheme 6.09).24 Starting from a trans-cis mixture of 60:30 of 6.36, the 
cyclic acetal 6.38 was obtained in 66% yield as a trans-cis mixture (ratio 60:30). The 
isomers could be separated by column chromatography and a yield of 95% of the trans-














Scheme 6.09. Transacetalization of the dimethoxyacetal to yield a cyclic acetal. 
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All synthesized ,-unsaturated carbonyl compounds were studied in the asymmetric 
conjugate addition of Grignard or zinc reagents.  
6.3 Catalytic asymmetric 1,4-additions 
All conjugate addition reactions were performed under a nitrogen atmosphere and at low 
temperature. The catalyst system developed in the Feringa group (CuBr·SMe2-Josiphos 
and CuBr·SMe2-reversed-Josiphos)9,11 and the system of Loh and coworkers (CuI/Tol-
Binap)10 were investigated in this project (figure 6.1). Furthermore, for two substrates 
the addition of diethylzinc with Cu(OTf)2-Leggy ligand was studied.4 
Using thioester 6.25, the addition of various Grignard reagents was examined (table 
6.06). The addition of MeMgBr gave the product with excellent enantioselectivity in 59-
65% yield with both catalytic systems (CuBr-Josiphos and CuI-TolBinap), but the CuBr-
Josiphos complex gave slightly better results (table 6.06, entry 1-2). When the more 
reactive EtMgBr was tested, the enantioselectivity dropped significantly to 50% (table 
6.06, entry 3). The reaction turned out to be very fast and is finished within one minute. 
Lowering the temperature to 100°C did not increase the ee, however. The CuI-
TolBinap catalyzed reaction gave an even lower ee of 14% (table 6.06, entry 4). Also, 
the addition of the sterically more hindered i-BuMgBr produced the corresponding 
adduct with very low ee using both catalyst systems (table 6.06, entry 5-6). In addition, 
when EtMgBr and i-BuMgBr were used, a mixture of regioisomers (approximately 
80:20 ratio)25 of the conjugate addition towards the thioester and towards the ester were 
produced. The addition of MeMgBr gave only one isomer, i.e. conjugate addition 
towards the product 6.39. 













R = Me  6.39
R = Et   6.40
R = iBu 6.41

OEt
R = Me  6.42
R = Et   6.43








entry catalyst RMgBr solvent ratio A:Ba yield [%] ee [%]d 
1 CuBr-6.07b Me MTBE >99:1 65 95 
2 CuI-6.09b Me MTBE >99:1 59 94 
3 CuBr-6.07c Et MTBE 80:20 44 50 
4 CuI-6.09b Et MTBE 80:20 51 14 
5 CuBr-6.07b i-Bu MTBE 80:20 36 9 
6 CuI-6.09b i-Bu MTBE 80:20 46 9 
7 - Et MTBE 80:20 38 - 
a Determined by 1H-NMR. b Reaction time 16 h, 5 mol% CuX, 6 mol% ligand. c Reaction time 1 min. d 
Absolute configuration not determined. 
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Furthermore, the addition of diethyl zinc to thioester 6.25 catalyzed by phosphoramidite 
ligand 6.03 and Cu(OTf)2 was investigated in order to extend the scope of this reaction. 
However, in toluene and DCM the product was formed as racemate at 40°C, whereas at 
lower temperature no reaction was observed (table 6.07, entry 1-2). Using Et2O as a 
solvent at lower temperatures, a low ee was observed in the adduct (table 6.07,entry 3). 

















entry catalyst solvent yield [%] ee [%] 
1 Cu(OTf)2-6.03a toluene nd rac 
2 Cu(OTf)2-6.03a DCM nd rac 
3 Cu(OTf)2-6.03b Et2O nd 21 
a 40°C. b 65°C. nd = not determined. 
Next, diethyl fumarate 6.45 was investigated as a substrate in the addition of 
ethylmagnesium bromide in order to desymmetrize 6.45. CuBr-Josiphos as catalyst gave 
the adduct 6.46 with moderate ee in MTBE as solvent, but a slightly higher ee was 
obtained in Et2O as solvent (table 6.08, entry 1 and 5). The addition of diethyl zinc gave 
in all cases racemic products (table 6.08, entry 2-3). 








6.45 6.46  
 
entry catalyst RM solvent yield [%] ee [%] 
1 CuBr-6.07a EtMgBr MTBE 56 46 
2 Cu(OTf)2-6.03b Et2Zn toluene nd rac 
3 Cu(OTf)2-6.03b Et2Zn DCM nd rac 
4 Cu(OTf)2-6.03a Et2Zn Et2O nd rac 
5 CuBr-6.03a  EtMgBr Et2O 53 63 
a 65°C. b 40°C. nd = not determined.  
Next, the addition of ethylmagnesium bromide was studied on tert-butyl-ethyl fumarate 
6.26 catalyzed by CuBr-Josiphos (scheme 6.10). For a selected substrate, the addition to 
tert-butyl esters gave a slightly higher enantioselectivity than the corresponding methyl 
Chapter 6: Catalytic asymmetric 1,4-addition of Grignard reagents to fumarate derivatives 
 183
or ethyl esters.26 Only moderate enantioselectivities (major isomer) and yields were 















Scheme 6.10. 1,4-Addition of EtMgBr to tert-butyl-ethyl fumarate. 
Also, N-benzyl-N-methylamide-ethyl fumarate 6.27 was investigated as substrate in the 
addition of ethylmagnesium bromide (table 6.09). Using CuBr-Josiphos as catalyst, the 
racemic adduct 6.48 was obtained in moderate yield (table 6.09, entry 1), whereas with 
CuI-TolBinap as catalyst, 6.48 was isolated nearly racemic (table 6.09, entry 2). The 
amide might coordinate to the copper catalyst and, therefore, influence the coordination 
of the olefin or carbonyl oxygen to the metal ions which is necessary to achieve high 
enantioselectivities.16  












entry catalyst RM solvent yield [%] ee [%] 
1 CuBr-6.07 EtMgBr MTBE 38 rac 
2 CuI-6.09 EtMgBr MTBE 38 4 
 
Furthermore, acetal- and orthoester-protected ester 6.32 and thioester 6.33 were tested as 
substrates for the addition of ethylmagnesium bromide catalyzed by CuBr-Josiphos. The 
orthoester 6.32 did not show conversion (table 6.10, entry 1). Using thioester 6.33, the 
racemic adduct was isolated in low yield (23%) (table 6.10, entry 2). This could result 
from coordination of the copper catalyst to the oxygen atoms of the substrate. 
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x = O (6.32)  









X = O (6.49)  




entry catalyst X yield [%] ee [%] 
1 CuBr-6.07a O - nd 
2 CuBr-6.09b S 23 rac 
a 65°C. b 60°C. 
In order to reduce the electron-withdrawing effect of the substituents at the -position of 
the alkene, the dimethoxyacetal-ester 6.36 was tested in the addition of various Grignard 
reagents catalyzed by CuBr-Josiphos (table 6.11). The addition of ethylmagnesium 
bromide catalyzed by Cu-Josiphos gave the adduct 6.51 with a high ee (88%) in good 
yield (table 6.11, entry 1), whereas the use of CuI-TolBinap gave a lower ee (66%). 
Also, using CuBr-reversed-Josiphos, the product was obtained with lower ee (63%, table 
6.11, entry 3). Based on these observations, the following additions of Grignard reagents 
were only tested with CuBr-Josiphos as catalyst. Using Et2O instead of MTBE as a 
solvent, a lower ee was obtained (table 6.11, entry 4). Adding the Grignard reagent 
slowly instead of the substrate 6.36 led to a drop in enantioselectivity as well (64% ee) 
(table 6.11, entry 5). Surprisingly, Grignard reagents with longer alkyl chains, such as 
hexyl- and butylmagnesium bromide, gave the products 6.52 and 6.53 with excellent ee 
(96%) (table 6.11, entry 6-7). Addition of i-pentylmagnesium bromide gave the product 
6.54 with high ee also (table 6.11, entry 8). However, by adding phenylethylmagnesium 
bromide to 6.36, a drop in enantiomeric excess to 66% was observed (table 6.11,entry 9). 
The addition of homoallylmagnesium bromide did not show conversion of the substrate 
6.36 (table 6.11, entry 10).  
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6.36 R = Et        6.51
R = Bu       6.52
R = hexyl   6.53
R = i-Pent  6.54
R = PhEt    6.55  
 
entry catalyst RMgBr solvent yield [%] ee [%]b 
1 CuBr-6.07 Et MTBE 82 88 
2 CuI-6.09  Et MTBE nd 66 
3 CuBr-6.07 Et MTBE nd 63 
4 CuBr-6.07 Et Et2O 55 64 
5 CuBr-6.07a Et MTBE 64 66 
6 CuBr-6.07 n-butyl MTBE 90c 96 
7 CuBr-6.07 n-hexyl MTBE 66 96 
8 CuBr-6.07 i-pentyl MTBE 56 97 
9 CuBr-6.07 PhEt MTBE 63 66 
10 CuBr-6.07 homoallyl MTBE - nd 
a Grignard added at a rate of 1 mL/h. b Absolute configuration not determined. c Experiment 
performed once. nd = not determined  
Finally, the addition of ethylmagnesium bromide to cyclic acetal-ester 6.31 was studied, 
employing CuBr-Josiphos as catalyst (scheme 6.11). However, the addition led to a drop 















Scheme 6.11. 1,4-Addition of EtMgBr to cyclic acetal-ester. 
In summary, the copper catalyzed asymmetric conjugate addition of methylmagnesium 
bromide to a fumarate mono-thioester was succesfully performed to give the adduct with 
excellent ee. However, more reactive Grignard reagents lead to a drop in the 
enantiomeric excess. Therefore, after testing a variety of electrophiles, a less activated 
substrate, the -acetal-substituted ester 6.36, was used in the conjugate addition of 
various Grignard reagents. Generally, Grignard reagents with long aliphatic chains gave 
higher ee’s. The -methyl substituted thioester is an interesting bifunctional building 
block for organic and pharmaceutical synthesis. Also, the -acetal--alkyl substituted 
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esters can be easily deprotected to the corresponding aldehyde, which might undergo a 
variety of reactions, such as Wittig or Horner-Wadsworth-Emmons olefination, 
reduction or oxidation. Subsequently, we tried to convert the products into -amino acids 
(see paragraph 6.4). 
6.4 Conversion to -amino acids 
To convert the obtained adducts into -amino acids, the thioester or the acetal group had 
to be hydrolyzed and subsequently transformed into an amine using the Curtius 
rearrangement as the key step. We did not succeed in developing a direct Curtius 
rearrangement (see chapter 5), and therefore the thioester was first hydrolyzed with 
LiOH and H2O2 (in 30 min) to the corresponding carboxylic acid 6.57 (scheme 6.12). 
During this short reaction time, less than 5% of the oxo-ester functionality was 
hydrolyzed. The crude product was treated with diphenylphosphoryl azide and refluxed 
to initiate the rearrangement. The crude isocyanate was reacted with tert-butanol to give 
2-N-Boc-amino ester 6.58 (scheme 6.12).28 GC-MS and NMR showed that the amino 
ester was formed,29 but it could not be separated from the diphenylphosphonate by-


















Scheme 6.12. Conversion of the conjugate addition product to a -amino acid. 
In a one-step procedure, the acetal was hydrolyzed and subsequently oxidized to give 
carboxylic acid 6.59 (scheme 6.13).24 A Curtius rearrangement of the crude carboxylic 
acid gave 3-N-Boc-amino ester 6.60. GC-MS and NMR showed that the amino ester 
was formed besides diphenyl phosphate and other phosphorus containing compounds,29 

















Scheme 6.13. Acetal hydrolysis and oxidation, followed by Curtius rearrangement. 
In summary, it was attempted to transform the thioester functionality in two steps into a 
protected amine. GS-MS and 1H-NMR spectra of the crude amino esters indicated that 
an amine was formed from the acetal group or the thioester functionality. However, both 
products, 6.58 and 6.60, were not isolated or characterized. In the future, the purification 
of both products, obtained via the Curtius rearragement, needs to be improved. It might 
be improved by using, for example, polymer supported phosphoryl azides which are 
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easier to separate from the products. The products might also be separated by preparative 
HPLC. Furthermore, another nucleophile might be used to hydrolyze the isocyanate. 
This route might become a useful method for the synthesis of -amino acid derivatives if 
the purification of the final product can be improved. Via the copper-catalyzed 
asymmetric conjugate addition, a variety of -alkyl substituted esters 6.50 are available. 
From these as substrates, the Curtius rearrangement needs to be optimized to access 3-
amino acids. 
6.5 Conclusion 
The asymmetric conjugate addition of Grignard reagents to bifunctional building blocks, 
for example, substituted with two electron withdrawing ester groups, was studied. The 
conjugate addition of methylmagnesium bromide to fumarate mono-thioester 6.25 
proceeded with high enantioselectivity. The stereoselective introduction of a methyl 
group is important and useful for the synthesis of pharmacologically active substances 
and natural products. However, the more reactive nucleophile ethylmagnesium bromide 
could only be added with moderate enantioselectivity to the fumarate mono-thioester. 
Also, i-butylmagnesium bromide addition resulted in the corresponding adduct produced 
with low ee. In general, the addition of i-BuMgBr has resulted in low enantioselectivity 
in the CuBr-Josiphos-catalyzed addition to ,-unsaturated esters,9 but usually it has 
shown good enantioselectivity when employing CuI-TolBinap in the addition to ,-
unsaturated thioesters (see paragraph 6.1).13 However, compared to the systems 
described in paragraph 6.110,13, in the present study no improvement was achieved in the 
addition of i-BuMgBr to fumarate mono-thioesters catalyzed by CuI-TolBinap. In 
contrast to compound 6.12, fumarate mono-thioester 6.25 has a highly activated ,-
unsaturated functionality due to the fact that the electron-withdrawing ethylester is 
situated in -postition. Therefore, even the uncatalyzed conjugate addition of 
ethylmagnesium bromide to 6.25 (that means without any copper salts) proceeded in a 
yield of about 50%. Diethyl fumarate 6.45, tert-butyl-ethyl fumarate 6.26 and orthoester-
thioester 6.33 have also electron-withdrawing substituents in the -position of their 
respective ,-unsaturated ester. Additionally, orthoester 6.33 bears three electron 
withdrawing oxygen atoms, which could further be involved in coordination to the 
copper catalyst. A coordination could also occur with the nitrogen atoms of the amide-
ester 6.27, additionally, it is a sterically more demanding group. The copper-catalyzed 
asymmetric conjugate addition of ethylmagnesium bromide to these substrates (6.45, 
6.26, 6.33 and 6.27) leads to the corresponding products with low enantiomeric excess or 
to racemic adducts. Finally, reducing the amount of oxygen atoms, we synthesized 
acetal-ester 6.36. The electron withdrawing ability is reduced in 6.36. This resulted in 
good to excellent enantioselectivities in the conjugate addition of various Grignard 
reagents to 6.36. 
Furthermore, a Curtius rearrangement was attempted to acces 2- and 3-amino acids 
from both building blocks, however, in both cases the corresponding amines could not 
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be isolated in pure form. A 2-amino acid derivative was attempted to be synthesized 
after the successful hydrolysis of the thioester functionality of 6.39, and a subsequent 
Curtius rearrangement of the corresponding carboxylic acid. But the protected amino 
ester could not be isolated or purified. For the attempted synthesis of a 3-amino acid 
derivative, a hydrolysis of the acetal moiety and an oxidation of the corresponding 
aldehyde to the carboxylic acid were performed. A subsequent Curtius rearrangement of 
the carboxylic acid functionality might give the 3-amino acid derivative, however, the 
final product was not isolated. The purification of these products needs to be further 
improved in the future.   
6.6 Experimental  
General methods. see chapter 2. All reactions were conducted under a N2 atmosphere 
using flame dried Schlenk flasks. 
 
General procedure for the  copper-catalyzed asymmetric 1,4-addition of Grignard 
reagents. The copper source (5 mol%) and ligand (6 mol%) were stirred in an anhydrous 
solvent until the complex was formed indicated by a color change to orange; 
alternatively, the preformed CuBr-Josiphos complex was dissolved in an anhydrous 
solvent. The copper-ligand complex was cooled to 75°C, the Grignard reagent (1.5 eq.) 
added, and the mixture stirred for 5 min. The substrate (1.0 eq.) was added dropwise via 
a syringe pump at a rate of 1mL/h. When the reaction was finished as indicated by TLC, 
MeOH (2 mL) and aq. sat. NH4Cl (2 mL) were added, and the mixture warmed to room 
temperature. The aqueous. layer was extracted with Et2O (3 x 10 mL), the combined 
organic layers washed with brine (10 mL) and dried over MgSO4. After evaporation of 
the solvent in vacuum, the crude product was purified by flash column chromatography 
on silica gel (n-pentane/Et2O). 
 
General procedure for the copper-catalyzed asymmetric 1,4-addition of diethyl 
zinc. Cu(OTf)2 (2 mol%) and (S,R,R)-6.03 (4 mol%) were stirred in an anhydrous 
solvent for 1 h. The copper-ligand complex was cooled to 40°C or 75°C, the substrate 
(1.0 eq.) was added dropwise, and the mixture was stirred for 5 min. Then diethyl zinc 
(1.1M in toluene, 2.0 eq.) was added. When the reaction was finished as indicated by 
TLC, MeOH (2 mL) and aq. sat. NH4Cl (2 mL) were added, and the mixture warmed to 
room temperature. The aqueous layer was extracted with Et2O (3 x 10 mL), the 
combined organic layers washed with brine (10 mL) and dried over MgSO4. After 
evaporation of the solvent in vacuum, the crude product was purified by flash column 
chromatography on silica gel (n-pentane/Et2O). 
 
General procedure for racemate synthesis: The anhydrous solvent (3 mL) was cooled 
to 75°C, the Grignard reagent (1.5 eq.) added, and the mixture was stirred for 5 min. 
The substrate (1.0 eq.) was added dropwise via a syringe pump at a rate of 1mL/h. When 
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the reaction was finished as indicated by TLC, MeOH (2 mL) and aq. sat. NH4Cl (2 mL) 
were added, and the mixture warmed to room temperature. The aqueous layer was 
extracted with Et2O (3 x 10 mL), the combined organic layers washed with brine (10 
mL) and dried over MgSO4. After evaporation of the solvent in vacuum, the crude 
product was purified by flash column chromatography on silica gel (n-pentane/Et2O). 
 
(E)-Ethyl 4-(ethylthio)-4-oxobut-2-enoate 6.25.18 N,N-Dicyclohexylcarbodiimide (1.09 
g, 5.28 mmol, 1.06 eq.) was added to mono-ethyl fumarate (0.62 g, 
5.00 mmol, 1.00 eq.), ethanethiol (0.48 mL, 6.50 mmol, 1.50 eq.) and 
4-dimethylaminopyridine (0.06 g, 0.50 mmol, 0.10 eq.) in CH2Cl2 (25 
mL) at 0°C. After stirring for 16 h at room temperature, the mixture 
was filtered, washed with Et2O and the filtrate concentrated in vacuum. The crude 
product was purified by column chromatography on silica gel (n-pentane/Et2O 96:4) to a 
yield a colorless oil (0.50 g, 2.66 mmol, 53%). 1H NMR (400 MHz, CDCl3): =1.22-
1.30 (m, 6H; CH3), 2.96 (q, 3J=6.3 Hz, 2H; CH2), 4.21 (q, 3J=6.1 Hz, 2H; CH2), 6.66 (d, 
3J=15.6 Hz, 1H; CH), 6.98 (d, 3J=15.6 Hz, 2H; CH). 13C NMR (100 MHz, CDCl3): 
=14.1 (CH3), 14.4 (CH3), 23.8 (CH2), 61.4 (CH2), 128.6 (CH), 138.8 (CH), 165.1 (CO), 
189.2 (CO). Spectral data were consistent with the literature.31 
 
tert-Butyl ethyl fumarate 6.26.19 N,N-Dicyclohexylcarbodiimide (4.54 g, 22.0 mmol, 
1.13 eq.) was added to mono-ethyl fumarate (2.88 g, 19.4 mmol, 1.0 
eq.), tert-butanol (4.45 g, 60.0 mmol, 3.09 eq.) and 4-
dimethylaminopyridine (0.22 g, 1.80 mmol, 0.09 eq.) in dry CH2Cl2 
(20 mL) at 0°C. After stirring for 3h at room temperature, the mixture was filtered and 
the filtrate washed with aq. 0.5N HCl (2 x 40 mL), and aq. sat. NaHCO3 solution (2 x 40 
mL). After drying over MgSO4, the solvent was removed in vacuum, and the crude 
product purified by column chromatography on silica gel to give a colorless oil (3.55 g, 
16.6 mmol, 91%). 1H NMR (300 MHz, CDCl3): =1.24 (t, 3J=6.1 Hz, 3H; CH3), 1.43 (s, 
9H; CH3), 4.18 (q, 3J=6.1 Hz, 2H; CH2), 6.69 (s, 2H, CH). 13C NMR (75 MHz, CDCl3): 
=14.0 (CH3), 26.8 (CH3), 61.0 (CH2), 81.6 (C), 132.5 (CH), 135.3 (CH2), 164.0 (CO), 
165.0 (CO). Spectral data consistent with the literature.32 
 
(E)-Ethyl 4-(benzyl(methyl)amino)-4-oxobut-2-enoate 6.27.20 To N-benzyl-N-
methylamine (1.29 mL, 10.0 mmol, 1.00 eq.) in DMF (40 mL) were 
added 1-hydroxybenzotriazole (1.49 g, 11.0 mmol, 1.10 eq.), mono-
ethyl fumarate (1.58 g, 11.0 mmol, 1.10 eq.) and N,N-
diethylcarbodiimide (2.11 g, 11.0 mmol, 1.10 eq.). After stirring for 
16h, the solvent was evaporated in vacuum, ethyl acetate (100 mL) was added to the 
residue and the organic layer washed with 2% aq. citric acid (50 mL), aq. sat. NaHCO3 
(50 mL) and brine (50 mL). The organic layer was dried over MgSO4, the solvent 














silica gel (n-pentane/ethyl acetate 1/1) to a colorless oil (2.40 g, 9.60 mmol, 96%). 1H 
NMR (300 MHz, CDCl3): =1.20-1.30 (m, 3H; CH3), 2.96 (s, 3H; CH3), 4.12-4.25 (m, 
2H; CH2), 4.56 (s, 1H; CH2), 4.62 (1H; CH2), 6.81 (d, 3J=15.2 Hz, 1H; CH), 6.06-6.15 
(m 1H; CH), 6.16-6.45 (m, 5H; CH). 13C NMR (65 MHz, CDCl3): =13.9 (CH3), 34.8 
(CH3), 50.9 (CH2), 60.9 (CH2), 126.3 (CH), 126.9 (CH), 128.5 (CH), 128.8 (CH), 131.4 
(CH), 135.5 (CH), 135.8 (C), 164.5 (CO), 165.0 (CO). Spectral data were consistent with 
the literature.20 
 
(E)-Ethyl 3-(4-methyl-2,6,6-trioxabicyclo[2.2.2]octan-1-yl)acrylate 6.32.21 N,N-
Dicyclohexylcarbodiimide (23.4 g, 114 mmol, 1.39 eq.) was added 
to mono-ethyl fumarate (13.2 g, 92.0 mmol, 1.12 eq.), 2-methyl-2-
oxetane methanol (8.38 mL, 82 mmol, 1.00 eq.) and 4-
dimethylaminopyridine (1.02 g, 8.40 mmol, 0.10 eq.) in CH2Cl2 
(120 mL) at 0°C. After stirring for 3h at room temperature, the mixture was diluted with 
pentane, filtered over Celite, and concentrated in vacuum. The crude product was 
purified by column chromatography (n-pentane/Et2O 1/1) to a colorless oil (9.30 g, 81.9 
mmol, 99%). The diester (8.50 g, 81.0 mmol, 1.0 eq.) in CH2Cl2 (200 mL) was treated 
with BF3 OEt2 (6.00 mL, 50 mmol, 0.62 eq.) and stirred for 2 h. NEt3 (6.00 mL, 60 
mmol) was added, the mixture diluted with Et2O and filtered over celite. The filtrate was 
concentrated in vacuum, and purified by column chromatography on silica gel (n-
pentane/Et2O 95/5, 2% NEt3) to provide a viscous oil (6.05 g, 26.5 mmol, 33%). 1H 
NMR (300 MHz, CDCl3): =0.82 (s, 3H; CH3), 1.18 (t, 3J=6.1 Hz, 3H; CH3), 3.95 (s, 
6H; CH2), 4.16 (q, 3J=6.1 Hz, 2H; CH2), 6.23 (d, 3J=15.9 Hz, 1H; CH), 6.63 (d, 3J=15.9 
Hz, 1H; CH). 13C NMR (65 MHz, CDCl3): =11.6 (C), 11.9 (CH3), 28.1 (CH3), 58.1 
(CH2), 60.4 (CH2), 103.0 (C), 122.1 (CH), 136.1 (CH), 163.2 (CO). HRMS calcd. 
229.1061, found 229.1069. 
 
(E)-S-Ethyl-3-(4-methyl-2,6,6-trioxabicyclo[2.2.2]octan-1-yl)prop-2-enethioate 
6.33.21 N,N-Dicyclohexylcarbodiimide (4.10 g, 20.0 mmol, 1.33 
eq.) in CH2Cl2 (5.0 mL) was added to mono-thioethyl fumarate (1.6 
mL, 16.0 mmol, 1.07 eq.), and 2-methyl-2-oxetane methanol (2.42 
g, 15.0 mmol, 1.00 eq.) in CH2Cl2 (20 mL) at 0°C. After stirring for 
1.5 h at room temperature, the mixture was diluted with n-pentane (100 mL), filtered 
over celite and concentrated in vacuum. The crude product was purified by column 
chromatography  (n-pentane/Et2O 1/1) to a colorless oil (2.88 g, 11.8 mmol, 69%). The 
diester (2.88 g, 11.8 mmol, 1.0 eq.) in CH2Cl2 (30 mL) was treated with BF3 OEt2 (0.38 
mL, 3.00 mmol) and stirred for 2 h. NEt3 (0.56 mL, 4.00 mmol) were added, the mixture 
diluted with Et2O and filtered over celite. The filtrate was concentrated in vacuum, and 
purified by column chromatography on silica gel (n-pentane/Et2O 60/30, 2% NEt3) to 
yield a viscous oil (1.61 g, 6.59 mmol, 56%). 1H NMR (300 MHz, CDCl3): =0.82 (s, 
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6.44-6.51 (m, 2H; CH). 13C NMR (65 MHz, CDCl3): =11.6 (C), 14.3 (CH3), 23.3 
(CH3), 30.5 (CH2), 62.9 (CH2), 105.6 (C), 130.6 (CH), 134.9 (CH), 189.6 (CO). HRMS 
calcd. 245.0842, found 245.0841.  
 
(E)-Ethyl 4,4-dimethoxybut-2-enoate 6.36.22 DMSO (0.66 mL, 12.5 mmol, 1.26 eq.) in 
dry THF (3.0 mL) was added to oxalyl chloride (0.96 mL, 11.3 
mmol, 1.14 eq.) in dry THF (30 mL) at 60°C, and stirred for 3 min 
at 30°C. The mixture was cooled to -60°C, glyoxaldehyde 
dimethylacetal (1.00 mL, 9.89 mmol, 1.00 eq.) added over 5 min, and 
the mixture stirred at 30°C for 30 min. After cooling to 60°C, NEt3 (6.00 mL, 50.4 
mmol, 5.10 eq.) was added, and the mixture stirred for 1h at room temperature, and 
cooled to 60°C. Triethylphosphonoacetate (4.00 mL, 20.2 mmol, 2.02 eq.) was added 
followed by NaH (50% in mineral oil, 0.96 g, 20.0 mmol, 2.02 eq.), and the mixture was 
stirred for 16 h at room temperature. The mixture was quenched with H2O, Et2O was 
added, and the organic layer washed with brine, dried over MgSO4, and the solvent 
evaporated in vacuum. The crude product was purified by column chromatography on 
silica gel (n-pentane/Et2O 8/1) to yield a colorless oil (1.06 g, 6.12 mmol, 62%). 1H 
NMR (400 MHz, CDCl3): =1.29 (t, 3J=6.0 Hz, 3H; CH3), 3.33 (s, 3H; CH3), 4.21 (q, 
3J=6.2 Hz, 2H; CH2), 4.92-4.96 (m, 1H; CH), 6.13 (dd, 3J=15.8 Hz, 3J=1.4 Hz, 1H; CH), 
6.66 (dd, 3J=15.8 Hz, 3J=3.8 Hz, 1H; CH). 13C NMR (100 MHz, CDCl3): =14.2 (CH3), 
52.8 (CH3), 60.6 (CH2), 100.5 (CH), 124.6 (CH), 142.5 (CH), 165.8 (CO). Spectral data 
were consistent with the literature.33 
 
(E)-Ethyl 3-(5,5-dimethyl-1,3-dioxane-2-yl)acrylate 6.38.24 2,2-Dimethyl-1,3-
propanediol (0.31 g, 3.00 mmol, 2.96 eq.) and BF3·OEt2 (0.38 mL, 
3.08 mmol, 3.05 eq.) were added to (E)-ethyl 4,4-dimethoxybut-2-
enoate (60:30 trans:cis ratio; 0.15 g, 1.01 mmol, 1.00 eq.) in Et2O 
(10 mL). After stirring for 16h, the mixture was added to n-pentane 
(40 mL), washed with 1N aq. NaOH (20 mL) and brine (20 mL) and dried over MgSO4. 
The solvent was evaporated in vacuum and the crude product was purified by column 
chromatography on silica gel (n-pentane/EtOAc 90/10) to give the trans-isomer (0.15 g, 
0.68 mmol, 66%; with respect to 60% trans-starting material: 95%). 1H NMR (400 
MHz, CDCl3): =0.66 (s, 3H; CH3), 1.20 (bs, 3H; CH3), 1.28 (t, 3J=6.2 Hz, 3H; CH3), 
3.52 (d, 2J=11.2 Hz, 2H; CH2), 3.68 (d, 2J=11.2 Hz, 2H; CH2), 4.20 (q, 3J=6.1 Hz, 2H; 
CH2), 4.99 (d, 3J=2.4 Hz, 1H; CH), 6.18.(dd, 3J=16.0 Hz, 4J=0.8 Hz, 1H; CH), 6.80.(dd, 
3J=15.9 Hz, 4J=3.4 Hz, 1H; CH). Spectral data were consistent with the literature.33 
 
Ethyl 4-(ethylthio)-2-methyl-4-oxobutanoate 6.39. Purified by colomn 
chromatography on silica gel (n-pentane/Et2O 6/1) to a colorless oil 
(38 mg, 0.19 mmol, 65%). 1H NMR (400 MHz, CDCl3): =1.16-1.26 













(m, 1H; CH2), 4.13 (q, 3J=6.1 Hz, 1H; CH). 13C NMR (100 MHz, CDCl3): =14.3 (CH3), 
14.9 (CH3), 16.0 (CH3), 23.5 (CH2), 36.3 (CH2), 46.0 (CH2), 60.9 (CH2), 165.1 (CO), 
196.8 (CO). EI-HRMS [M-OEt] calcd. 159.0848, found 159.0848. EI-MS [M-OEt]=159, 
M = 143, M=115. Data were consistent with the literature.34 HPLC (OD-H, n-heptane/i-
PrOH 99.5/0.5) 15.6 (minor), 24.6 (major) min. []D20= +18 (c=0.08 in CHCl3). 
 
Ethyl 2-ethyl-4-(ethylthio)-4-oxobutanoate 6.40. Purified by column chromatography 
on silica gel (n-pentane/Et2O 6/1) to a mixture of regioisomers. 1H 
NMR (400 MHz, CDCl3): =0.90 (t, 3J=6.4 Hz, 3H; CH3), 1.24 (m, 
6H; CH3), 1.50-1.65 (m, 2H; CH2), 2.65 (dd, 4J=15.6 Hz, 3J=5.2 Hz, 
1H; CH2), 2.68-2.99 (m, 3H; CH + CH2), 4.09-4.18 (m, 2H; CH2). 13C 
NMR (100 MHz, CDCl3): =11.5 (CH3), 14.4 (CH3), 14.9 (CH3), 23.6 (CH), 25.1 (CH2), 
43.1 (CH2), 45.2 (CH3), 60.8 (CH2), 164.6 (CO), 198.0 (CO). EI-HRMS [M-OEt] calcd. 
163.064, found 163.064. EI-MS [M-OEt]=163, M = 156, M=129. HPLC (Whelk, n-
heptane/ i-PrOH 99.5/0.5) 16.8 (minor), 19.2 (major) min . 
 
Ethyl 2-(2-(ethylthio)-2-oxoethyl)-4-methylpentanoate 6.41. Purified by column 
chromatography on silica gel (n-pentane/Et2O 6/1) to a mixture of 
regioisomers (23 mg, 0.09 mmol, 36%).1H NMR (400 MHz, CDCl3): 
=0.86 (d, 3J=6.0 Hz, 3H; CH3), 0.91 (d, 3J=6.0 Hz, 3H; CH3), 1.20-
1.30 (m, 6H; CH3 + CH), 1.51-1.61 (m, 2H; CH2), 2.59-2.68 (m, 1H; 
CH), 2.83-2.95 (m, 4H; CH2), 4.14  (q, 3J=6.2 Hz, 2H; CH2). 13C 
NMR (100 MHz, CDCl3): =14.2 (CH3), 14.6 (CH3), 22.1 (CH3), 22.6 (CH3), 24.3 CH), 
25.8 (CH), 39.8 (CH2), 41.1 (CH2), 45.9 (CH2), 60.6 (CH2), 164.9 (CO), 196.6 (CO). 
HRMS [M-OEt] calcd. 201.095, found 201.094; Ms [M-OEt]=201, M = 185, M=111. 
HPLC (OD-H, n-heptane/ i-PrOH 99.5/0.5) 9.8 (minor), 13.6 (major) min. 
 
Ethylsuccinic acid diethylester 6.46 Purified by column chromatography on silica gel 
(n-pentane/Et2O 6/1). 1H NMR (400 MHz, CDCl3): =0.91 (t, 3J=6.6 
Hz, 3H; CH3), 1.20-1.28 (m, 6H; CH3), 1.51-1.61 (m, 2H; CH2), 2.40 
(dd, 4J=15.6 Hz, 3J=1.8 Hz, 2H; CH2), 2.64-2.80 (m, 2H; CH + CH2), 
4.06-4.16 (m, 3H; CH2 + CH). 13C NMR (100 MHz, CDCl3): =11.2 
(CH3), 14.1 (CH3), 14.1 (CH3), 25.0 (CH2), 35.6 (CH2), 42.2 (CH), 60.4 (CH2), 60.4 
(CH3), 161.9 (CO), 164.6 (CO). Spectral data were consistent with the literature.35 GC 
(Chiraldex G-TA) 65.4 (major), 65.8 (minor). 
 
1-tert-Butyl 4-ethyl 2-ethyl succinate 6.47. Purified by column chromatography on 
silica gel (n-pentane/Et2O 6/1) to provide a mixture of regioisomers 
(33 mg, 0.14 mmol, 56%). 1H NMR (300 MHz, CDCl3): =0.92 (t, 
3J=6.5 Hz, 6H; CH3), 1.22-1,29 (m, 6H; CH3), 1.43 (s, 9H; CH3), 
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2.56-2.66 (m, 4H; CH2), 4.08-4.21 (m, 4H; CH2). 13C NMR (65 MHz, CDCl3): =11.5 
(CH3), 14.2 (CH3), 25.6 (CH3), 29.6 (C), 36.6 (CH), 38.8 (CH2), 51.0 (CH2), 60.5 (CH2). 
126.8 (CO), 165.1 (CO). GC (CP Chiralsil Dex CB) 65.5 (major), 66.3 (minor) min. 
 
Ethyl 3-(benzyl(methyl)carbamoyl)pentanoate 6.48. Purified by column 
chromatography on silica gel (n-pentane/Et2O 2/1) to yield a 
colorless oil (21 mg, 0.08 mmol, 38%).1H NMR (300 MHz, CDCl3): 
=1.19-1.30 (m, 3H; CH3), 2.96 (s, 3H; CH3), 4.12-4.25 (m, 2H; 
CH2), 4.55-5.59 (m, 1H; CH2), 4.60-4.64 (m, 1H; CH2), 6.81 (d, 
3J=11.1 Hz, 1H; CH), 6.08-6.45 (m, 6H; CH). 13C NMR (65 MHz, CDCl3): =13.9 
(CH3), 34.8 (CH2), 50.9 (CH3), 53.3 (CH2), 126.3 (CH), 126.4 (CH), 126.9 (CH), 128.5 
(CH), 128.8 (CH), 131.4 (CH), 135.5 (CH), 136.3 (C), 164.5  (CO), 165.0 (CO). HPLC 
(OJ-H, n-heptane/ i-PrOH 95/5) 15.6 (minor), 19.2 (major) min. 
 
S-Ethyl 3-(4-methyl-2,6,6-trioxabicylco[2.2.2]octan-1-yl)pentanethioate 6.50. 
Purified by column chromatography on silica gel (n-pentane/Et2O 
6/1) to provide a colorless oil (16 mg, 0.06 mmol, 23%). 1H NMR 
(300 MHz, CDCl3): =0.66 (s, 3H; CH3), 0.88 (t, 3J=6.3 Hz, 3H; 
CH3), 1.16-1.30 (m, 5H; CH2 + CH3), 1.62-1.66 (m, 1H; CH), 2.23-
2.31 (m, 1H; CH2), 2.42 (dd, 4J=15.6 Hz, 3J=6.2 Hz, 1H; CH2), 2.81-2.90 (m, 3H; CH2), 
3.83-3.96 (m, 6H; CH2). 13C NMR (65 MHz, CDCl3): =11.6 (CH3), 14.9 (C), 16.1 
(CH3), 23.6 (CH2), 25.3 (CH2), 41.0 (CH), 43.3 (CH3), 45.2 (CH2), 66.0 (CH2), 113.3 
(C), 198.4 (CO). HRMS calcd. 265.1312, found 265.1310. HPLC (OD-H, n-heptane/ i-
PrOH 95/5) 11.3, 12.1 min. 
 
Ethyl 3-(dimethoxymethyl)pentanoate 6.51 Purified by column chromatography on 
silica gel (n-pentane/Et2O 4/1) to yield a colorless oil (43 mg, 0.21 
mmol, 82%). 1H NMR (400 MHz, CDCl3): =0.91 (t, 3J=6.6 Hz, 3H; 
CH3), 1.25 (t, 3J=6.2 Hz, 3H; CH3), 1.28-1.36 (m, 1H; CH2), 1.48-
1.60 (m, 1H; CH2), 2.15 (sextet, 3J=6.3 Hz, 1H; CH2), 2.23 (dd, 
2J=15.2 Hz, 3J=6.8 Hz, 1H; CH2), 2.41 (dd, 2J=15.4 Hz, 3J=6.2 Hz, 
1H; CH2), 3.35 (s, 3H; CH3), 3.36 (s, 3H; CH3), 4.12 (q, 3J=6.2 Hz, 2H; CH2), 4.20 (d, 
3J=5.6 Hz, 1H; CH). 13C NMR (65 MHz, CDCl3): =11.1 (CH3), 14.2  (CH2), 22.4 
(CH3), 29.6 (CH), 34.1 (CH2), 39.4 (CH3), 60.2 (CH2), 106.0 (CH), 163.4 (CO). GC 
(Chiralsil Dex CB) 82.6 (minor), 83.0 (major) min. []D20= +26 (c=0.06 in CHCl3). 
 
Ethyl 3-(dimethoxymethyl)heptanoate 6.52. Purified by column chromatography on 
silica gel (n-pentane/Et2O 4/1) to yield a colorless oil (59 mg, 0.24 
mmol, 96%). 1H NMR (400 MHz, CDCl3): =0.86 (t, 3J=6.6 Hz, 3H; 
CH3), 1.20-1.30 (m, 8H; CH3 + CH2), 2.15-2.25 (m, 2H; CH2 + CH), 




















(q, 3J=6.24. Hz, 2H; CH2), 4.18 (d, 3J=5.2 Hz, 3H; CH3). 13C NMR (100 MHz, CDCl3): 
=14.2 (CH3), 14.5 (CH3), 23.1 (CH2), 29.2 (CH2), 29.5 (CH2), 34.6 (CH), 54.5 (CH3), 
55.3 (CH3), 60.2 (CH2), 106.5 (CH), 163.6  (CO). HR-ESI-MS [M+Na] calcd. 255.1566, 
found 255.1564. GC (Chiraldex G-TA) 85.5 (minor), 85.9 (major) min. []D20= +16 
(c=0.06 in CHCl3).  
 
Ethyl 3-(dimethoxymethyl)nonanoate 6.53. Purified by column chromatography on 
silica gel (n-pentane/Et2O 4/1) to yield a colorless oil (43 mg, 0.16 
mmol, 66%).1H NMR (300 MHz, CDCl3): =0.86 (t, 3J=6.9 Hz, 3H; 
CH3), 1.16-1.34 (m, 13H; CH3 + CH2), 2.13-2.26 (m, 2H; CH2 + 
CH), 2.33-2.45 (m, 1H; CH2), 3.34 (s, 3H; CH3), 3.36 (s, 3H; CH3), 
4.05-4.20 (m, 3H; CH2 + CH). 13C NMR (65 MHz, CDCl3): =14.1 
(CH3), 14.2 (CH3), 22.6 (CH2), 26.6 (CH2), 29.5 (CH2), 31.6 (CH2),  
34.5 (CH2), 38.1 (CH2), 54.3 (CH2), 60.2 (CH3), 60.4 (CH3), 106.2 (CH), 163.4 (CO). 
GC (Chiraldex G-TA) 91.2 (minor), 92.2 (major) min. []D20= + 20 (c=0.08 in CHCl3). 
 
Ethyl 3-dimethoxymethyl)-6-methylheptanoate 6.54. Purified by column 
chromatography on silica gel (n-pentane/Et2O 4/1) to yield a 
colorless oil (39 mg, 0.16 mmol, 63%). 1H NMR (400 MHz, CDCl3): 
=0.86 (d, 3J=6.4 Hz, 3H; CH3), 0.86 (d, 3J=6.4 Hz, 3H; CH3), 1.12-
1.23 (m, 3H; CH2 + CH), 1.25 (t, 3J=6.2 Hz, 3H; CH3), 1.44-1.55 (m, 
2H; CH2), 2.12-2.52 (m, 2H; CH2 + CH), 2.40 (dd, 2J=15.0 Hz, 
3J=6.2 Hz, 1H; CH2), 3.35 (s, 3H; CH3), 3.36 (s, 3H; CH3), 4.12 (q, 
3J=6.1 Hz, 2H; CH2), 4.18 (d, 3J=5.6 Hz, 1H; CH). 13C NMR (100 MHz, CDCl3): =14.2 
(CH3), 22.4 (CH3), 22.6 (CH3), 26.3 (CH2), 28.3 (CH), 34.4 (CH2), 36.0 (CH2), 38.3 
(CH2), 54.3 (CH3),  55.2 (CH3), 60.1 (CH2), 106.2 (CH), 163.4 (CO). HR-ESI-MS 
[M+H+] 269.1623, found 269.1621. GC (Chiraldex G-TA) 88.3 (minor), 92.5 (major) 
min. []D20= +24 (c=0.05 in CHCl3). 
 
Ethyl 3-(dimethoxymethyl)-5-phenylpentanoate 6.55. Purified by column 
chromatography on silica gel (n-pentane/Et2O 4/1) to yield a 
colorless oil (38 mg, 0.14 mmol, 56%). 1H NMR (400 MHz, CDCl3): 
=1.26 (t, 3J=6.2 Hz, 3H; CH3), 1.55-1.65 (m, 1H; CH2), 1.68-1.90 
(m, 1H; CH2), 2.23-2.35 (m, 2H; CH2 + CH), 2.49 (dd, 2J=14.6 Hz, 
3J=5.4 Hz, 1H; CH2), 3.32 (s, 3H; CH3, 3.35 (s, 3H; CH3), 4.13 (q, 
3J=6.1 Hz, 2H; CH2), 4.23 (d, 3J=5.6 Hz, 3H; CH3), 6.14-6.34 (m, 3H; CH), 6.24-6.31 
(m, 2H; CH). 13C NMR (100 MHz, CDCl3): =14.2 (CH3), 31.5 (CH3), 33.2 (CH), 34.4  
(CH2), 36.8 (CH2), 54.3 (CH3), 55.0 (CH3), 60.2 (CH2), 106.0 (CH), 125.6 (CH), 128.3 
(CH), 128.3 (CH), 142.2 (C), 163.1 (CO). HR-ESI-MS [M+Na] calcd. 303.1566, found 
303.1568; HPLC (OD-H, n-heptane/ i-PrOH 99/1) 16.6 (minor), 19.0 (major) min. 
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Ethyl 3-(5,5-dimethyl-1,3-dioxan-2-yl)pentanoate 6.56. Purified by column 
chromatography on silica gel (n-pentane/Et2O 6/1) to yield a 
colorless oil (53 mg, 0.22 mmol, 86%). 1H NMR (300 MHz, 
CDCl3): =0.68 (, 3H, CH3), 0.90 (t, 3J=6.5 Hz, 3H; CH3), 1.14 (s, 
3H; CH3), 1.23 (t, 3J=6.1 Hz, 3H; CH3), 1.26-1.42 (m, 1H; CH2), 
1.46-1.63 (m, 1H; CH2), 2.01-2.14 (m, 1H; CH2), 2.22 (dd, 2J=15.6 
Hz, 3J=6.2 Hz, 1H; CH2), 2.56 (dd, 2J=15.6 Hz, 3J=6.3 Hz, 1H; CH2), 3.35 (dd, 2J=11.0 
Hz, 3J=4.4 Hz, 2H; CH2), 3.56 (d, 2J=10.8 Hz, 2H; CH2), 4.10 (q, 3J=6.1 Hz, 2H; CH2), 
4.41 (d, 3J=3.3 Hz, 1H; CH). 13C NMR (65 MHz, CDCl3): =11.5 (CH3), 14.2 (CH2), 
21.6 (CH3), 22.5 (CH3), 22.9 (CH2), 30.1 (CH), 33.6 (CH2), 41.2 (CH3), 60.0 (CH2), 
(66.1 (CH2), 66.1 (CH2), 102.4 (CH), 163.5 (CO). HPLC (OB-H, n-heptane/ i-PrOH 
100/0) 9.3 (major), 11.1 (minor) min.  
 
3-tert-Butoxycarbonylamino-pentanoic acid ethyl ester 6.60.24,28 A solution of CrO3 
(8.0 mg, 0.08 mmol, 0.25 eq.), H5IO6 (0.13 g, 0.57 mmol, 1.8 eq.) 
and H2O (17 L) in MeCN (2.0 mL) was added to acetal 6.51 (65 
mg, 0.32 mmol, 1.0 eq.) in MeCN (2.0 mL) at 0°C. After strirring for 
1.5 h at 0°C, the mixture was warmed to room temperature and 
continued to stir for 1h. H2O (10 mL) and EtOAc (10 mL) were added, and the organic 
layer was extracted with EtOAc (3 x 10 mL), dried over MgSO4 and concentrated in 
vacuum. The crude reaction mixture was filtered over silica gel (n-pentane/EtOAc 1/1) 
and concentrated in vacuum to give carboxylic acid 6.59 (52 mg, 0.30 mmol, 93%). tert-
Butanol (2.0 mL), NEt3 (0.67 mL, 1.5 mmol, 5.0 eq.) and diphenylphosphoryl azide 
(0.67 mL, 0.31 mmol, 1.1 eq.) were added to the carboxylic acid (52 mg, 0.30 mmol, 1.0 
eq.) and the mixture heated to 75°C. After heating overnight, the solvent was removed in 
vacuum, and the crude product was attempted to be purified by column chromatography 
on silica gel (CH2Cl2, up to 0.5% MeOH) to yield a yellow oil. 1H NMR (400 MHz, 
CDCl3): =0.88 (t, 3J=7.4 Hz, 3H; CH3), 1.13-1.25 (m, 12H; CH3), 1.38-1.45 (m, 1H; 
CH2), 1.47-1.56 (m, 1H; CH2), 2.49 (d, 3J=5.6 Hz, 1H; CH), 2.81-2.94 (m, 2H; CH2), 
4.09 (q, 3J=6.9 Hz, 2H; CH2), 6.09 (s, 1H; NH). Impurities =1.13-1.25, 1.59-1.66, 2.62-
2.96, 3.88-3.97, 6.92-7.02, 7.12-7.40. Data were consistent with the literature.36  
 
Ethyl-3-tert-butoxycarbonylamino-2-methyl-propionate 6.58.37,28 To thioester 6.39 
(51 mg, 0.25 mmol, 1.0 eq.) in THF (0.75 mL) and H2O (0.25 mL), 
LiOH (55 mg, 2.3 mmol, 9.1 eq.) and 30% aq. H2O2 solution (0.40 
mL, 3.9 mmol, 16 eq.) were added at 0°C. After 30 min, 1N aq. HCl 
(5 mL) was added, and the aqueous layer extracted with Et2O (3 x 5 mL). The combined 
organic layers were dried over MgSO4 and concentrated in vacuum. The crude product 
was dissolved in toluene (5.0 mL), NEt3 (0.67 mL, 1.5 mmol, 5.0 eq.) and 













heated to 100°C for 16 h. The solvent was removed in vacuum, tert-butanol (2.0 mL) 
and NEt3 (0.70 mL, 1.5 mmol) were added, and the mixture heated to 75°C for 16h. The 
solvent was evaporated in vacuum, and the crude product was attempted to be purified 
by column chromatography on silica gel (CH2Cl2, up to 0.5% MeOH) to yield a yellow 
oil. 1H NMR (400 MHz, CDCl3): =1.10-1.28 (m, 12H; CH3), 3.16-3.35 (m, 2H; CH2), 
3.38-3.58 (m, 1H; CH), 4.13 (q, 3J=6.9 Hz, 2H; CH2). Impurities =1.30-1.34, 2.65-2.74, 
3.16-3.35, 3.38-3.58, 7.12-7.35. Data were consistent with the literature.38 
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Veel chemische reacties vinden plaats in de aanwezigheid van katalysatoren, b.v. 
overgangsmetalkatalysatoren, of biokatalysatoren. Het gebied van katalyse was in de 
laatste vijftig jaar van groot belang voor de synthese van farmaceutica en andere 
biologisch actieve stoffen. Basiscomponenten van organische verbindingen zijn de 
elementen koolstof, waterstof, zuurstof en stikstof. Koolstof kan met chemische 
bindingspartners maximaal vier bindingen aangaan. Zijn deze substituenten niet identiek 
dan heeft het koolstofatoom een stereocentrum, wat er voor zorgt dat het hele molecuul 
chiraal is. Een molecuul is chiraal als het verschillend van zijn spiegelbeeld is. Twee 
spiegelbeelden van moleculen, die niet op elkaar afgebeeld kunnen worden, worden 
enantiomeren genoemd. De synthese van enantiomeerzuivere verbindigen is een 
belangrijke taak voor scheikundigen en is relevant voor de bereiding van medicijnen, 
smaakstoffen, parfums en agrochemicaliën. De stereochemische informatie wordt in een 
gekatalyseerde asymmetrisch reactie van de katalysator op het product overgedragen. 
Asymmetrische katalyse heeft veel voordelen ten opzichte van het gebruik van 
enantiomeerzuivere natuurstoffen. Een voorbeeld van een van deze voordelen is dat 
maar een kleine hoeveelheid katalysator gebruikt hoeft te worden om een grote 
hoeveelheid uitgangsstof asymmetrisch om te zetten tot een chiraal product. 
Biokatalysatoren, bijvoorbeeld enzymen, zijn interessant voor chemische synthese: het 
zijn niet giftige, natuurvriendelijke katalysatoren die vaak in water kunnen worden 
gebruikt. Enzymgekatalyseerde reacties vinden normaal onder zeer milde condities 
plaats. Soms kunnen enzymen ook opnieuw gebruikt worden voor dezelfde omzetting. In 
vergelijk met overgangsmetalen zijn enzymen echter zeer substraatspecifiek, dit betekent 
dat veel substraten niet geaccepteerd worden door het enzym. Doel van dit proefschrift is 
om nieuwe en efficiënte methodes te ontwikkelen voor de synthese van -aminozuren 
vanuit goedkope uitgangsstoffen gebruikmakend van enzym- en overgangsmetaal-









Schema 1. Synthese van -aminozuren. 
-Aminozuren zijn belangrijke bestanddelen van peptides, peptidomimetica en andere 
natuurstoffen. Daarnaast zijn het essentiële bouwstenen voor de synthese van 
medicijnen. Sommige -aminozuren bezitten biologische activiteit en andere belangrijke 
farmacologische eigenschappen maar meestal worden ze gebruikt als bouwstenen in het 
ontwerp van nieuwe moleculen met biologische en farmacologische functies.  
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In hoofdstuk 1 worden katalytische asymmetrische methoden beschreven die in de 
recente literatuur voor de synthese van -aminozuurderivaten gebruikt zijn. Hoofdstuk 2 
beschrijft studies om het enzym aspartaat ammoniak lyase (AspB) van het organisme 
Bacillus sp. YM55-1 voor de geconjugeerde additie van ammoniak aan fumaarzuur te 
gebruiken. Dit enzym is gebruikt voor de synthese van N-gesubstitueerde 
asparaginezuurderivaten door middel van Michael additie van hydroxylamine, 
hydrazine, methoxylamine en methylamine aan fumaarzuur. De producten van deze 
reactie worden geïsoleerd en gekarakteriseerd om te laten zien dat AspB al deze reacties 
met uitstekende enantioselectiviteit (97%) katalyseerd. De brede specificiteit voor 
verschillende nucleofielen en de hoge katalytische activiteit zorgen ervoor dat AspB een 
belangrijk enzym voor de synthese van N-gesubstituteerde asparaginezuur derivaten is. 
Deze derivaten zijn belangrijke bouwstenen voor de synthese van peptiden en 








Nu = NH3, H2NOH, H2NNH2, MeNH2, MeONH2  
Schema 2. AspB-gekatalyseerde synthese van N-gesubstitueerde asparaginezuur derivaten.  
Hoofdstuk 3 beschrijft experimenten met het enzym phenylalanine amino mutase (PAM) 
van de boom Taxus chinensis. Dit enzym is een katalysator voor de stereoselective 
isomerisatie van - naar -aminozuren. Mechanistische studies hebben laten zien dat 
kaneelzuur een tussenproduct in deze isomerisatie is. In dit hoofdstuk wordt de additie 
van ammoniak aan kaneelzuurderivaten onderzocht, waarbij - en -aminozuren met 
uitstekende enantioselectiviteit (>99%) worden gesynthetiseerd. Substraten met ortho-
substituenten vormen selectief -aminozuren omdat sterische hindering de vorming van 
-aminozuren verhindert. -Aminozuren worden in overmaat (>90%) uit 
kaneelzuurderivaten met donorsubstituenten in para-positie en, in mindere mate, uit 
derivaten met donorsubstituenten in meta-positie gevormd. Als substraten met 









-aminozuur -aminozuur  
Schema 3. Synthese van - en -aminozuren gekatalyseerd door PAM. 
In hoofdstuk 4 worden aldehyde-selectieve Wacker oxidaties van allylische phthalimide-
beschermde amines beschreven. De Wacker oxidatie is een belangrijk industrieel en 
synthetisch proces om alkenen om te zetten. De aldehyde-selectieve Wacker oxidatie is 
deel van een nieuwe katalytische route naar -aminozuren. Er zijn echter weinig 
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voorbeelden waarbij het aldehyde selectief gevormd wordt. Tot op heden is de 
palladium-gekatalyseerde anti-Markovnikov Wacker oxidatie een belangrijk onopgelost 
probleem. In dit project werd aangetoond dat allylische phthalimide-beschermde amines 
selectief tot aldehydes geoxideerd kunnen worden. Hierbij werden PdCl2 in combinatie 
met CuCl of Pd(MeCN)2Cl(NO2) in combinatie met CuCl2 als katalytische systemen 
bestudeerd. De aminoaldehydes worden in uitstekende opbrengst gevormd (95%) met 
een grote substraattolerantie. Vervolgens werden -aminozuren door oxidatie van het 


















Schema 4. Aldehyde-selectieve Wacker oxidatie voor de synthese van -aminozuren. 
Het doel van het project beschreven in hoofdstuk 5 was om een Curtius omlegging van 
thioesters uit te voeren zonder deze vooraf te hydroliseren. Op deze manier moesten 
vanuit de thioesters amines geproduceerd worden. Helaas is het niet gelukt hiervoor een 







Schema 5. Curtius rearrangement van thioesters. 
Hoofdstuk 6 beschrijft de koper-gekatalyseerde asymmetrische additie van Grignard 
reagentia aan diesters, oxathiolen en acetaal-esters. De producten van deze reactie zijn 
essentiële bouwstenen voor natuurstoffen en farmaceutica. Voor deze reactie wordt 
Josiphos (L) als chiraal ligand gebruikt. Hoge enantioselectiviteit werd voor de additie 
van verschillende Grignard reagentia verkregen. De additie van methylmagnesium 
bromide aan het oxathiol verliep met hoge enantioselectiviteit (95%). Voor de meer 
reactieve Grignard reagentia werd het acetaal-ester als substraat gebruikt om hoge 
enantioselectiviteit te verkrijgen. -aminozuur derivaten werden vervolgend verkregen 











R1=CO2Et, R2=Me, X=S: 65%, 95% ee








Viele chemische Reaktionen werden durch Katalysatoren beschleunigt. Diese können 
Übergangsmetalle in Verbindung mit organischen Molekülen (Liganden), kleine 
organische Moleküle alleine (Organokatalysatoren) oder Enzyme (Biokatalysatoren) 
sein. Das Fachgebiet der Katalyse war in den letzten fünfzig Jahren von großer 
Bedeutung für die Synthese von pharmazeutischen Wirkstoffen und anderen biologisch 
aktiven Substanzen.  Grundbestandteile organischer Verbindungen sind die Elemente 
Kohlenstoff, Wasserstoff, Sauerstoff und Stickstoff. Kohlenstoff in chemischen 
Verbindungen kann bis zu vier Bindungen mit Substituenten formen. Falls diese 
Substituenten nicht identisch sind, besitzt das Kohlenstoffatom ein stereogenes Zentrum, 
d. h. das gesamte Molekül ist chiral. Eine Verbindung wird als chiral bezeichnet, wenn 
sie sich von ihrem Spiegelbild unterscheidet, wie z. B. die menschlichen Hände. Zwei 
Spiegelbilder, die sich nicht aufeinander abbilden lassen, werden als Enantiomere 
bezeichnet. Die Synthese von enantiomerenreinen Substanzen ist eine wichtige Aufgabe 
für Chemiker und relevant für die Herstellung von Medikamenten, Geschmacksstoffen, 
Parfüms and Agrochemikalien. Die asymmetrische Katalyse, in der chirale 
Katalysatoren benutzt werden, hat viele Vorteile gegenüber der Verwendung von 
Ausgangsstoffen aus dem ‚chiral Pool’. So werden im Vergleich zu den 
Ausgangsmaterialien nur kleine Mengen des Katalysators benötigt, außerdem wird die 
Reaktionsgeschwindigkeit beschleunigt und die stereogene Information durch den 
Katalysator induziert. Der Katalysator beschleunigt ebenfalls die 
Reaktionsgeschwindigkeit. Biokatalysatoren sind interessant für die chemische 
Synthese: Sie sind ungiftige, grüne Katalysatoren, unbedenklich für die Umwelt; Wasser 
wird normalerweise als Lösungsmittel gebraucht; zudem finden enzymkatalysierte 
Reaktionen oft unter sehr milden Bedingungen statt. In einigen Fällen können die 
Enzyme sogar wiederverwendet werden. Im Vergleich zu Übergangsmetall-
Katalysatoren sind Enzyme jedoch sehr spezifisch, d. h. nur wenige Substrate werden 
akzeptiert. Ziel dieser Dokorarbeit war es, Enzym- und Übergangmetall-katalysierte 
Reaktionen zu untersuchen, um neue und effiziente Methoden für die Synthese von -









Schema 1. Synthese von -Aminosäuren. 
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-Aminosäuren sind wichtige Bestandteile von Peptiden, Peptidmimetika und anderen 
Naturstoffen und daher essenzielle Bausteine für die Synthese von Medikamenten. 
Einige -Aminosäuren zeigen eine eigene biologische Aktivität und eine interessante 
pharmakologische Wirkung.  
In Kapitel 1 der Dissertation werden katalytisch asymmetrische Methoden beschrieben, 
die seit 2002 für die Synthese von -Aminosäuren eingesetzt wurden. Kapitel 2 
beschreibt den Einsatz des Enzyms Aspartat Ammoniak Lyase (AspB) des Organismus 
Bacillus sp. YM55-1. Dieses Enzym wird zur Herstellung von N-substituierten 
Asparaginsäurederivaten durch die Michael-Addition von Hydroxylamin, Hydrazin, 
Methoxylamin und Methylamin an Fumarsäure genutzt (Schema 2). Die Produkte dieser 
Reaktion werden mit ausgezeichneter Enantioselektivität (>97%) erhalten. Der breite 
Anwendungsbereich verschiedener Nukleophile und die hohe katalytische Aktivität 
zeigen, dass AspB ein vielversprechendes Enzym für die enantioselektive Synthese von 
N-substituierten Asparaginsäurederivaten ist, die als Bausteine in der Peptid- und 








Nu = NH3, H2NOH, H2NNH2, MeNH2, MeONH2  
Schema 2. AspB-katalysierte Synthese von N-substituierten Asparaginsäurederivaten. 
Kapitel 3 behandelt Versuche zur Nutzung des Enzyms Phenylalanin Amino Mutase 
(PAM) vom Baum Taxus chinensis. Dieses Enzym wird als Katalysator für die 
stereoselektive Isomerisation von -Aminosäuren zu -Aminosäuren beschrieben. Dabei 
zeigten mechanistische Untersuchungen, dass die Zimtsäure eine Zwischenstufe dieser 
Isomerisierung ist. In diesem Kapitel wird die Addition von Ammoniak an 
Zimtsäurederivate untersucht, welche zu - und -Aminosäuren führt (Schema 3). 
Untersuchungen im Hinblick auf die Affinität (Km) des Enzyms für seine Substrate 
zeigen, dass eine kleine hydrophobische Tasche um die ortho-Position des Substrates 
herum vorhanden sein könnte, und dass eine größere Tasche um die para-Position herum 
existieren könnte, die Substrate mit langen aliphatischen und unverzweigten Ketten 
toleriert. Substrate mit ortho-Substituenten führen sehr selektiv zu -Aminosäuren, da 
eine sterische Hinderung die Bildung von -Aminosäuren verhindert. Diese werden im 
Überschuss (>90%) aus Zimtsäuren mit Donorsubstituenten in der para-Position und in 
geringeren Maßen in der meta-Position gebildet. Wenn Substrate mit 











-Aminosäure -Aminosäure  
Schema 3. Synthese von - und -Aminosäuren katalysiert durch PAM. 
In Kapitel 4 werden Aldehyd-selektive Wacker-Oxidationen von Phthalimid geschützten 
allylischen Aminen beschrieben. Die Wacker Oxidation ist ein wichtiger industrieller 
und synthetischer Vorgang, um Olefine selektiv zu Methylketonen umzusetzen. Bis 
heute bleibt die Palladium-katalysierte anti-Markownikow Wacker Oxidation ein großes 
ungelöstes Problem. In dieser Arbeit wurde gezeigt, dass Phtalimid geschützte allylische 
Amine selektiv zu Aldehyden oxidiert werden können. In dieser Wacker Oxidation 
wurden PdCl2 und CuCl oder Pd(MeCN)2Cl(NO2) und CuCl2 als Katalysatorsysteme 
studiert. Die -Aminoaldehyde haben eine ausgezeichnete Ausbeute (bis zu 94%), 
zusätzlich weist die neue Oxidationsmethode eine hohe Substratbandbreite auf. Die 




















Schema 4. Aldehyd-selektive Wacker Oxidation für die Synthese von -Aminosäuren. 
Das Ziel des Projektes, wie in Kapitel 5 beschrieben, war es, einen Curtius-Abbau an 
Thioestern durchzuführen, ohne diese vorher zur Carbonsäure zu hydrolisieren. Auf 
diese Weise sollten Amine aus den Thioestern hergestellt werden. Es ist jedoch nicht 







Schema 5. Curtius Abbau von Thioestern. 
In Kapitel 6 wird die Kupfer-katalysierte asymmetrische Addition von Grignard- und 
Dialkylzink-Reagenzien an Diester, Oxathiole und Acetal-Ester dargestellt. Die Produkte 
dieser Reaktionen sind wesentliche Bausteine von Naturstoffen und Pharmazeutika. Als 
chiraler Ligand wird hierfür Josiphos benutzt. Hohe Enantioselektivitäten werden durch 
die Addition verschiedener Grignard-Reagenzien erzielt. Die Addition von weniger 
reaktivem Methylmagnesiumbromid an Oxathiole erfolgt mit hoher Enantioselektivität 
(95%). Für andere reaktivere Grignard-Reagenzien wird der Acetal-Ester als Substrat 
verwendet, um hohe Enantioselektivitäten (65-96%) zu erreichen. Die 
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Carbonsäurederivate der Produkte werden nach einem Curtius Abbau zu -
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Schema 6. Konjugierte Addition von Grignard-Reagenzien an ,-ungesättigte Carbonylverbindungen. 
Diese Arbeit behandelt die Entwicklung neuer katalytischer Methoden für die 
Herstellung von -Aminosäuren, sowohl durch Biokatalyse als auch durch 
Übergangsmetallkatalyse. Diese Methoden werden für den stereoselektiven Aufbau von 
C-N und C-C Bindungen verwendet und für die regioselektive Synthese von C-O 
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